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Abstract
Background
Aphasia is a neurological condition that affects the expression and/or comprehension of
language and can have considerable impact on a person’s quality of life. Treatment for aphasia from
speech language pathologists is effective. However, more information is needed on the nature of
effective intervention including consideration for what therapy is provided, when it is commenced and
how it is delivered. Treatment fidelity is concerned with ensuring research treatment protocols are
implemented as they were intended, which assists in uncovering the specifics of how and why
treatments work. When treatment fidelity is investigated thoroughly, researchers and research
consumers can be confident of the research findings. Increased confidence in the highest level of
evidence may improve research translation and ultimately improve the delivery of services to people
with aphasia. Treatment fidelity within aphasia research is receiving increasing attention as greater
rigour is applied to clinical trials. Each publication in this thesis addresses a different aspect of
treatment fidelity within an aphasia randomised controlled trial including treatment integrity,
differentiation, dosage and reporting of usual care therapy provision.
Methods
A published literature review of the reporting of treatment fidelity in aphasia randomised
controlled trials is presented in Chapter Three. For the remaining studies, data was collected using an
observational study design involving the analysis of therapy videos collected within the Very Early
Rehabilitation in SpEech (VERSE) trial. VERSE was a multicentre randomised controlled trial that
investigated whether intensive aphasia therapy was more effective and cost saving than usual care in
very early aphasia recovery after stroke. Within the trial, therapists video recorded therapy sessions in
the prescribed therapy conditions. Fifty three of these therapy videos were randomly selected
comprising 12% of the total received in the trial. Therapy videos were transcribed and coded
according to the aims of this thesis. Using this data, treatment differentiation and integrity is
investigated statistically in Chapter Five. Dosage, is quantified by the number of active ingredients
present within each session and is described using a model of cumulative intervention intensity in
Chapter Six. In Chapter Seven, descriptive data is presented for the Usual Care-Plus therapy arm
according to the Template for Intervention Description and Replication (TIDieR) statement
Results
The literature review reports nine (21%) of forty-two aphasia randomised controlled trial
articles explicitly reporting treatment fidelity. From the video analysis, therapists in the VERSE arm
of the study were found to be highly adherent to the treatment protocol however, treatment
differentiation between trial arms was not established in this sample. Total verbal utterances and cues
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used with success were independent positive predictors of outcome at six months post stroke and
hypothesized as key therapeutic ingredients of the trial treatments. According to a model of
cumulative intervention intensity, collectively, these key ingredients occurred over 10,000 times per
participant during the treatment period. Usual care therapy provision according to the TIDieR
statement was documented and showed considerable variability in task selection and therapists
producing the majority of verbal utterances during sessions.
Conclusions
This thesis provides a detailed insight into the aphasia interventions delivered within the
VERSE trial to assist in the interpretation of the trial outcomes. It documents the current status of
treatment fidelity reporting in aphasia randomised controlled trials and provides recommendations for
measuring treatment fidelity in future research. These include the suggestion that significant attention
should be given to operationalising treatment fidelity procedures, using piloting to establish active
ingredients, prior to the commencement of the main trial. This work also heightens the general
understanding of therapy provision for aphasia. The challenge for further developing the methodology
for measuring dosage in aphasia rehabilitation is set.
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Chapter 1: Thesis Overview
1.1 Treatment Fidelity
Treatment fidelity is at the heart of research. Through fidelity processes researchers can
rigorously monitor treatment design and implementation procedures to facilitate the interpretation of
results and maximise the impact of the investigation. Treatment fidelity includes components such as
treatment integrity, treatment differentiation and treatment receipt. The most consistently used
definition of treatment fidelity is the degree to which the administration of a treatment corresponds to
the specified protocol for the implementation of that treatment (Kadervak & Justice, 2010). However,
rather than encapsulating the broader sense of treatment fidelity, this definition addresses the
treatment integrity aspect of treatment fidelity. Treatment differentiation, a second aspect of a broader
view of treatment fidelity, is concerned with ensuring that treatments given within the intervention
protocol are sufficiently different from each other. Treatment fidelity is also concerned with
describing the intervention arms in detail including how therapy is implemented and why components
of therapy were selected. Documenting fidelity involves investigating the impact of elements such as
therapeutic active ingredients and their delivered dosage on therapy effectiveness (Kaderavek &
Justice, 2010). Establishing treatment integrity and differentiation relies on the specification of core
treatment ingredients. It is multifaceted and each publication within this thesis addresses a different
aspect of treatment fidelity. Definitions will be discussed throughout the literature review and
publications in detail.

1.2 Aphasia
Aphasia is an impairment using or comprehending language after a significant brain event
such as a stroke. It affects approximately 30% of people post stroke and has considerable impacts on a
person’s recovery within hospital, social and vocational pursuits and general quality of life (Engelter
et al., 2006; Pedersen, Jorgensen, Nakayama, Raaschou, & Olsen, 1995). Treatment for aphasia
following stroke from speech language pathologists (SLPs) is effective, however research has not
answered questions related to the what, when and how specifics of therapy. As such, research into the
recovery from aphasia has been identified as one of the top ten research priorities related to life after
stroke (Pollock, St George, Fenton, & Firkins, 2012). Priorities for aphasia research that are addressed
here include: i) increasing treatment fidelity reporting in aphasia, ii) building a body of evidence on
the optimal intervention intensity for aphasia interventions and iii) describing usual care practices.

1.3 Significance of the Research
Developing a greater understanding of treatment fidelity and the processes involved in
assessing fidelity is important for researchers who are developing, trialling and analysing the
effectiveness of interventions. This thesis provides an update on treatment fidelity reporting in aphasia
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(Brogan, Ciccone, & Godecke, 2019). A greater understanding of treatment fidelity is also important
for research consumers including patients, therapists and other stakeholders. Sound incorporation of
treatment fidelity processes can increase the researcher’s confidence that the intervention outcomes
are due to the effect of treatment (Rixon et al., 2016). It may also increase the therapist’s confidence
in the research findings and the knowledge they are implementing an evidenced based treatment as it
was intended. Research stakeholders would like to know that treatments are thoroughly investigated
and due diligence has been performed. The papers in this thesis report therapy fidelity from a subset
of an aphasia randomised controlled trial (RCT) to assist research consumers with their interpretation
of the trial results. Future behavioural research may be helped by the method piloted in this research
for measuring treatment integrity and differentiation in a complex behavioural intervention. The
ultimate aim of aphasia research is to build a body of evidence for therapies to add value to the service
that SLPs provide. Thorough therapy fidelity reporting will assist in answering questions about why
therapy works and what makes one treatment different from another. The dosage analysis undertaken
in this thesis aims to further the theoretical debate about key ingredients within aphasia therapy. It is
hoped that this will assist therapists to make decisions about the constituents of aphasia therapy and
the therapy regimen and will result in better outcomes for People with Aphasia (PWA). It will also
help in the development and interpretation of clinical guidelines for aphasia.

1.4 Aims
This research is concerned with completing a thorough treatment fidelity analysis of an
aphasia intervention. The aims are addressed through data sourced from the Very Early Rehabilitation
in SpEech (VERSE) RCT and are outlined below:
1. To provide an update on current treatment fidelity practices and reporting within aphasia
RCTs.
2. To report and interpret the treatment integrity from a subset of the treatment delivered in the
VERSE RCT.
3. To investigate utterance level treatment differentiation from a subset of the high intensity
treatment delivered in the VERSE RCT.
4. To provide a thorough dosage analysis (number of therapeutic inputs and client acts) of
sessions from a subset of the treatment delivered in the VERSE RCT.
5. To document and describe usual care practices for aphasia therapy through observational data.

1.5 Thesis Outline
This thesis is divided into nine chapters including four chapters that are presented as articles for
publication. The chapters already published and submitted for publication are presented in the style of
the selected journal. However, to assist the cohesion and readability of the thesis, table and figure
numbers, headings, references, and general formatting have been continued throughout.
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•

Chapter One: Thesis overview
This chapter provides a brief background into aphasia, treatment fidelity, the significance and

aims of the research and an outline of the thesis chapters.
•

Chapter Two: Introduction
This chapter provides a general review of the literature and key concepts for the thesis. Detailed

focused literature reviews are provided at the beginning of each publication and in the review
publication.
•

Chapter Three: Treatment fidelity in Aphasia Randomised Controlled Trials
Chapter Three is a published literature review of treatment fidelity in aphasia randomised

controlled trials.
•

Chapter Four: Methodological Overview
Chapter Four provides an overview of the VERSE RCT, which provided the participants for this

study, as well as presenting the methodological approach to this research.
•

Chapter Five: Treatment Integrity and Differentiation in the Very Early in SpEech (VERSE)
trial
This study investigated treatment fidelity of the trial including a detailed analysis of the

components of treatment integrity and treatment differentiation in 53 videos.
•

Chapter Six: An Exploration of Aphasia Therapy Dosage in the First Six Months of Stroke
Recovery
Chapter Six explores the concept of dosage in aphasia therapy using a subset the VERSE RCT

data in order to provide a detailed analysis of the behavioural components within therapy sessions
including which key active ingredients were delivered. This chapter proposes an extension of the
definition of dosage that considers the number of times a behaviour is completed within the therapy
sessions, rather than reporting dosage as a factor of time alone.
•

Chapter Seven: Behind the Therapy Door: What is ‘Usual Care’ Aphasia Therapy in Acute
Stroke Management?
This study examined therapy provision including therapy type, therapeutic inputs and the dosage

(as defined in Chapter Six) of these in usual care therapy within Australia.
•

Chapter Eight: Other Results
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Chapter Eight presents additional results from this work, including the location therapy took
place, the therapy tasks completed specifically within the VERSE arm and dosage measures by
aphasia classification, that are not included in the publications.
•

Chapter Nine: Final Discussion
The final chapter pulls together and discusses the key findings and conclusions of this research

and outlines the implications for the study, the study limitations and presents future directions of the
research.
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Chapter 2: Introduction
A summary of the key literature related to the main concepts of this thesis is reported here.
The introduction begins broadly with the concept of treatment fidelity and how it is applied and
reported in research. Next, aphasia treatment in research, and the scope of this work is introduced.
The two topics are then combined with treatment fidelity in aphasia research and the key theoretical
models that will be used to explore this further. Additional detailed literature reviews are provided at
the beginning of each publication.

2.1 Treatment Fidelity
2.1.1 Concept
At a basic level, treatment fidelity is concerned with the degree to which a protocol and the
treatment delivered within the intervention match (Kaderavek & Justice, 2010). Definitions have
broadened over the last twenty years reflecting an increased complexity of research and the
importance placed on treatment fidelity (Borrelli et al., 2005). Consideration for treatment fidelity
processes should be incorporated when designing a study, when measuring what exactly happened
during the intervention and when reporting the findings.
Conceptually, Moncher and Prinz (1991) defined treatment integrity and treatment
differentiation as the two main components within treatment fidelity. Treatment integrity refers to the
extent to which the treatment is given as intended and monitors if therapists drift from the treatment
protocol. Treatment differentiation ensures that the intervention and control groups are sufficiently
different on key therapy ingredients. These concepts have been used in the second publication of this
thesis which addresses treatment integrity and differentiation in a subset of the VERSE RCT sample.
The concept of treatment fidelity can also be extended beyond that of integrity and differentiation to
consider what happened within the therapy(ies) provided. While treatment integrity considers how
well the intervention matched what was intended, an examination of the therapy provided may also
allow for a more detailed exploration of the active ingredients of therapy as implemented within the
study and provide new or unexpected insight into the therapy(ies). Central to treatment fidelity is the
examination of active ingredients and the dosage with which these are provided to describe how and
why the intervention brings about outcomes (Kaderavek & Justice, 2010).
Strengthening the implementation of treatment fidelity processes in clinical trials assists in
determining that interventions are delivered as per the study protocol, and that the integrity of the
treatment is preserved. Studies with high levels of fidelity have increased external and internal
validity and are likely to be more replicable and comparable to other treatment research (Hildebrand
et al., 2012; Moncher & Prinz, 1991; Resnick et al., 2005; Schlosser, 2002). Recognising this, the
importance of assessing treatment fidelity has been emphasized in recent guidelines and
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recommendations for evaluating complex interventions (Rixon et al., 2016). However, treatment
fidelity has not always been reported consistently in the literature. For example Borrelli et al., (2005)
found that 54% of health behaviour change studies did not report on intervention fidelity. To help
standardise the use and reporting of treatment fidelity processes, the treatment fidelity workgroup of
the National Institutes of Health Behaviour Change Consortium (Bellg et al., 2004) made
recommendations for addressing treatment fidelity in behaviour change studies. These
recommendations addressed five main areas: study design, training providers, delivery of treatment,
receipt of treatment and enactment of treatment skills (Bellg et al., 2004). Each of these areas has
associated treatment fidelity goals for researchers to address (Bellg et al., 2004). A more detailed
explanation of this work is provided in section 2.4 Key frameworks. The recommendations provide a
comprehensive way to conceptualise treatment fidelity and are commonly used within intervention
studies (O’Shea, McCormack, Bradley, & O’Neill, 2016). Gearing (2011) has also provided a
framework for treatment fidelity identifying four core components from articles that addressed
treatment fidelity. The framework is sequential in nature moving from study design, provider training,
monitoring intervention delivery and monitoring intervention receipt. A lack of uniformity was
highlighted in the way researchers use and define treatment fidelity concepts and that different
researchers place different weights on aspects of treatment fidelity processes (Gearing et al., 2011).
This does not reflect that treatment fidelity is imperative across all stages and phases of research
(Gearing et al., 2011). Gearing’s (2011) framework has not been as widely used in the literature as
Bellg et al.’s (2004) goals (O’Shea et al., 2016).
2.1.2 Application of treatment fidelity in general research
Despite understanding of the importance of implementing treatment fidelity processes within
an intervention study, the uptake of treatment fidelity recommendations is poor across behavioural
interventions. Checklists for rating treatment adherence based on training manuals and therapist
training are frequently used. Direct observation of treatment sessions using a priori coding categories
according to the potential factors or key therapy elements that are identified in the study design is
considered to be the objective gold standard (Kaderavek & Justice, 2010). This serves the purpose of
monitoring treatment integrity and collecting data for treatment differentiation (Hildebrand et al.,
2012). Some studies have successfully implemented the recommendations and lead the way for
incorporating treatment fidelity from the study design phase (Damschroder et al., 2016; Hildebrand et
al., 2012; Seng & Lovejoy, 2013; Thomas et al., 2016). These are explained below.
In a protocol publication for an investigation into Behavioural Action Therapy for Depression
after Stroke (BEADS) (Thomas et al., 2016) treatment fidelity has been incorporated within the study
design phase with key therapy elements identified during the planning phase enabling treatment
adherence to be monitored. A customised therapy record form has been created to capture key therapy
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elements and purposefully sampled video recordings have been watched and analysed using this
record form.
Implementation of treatment fidelity processes was seen in research completed by Hildebrand
and colleagues (2012) into an enhanced medical rehabilitation intervention. The authors published
their enhanced medical rehabilitation adherence and competence rating form which was used by
independent members of the research team to rate sixty therapy videos (Hildebrand et al., 2012). A
checklist was developed that clearly highlighted the components of their intervention and researchers
tallied the frequency with which the therapists performed key behaviours. The therapist’s competence
on these behaviours was also rated on a scale. In monitoring treatment adherence the researchers
clearly specified the components of their intervention which is central to measuring the integrity of a
treatment. The mean times a behaviour occurred and the mean competence scores were presented as
measures of adherence to the core treatment components. These scores were compared to those of
standard care interventions for treatment differentiation showing significantly higher frequency of
core therapy elements and competence in the enhanced medical rehabilitation group (Hildebrand et
al., 2012). Recommendations from their study included: i) the development of short video clips to
illustrate appropriate treatment techniques; and ii) in person observation together with video recorded
monitoring in order to prevent therapist drift (Hildebrand et al., 2012).
Damschroder et al. (2016) developed and validated a checklist for assessing fidelity in a
weight loss RCT. Within the study, the ASPIRE Coaching Fidelity Checklist was developed to assess
the degree to which the intervention protocol was followed during weight loss coaching sessions.
Classical test theory was used which assumes there is a true score on a measure but also that there will
be a degree of error. A checklist was used to rate adherence by the coaches to the main components of
coaching sessions. The researchers specified three main components of the coaching intervention and
then linked these to outcomes in a first step towards identifying the “active ingredients” of the
approach (Damschroder et al., 2016). Analysing the active ingredients of the intervention addressed
one of the most difficult but essential aspects of treatment fidelity. Knowledge of these key
therapeutic elements means the intervention can be replicated in other contexts.
The SAFER study implemented high quality therapy fidelity processes to evaluate the effect
of motivational interviews to reduce sexual risk behavioural in people living with HIV (Seng &
Lovejoy, 2013). A treatment integrity code was developed in the design stage of the trial, as a system
to assess treatment fidelity. A 20 minute segment of the motivational interviews was recorded and
transcribed. Clinician utterances were coded as adherent or non-adherent over 170 sessions. The trial
demonstrated that greater adherence to motivational interviewing was associated with fewer reported
unprotected sex acts by study participants after treatment. Therefore, greater integrity to the treatment
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was beneficial for participants. Inter-rater reliability of the treatment integrity code was addressed
with interclass correlation coefficients in excess of 0.90.
2.1.3 Reporting of treatment fidelity in general research
Treatment fidelity information should be included in detailed treatment descriptions. When
this information is not included it is difficult to distinguish between poor reporting and poor
implementation. This is not unique to treatment fidelity but applies to treatment descriptions in
general (Hoffmann, Erueti, & Glasziou, 2013). The Template for Intervention Description and
Replication (TIDieR) (Hoffmann et al., 2014) was developed to improve intervention description
quality by giving researchers a framework with which to describe interventions. It includes general
items related to the therapy such as task selection, therapy location and dosage (although it is not
specified dosage is defined). The checklist is explained in detail in 2.4 Theoretical models. The
checklist can be used as a measurement of the completeness of treatment descriptions. In a review of
reporting standards in communication partner training 71% of studies addressed half the TIDieR
checklist items (Cruice, Blom Johansson, Isaksen, & Horton, 2018).
The poor reporting of treatment fidelity has been emphasised to encourage greater
incorporation of treatment fidelity in publications (Bakas, McCarthy, & Miller, 2017; O’Shea et al.,
2016; Rixon et al., 2016). Within the broader stroke rehabilitation literature most papers have only
reported one aspect of fidelity such as dose, frequently reported as the session duration (Walker et al.,
2017). As many trials do not report all the procedures implemented around treatment fidelity it is hard
for research consumers to know whether procedures were implemented but not reported or neither
implemented nor reported. TIDieR includes the explicit mention of treatment fidelity in items 11 and
12 for planned and actual treatment fidelity respectively (Hoffmann et al., 2014). Item 11 suggests
describing how adherence of fidelity was assessed and item 12 refers to describing the extent to which
the actual intervention was delivered as planned. Although these sections have been criticized for
lacking practical detail (O’Shea et al., 2016), they encourage researchers to give consideration to
treatment fidelity in their intervention descriptions.
Many studies across disciplines do not report treatment fidelity within their results
publications. Only two of ten studies reported on treatment fidelity in an update on the state of the
evidence for stroke family caregiver and dyad interventions (Bakas et al., 2017). One of the best
designed studies incorporated and reported on treatment fidelity (Bakas et al., 2015). In a review of 65
physiotherapy intervention papers O’Shea et al. (2016) reported that most papers limited their
treatment fidelity processes to protocol adherence only. While the most commonly used definition of
treatment fidelity was that provided by Bellg et al., (2004), only 3% of studies included all five areas
from Bellg et al., (2004) and overall reporting of treatment fidelity was poor (O’Shea et al., 2016).
Similar findings of poor treatment fidelity reporting have been identified in other disciplines such as
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occupational therapy (Persch & Page, 2013). Research agendas have emphasized that the optimal dose
(with a consistent definition), frequency and salient elements of the interventions be identified.
Additionally, Turkstra, Norman, Whyte, Dijkers, and Hart (2016) recommended treatment be
specified using three elements of treatment theory – targets, ingredients and mechanisms of action
within SLP reporting.
Treatment fidelity specific protocol and results papers have been published more recently
reflecting the increased priority of planning for treatment fidelity processes within research
(Carragher et al., 2019; Kladouchou, Papathanasiou, Efstratiadou, Christaki, & Hilari, 2017;
McLennon et al., 2016; Resnick et al., 2011). It is becoming an increasingly presented topic at
conferences (Behn et al., 2018; Godecke et al., 2015; M. Rose et al., 2017). Comprehensive treatment
fidelity descriptions in standalone papers reflects the increased understanding and priority of
treatment fidelity. For example, McLennon et al., (2016) compared treatment fidelity among
treatment arms in the Telephone Assessment and Skill-building Kit study for stroke caregivers (TASK
II). The areas of treatment fidelity investigated were protocol adherence, intervention dosage (defined
as duration) and nurse intervener perspectives. Intervention dosage was measured by the number of
minutes caregivers spent reading materials and talking with the nurse. A 27 item checklist was used
for monitoring audio recordings of the phone calls. Receipt of the intervention was determined
through focus groups gaining the perspectives of the nurses. This study mapped how treatment fidelity
was addressed using Bellg et al., (2004) areas in a diagram and the researchers reported 80% protocol
adherence. The researchers also acknowledged that intervention adherence was frequently only
measured in the intervention arm and not in the control groups and that monitoring of differentiation
was infrequently completed.
A treatment fidelity specific protocol was also published in an investigation of whether
patients with chronic stroke who underwent task oriented treadmill training could motor learn and
improve cardiovascular fitness (Resnick et al., 2011). The publication included the design of the
study, the training of interventionists (therapy protocol, observations of the intervention, experienced
therapists supervising less experienced), delivery (48% of the sample reached the study goal of
exercising at 60-70% of their maximum heart rate), 20 random observations using a checklist across
both control and intervention conditions, receipt of the training (log of participants attending). This
study incorporated treatment fidelity in all of Bellg et al., (2004) goals and followed through with
publishing the protocol. The protocol addressed complex issues related to treatment fidelity such as
staff turnover and potential cross exposure between treatment conditions. The study used the
treatment fidelity analysis to help interpret the neutral finding with confidence. The reporting of the
exact dosage (time spent in the intervention and the heart rate achieved) that was attained in the study
(not the planned dosage) enabled greater external validity. The dosage given produced a 51% increase
in peak effort treadmill walking velocity (Resnick et al., 2011).
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2.2 Aphasia Recovery
Aphasia is an acquired language disorder that may affect all domains of language (production
and comprehension of verbal and written language) and commonly occurs after stroke. It affects
approximately 30% of the 16.9 million stroke survivors each year (Bejot, Daubail, & Giroud, 2016)
and has major implications for daily living and social participation (Ali, Lyden, & Brady, 2015).
Increased age and severity of initial stroke have been associated with poor recovery however,
technological advances in stroke management such as thrombolysis has been associated with
improved recovery (Ali et al., 2015). PWA experience longer stays in hospital, greater morbidity and
mortality than stroke survivors without aphasia (Ellis, Simpson, Bonilha, Mauldin, & Simpson, 2012).
Aphasia is often a chronic condition and can persist, in at least a quarter of people, three months after
stroke (Ali et al., 2015). In monetary terms, this is costly and estimated at AUD$49.3 billion globally
based on the length of stay in hospital (Ellis et al., 2012).
SLPs are trained to provide intervention to PWA. SLP therapy typically involves complex
interventions for a heterogeneous population which means the interventions i) have many
components, ii) may require extended practice by those receiving the intervention and iii) show
inconsistent outcomes (Doogan, Dignam, Copland, & Leff, 2018; van de Sandt-Koenderman, van der
Meulen, & Ribbers, 2012). Behavioural therapy for impairments after a lesion aim not to cure but to
maximise the capacity of the damaged networks to re-learn (Murphy & Corbett, 2009). It is clear that
experience and learning alter the brain at a synaptic level (Varley, 2011). This is the level at which
restorative therapy is hypothesized to work in PWA. The main therapy approaches used within SLP
interventions are: i) impairment based (restoring linguistic processing through linguistic treatment); ii)
functional (achieving an optimal level of communication given deficits); iii) participant orientated
(dealing with the consequence of aphasia by removing social barriers); or iv)
pharmacological/instrumental (for example aiming to enhance the brain’s responsiveness by using
equipment such as transcranial direct current stimulation, however, these interventions are still in the
experimental phase) (van de Sandt-Koenderman et al., 2012; World Health Organization, 2001). Most
clinicians argue that all of these treatment types have a role in speech therapy and therapists may be
eclectic and use a combination of treatments at any time in recovery (Verna, Davidson, & Rose,
2009). This is one reason that evaluations of aphasia treatments, in particular those provide to
participants in control groups, are complex because usual care may include multiple treatments within
one session.
Therapists make treatment decisions taking into account the PWA’s impairment level,
environment and personal goals. Accounting for all of these factors, many therapists choose a holistic
or functional approach to therapy (Verna et al., 2009). This may be influenced by the Cochrane
review that indicates the provision of SLP treatment is favoured, however one treatment has not been
identified as being superior to other treatments (Brady, Kelly, Godwin, Enderby, & Campbell, 2016).
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In Australia there isn’t a universal aphasia pathway let alone treatment practice (Foster, Worrall,
Rose, & O’Halloran, 2016). Therefore, despite the number of guidelines available and the content of
these, much remains unknown about what happens behind the therapy door for treatment of aphasia
(Foster, Worrall, et al., 2016).
Helping people with aphasia achieve their goals requires, at least in part, a focus on therapy
time, or the amount of practise required to improve their language ability (Palmer, Witts, & Chater,
2018). A therapist may deliver therapy through the implementation of treatments tasks. The type of
therapy given in these tasks is a key research consideration. Therapists expect that the tasks they use
will be the foundation of change in the patient, however, true evidence for the mechanism of action
behind therapies is rare (Ratner, 2006). Dosage of key ingredients, rather than the session duration, is
one aspect of therapy to be investigated. The optimal treatment dosage in aphasia rehabilitation is
unknown (Dignam 2015) and there is a dearth of literature on optimal intervention intensity across
many areas in speech language pathology including aphasia (Baker, 2012; Off, Griffin, Spencer, &
Rogers, 2016). There is no consensus on the definition for dosage in behavioural intervention
research.

2.3 Treatment Fidelity and Aphasia
Treatment fidelity reporting in aphasia specifically has been investigated in a seminal paper.
Hinckley and Douglas (2013) completed a review of articles that were published between 2002-2011
and reported that 14% of the 149 studies reviewed, including single case through to RCT designs,
reported on treatment fidelity. No apparent upward trend towards an increase in reporting over the ten
year publication period was identified. As a result of their findings the authors called for journals to
firm up guidelines for reporting treatment fidelity as a requirement for publication. More recently,
treatment fidelity within the context of TIDieR has been investigated across all SLP practice areas
including aphasia (Ludemann, Power, & Hoffmann, 2017). This study found a higher rate of
treatment fidelity reporting, in comparison to the Hinckley and Douglas (2013) study, with 46% of
studies reporting on treatment fidelity (Ludemann et al., 2017). However, methodological differences
between the two studies, such as using different treatment fidelity checklists, mean that it is not
directly comparable with Hinckley and Douglas (2013). Examination and reporting of assessment
fidelity seems more widely completed than treatment fidelity. Richardson, Dalton, Shafer, and
Patterson (2016) reported 57% of the 88 aphasia studies reviewed provided information related to
assessment fidelity.
Currently, there are aphasia trials underway that have published research protocols which
include treatment fidelity procedures. They are also using the current gold standard technique of video
recording therapy sessions and assessing these according to a priori criteria. These studies include the
Aphasia Action Success Knowledge (ASK) trial (Worrall et al., 2016), the Very Early Rehabilitation
11

in SpEech (VERSE) trial (Godecke et al., 2013), Predicting and Promoting Sub-acute Aphasia
Recovery (PAPAR) (Copland, 2017), SUpporting well-being through PEeR-Befriending (SUPERB)
trial (Behn et al., 2018) and the COMPARE trial (M. Rose et al., 2017). Other studies such as BIG
CACTUS (Palmer et al., 2015) have advantages with computerised therapy in accruing fidelity data
via logs without relying on therapist report or monitoring therapist participant interactions. This will
assist in addressing intensity compliance during practice, however further procedures will be required
to describe how the participants practiced (Ball, de Riesthal, & Steele, 2018). The incorporation of
therapy fidelity procedures in current trials is reflective of an increased focus on reporting treatment
fidelity in aphasia and including more rigorous procedures in the study design and evaluation.

2.4 Key Frameworks
Key theoretical models are outlined below to provide a foundation for their use throughout
the thesis. These include i) the TIDieR checklist for intervention descriptions ii) a treatment fidelity
specific framework (Bellg et al. 2004) and iii) models of dosage in behavioural interventions (Warren
et al. (2007) and Baker (2012). Finally, these frameworks have been incorporated figuratively to
represent the aims of this study and provide a visual linking of treatment fidelity concepts.
2.4.1 Template for Intervention Description and Replication (TIDieR) (Hoffmann et al., 2014)
Guidelines such as the Template for Intervention Description and Replication (TIDieR)
(Hoffmann et al., 2014) have been developed to encourage more complete reporting and transparency
of treatments and to address the “remarkably poor” (p. 1) intervention description quality. Checklists
such as TIDieR (Table 1.) provide a framework which can be used to describe interventions provided
within a study. The instructions for TIDieR state that it should be used to describe all interventions
not just the main one under investigation. The quality of intervention descriptions needs to be
improved across all conditions including the control group (Hoffmann & Walker, 2015). To develop
the TIDieR checklist, a steering committee combined potential items from CONSORT and relevant
checklists and then established consensus. The use of a checklist such as TIDieR has been emphasised
in complex therapy interventions such as those for people after stroke and it has been used in stroke
rehabilitation studies as a systematic way to describe the interventions (van Vliet, Hunter, Donaldson,
& Pomeroy, 2016). The TIDieR checklist includes general items related to the therapy such as task
selection, therapy location and dosage as well as treatment fidelity specific items 11 and 12 for
planned and actual treatment fidelity respectively (Hoffmann et al., 2014). The TIDieR checklist has
been used throughout this thesis particularly in relation to reporting the methodology used within the
studies and describing the control condition of the VERSE RCT.
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Table 1. TIDieR checklist in brief (Hoffmann et al., 2014)
Item Number

Item

Detail

1

Brief Name

Provide the name or a phrase that describes the
intervention

2

Why

Describe any rationale, theory, or goal of the elements
essential to the intervention

3

What - Materials

Describe any materials used in the intervention and
where they can be accessed

4

What - Procedures

Describe each of the procedures, activities, and/or
processes used in the intervention

5

Who Provided

Describe the expertise of the interventionists

6

How

Describe the modes of delivery of the intervention

7

Where

Describe the types of locations where the intervention
occurred

8

When and How much

Describe the number of times the intervention was
delivered and over what period of time

9

Tailoring

If the intervention was planned to be personalised or
adapted then describe how

10

Modifications

If the intervention was modified during the course of
the study describe the changes

11

How Well – Planned

If intervention adherence or fidelity was assessed,
describe how

13

12

How Well - Actual

If intervention adherence or fidelity was assessed
describe the extent to which the intervention was
delivered as planned

2.4.2 Bellg et al.’s (2004) treatment fidelity areas and goals
The Treatment Fidelity Workgroup of the National Institutes of Health Behaviour Change
Consortium reviewed 15 health behaviour research studies in order to identify the treatment fidelity
strategies used within these studies. From the review, the Working Group made recommendations
regarding how these strategies could be incorporated within other research projects (Bellg et al.,
2004). The recommendations address five broad categories, these are: study design, training
providers, delivery of treatment, receipt of treatment and enactment of treatment skills. An
explanation for each of these categories and their associated goals is provided in Table 2. These
recommendations have been used as framework throughout this thesis. In particular the areas of
delivery and receipt of treatment are addressed. The goals provide a comprehensive way to
conceptualise treatment fidelity and are commonly used (O’Shea et al., 2016). More detail can be
found in the original publication (see (Bellg et al., 2004)) and throughout this thesis.
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Table 2. Bellg et al.’s (2004) treatment fidelity areas and goals
Area

Goal

Study Design

Ensure same treatment dose within conditions

Ensures the study can adequately test hypotheses Ensure equivalent dose across conditions
in relation to theory and clinical processes.

Plan for implementation setbacks

Training providers

Standardise training

Assessing and improving the training of

Ensure provider skill acquisition

treatment providers to ensure they are trained to

Minimise therapist drift

deliver the intervention.
Accommodate provider differences
Delivery of treatment

Control for provider differences

Treatment fidelity processes that monitor and

Reduce differences within treatment

improve delivery of the intervention so that it is

Ensure adherence to protocol

delivered as intended.
Minimise contamination between conditions
Receipt of treatment

Ensure participant comprehension

Monitors ability of patients to understand and

Ensure participant ability to use cognitive

perform treatment-related behaviours during

skills

treatment delivery.

Ensure participants ability to perform
behavioural skills

Enactment of treatment skills

Ensure participant use of cognitive skills
Ensure participant use of behavioural skills
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Processes to monitor and improve the ability of
patients to perform treatment related behavioural
skills in real life settings.

2.4.3 Warren et al. (2007) concept of intervention intensity
Warren, Fey and Yoder (2007) called for behavioural scientists to adopt a similar approach to
pharmacological studies and investigate therapeutic effects for different dosage levels. To assist with
this they proposed a comprehensive model for defining dosage and calculating cumulative
intervention intensity which is outlined in Table 3. This model is unique in that it requires researchers
to specify the key active ingredients of their treatments. Documenting fidelity involves investigating
therapy effectiveness including defining key ingredients and the dosage with which these ingredients
are delivered (Kaderavek & Justice, 2010). This model has been used in the second and third
publication included in this thesis.
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Table 3. Terms and definitions from Warren et al. (2007) concept of intervention intensity
Term

Definition

Dose form

The task or activity within which the teaching episodes are
delivered. Teaching episodes occur during a task or activity
and contain the important active ingredients of intervention.
For example, in aphasia treatment this would include word
drills, picture naming, word to picture matching.

Dose

The number of times an active ingredient or a teaching
episode containing a unique combination of active
ingredients occurs per session. To determine the dosage rate,
session duration is also required. For example 30 words said
per minute.

Dose frequency

The number of intervention sessions per unit of time, such as
per day, per week or per month. For example, five sessions
per week.

Total intervention duration

The total period of time in which a particular intervention is
provided. For example, 12 weeks.

Cumulative intervention intensity

This is a calculation of the product of dose x dose frequency
x total intervention duration. For example, 100 production
practice trials x 3-times per week x 10 weeks = 3000 trials.

2.4.4 Baker (2012) model of therapeutic inputs and client acts that comprise SLP interventions
Baker (2012) extended the work of Warren et al., (2007) by considering both therapeutic
inputs and client acts as active ingredients within the intervention intensity model. Learning within
therapy sessions is concerned with both the client acts and the therapeutic inputs from the therapist
(Kleim & Jones, 2008) and this, along with dose, or how often these ingredients occur, is reflected in
the model. In aphasia therapy client acts are the target behaviours from the PWA and therapeutic
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inputs are the techniques used by the therapist to induce these behaviours. This model has been used
predominantly in the third publication concerning dosage however, references to therapeutic inputs
and client acts are throughout the thesis. Dosage has been conceptualised throughout this thesis using
these two models (Baker, 2012; Warren et al., 2007) and unless otherwise specified refers to the
number of times key ingredients (therapeutic inputs and client acts) occur within a session.

Figure 1. Baker (2012) model of SLP interventions
2.4.5 Integration of research aims and key frameworks
The TIDieR checklist (Hoffmann et al., 2014) and Bellg et al., (2004) treatment fidelity areas
have been used as a conceptual framework throughout this thesis. Figure 2. maps these concepts to the
aims of this thesis. The relationship between treatment fidelity areas is complex. Specifying
therapeutic inputs and client acts and the dosage of these ingredients is not a category of treatment
fidelity itself. However, it is essential for all areas of treatment fidelity. Primarily, this research is
focused on the delivery and receipt of treatment (Bellg et al., 2004) and both of these are concerned
with the therapy ingredients and dosage, or the number of times these ingredients occur in a session.
These components are used to measure treatment integrity and differentiation.
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TIDieR 11a

TIDieR 12a

Planned

Design of Studyb
Within VERSE RCT

Actual

Provider Training b

Delivery of Treatment

Within VERSE RCT

b

In VERSE-TFc

Treatment Integrity

Monitor protocol
adherence to
therapy ingredients

Treatment
Differentiation

Monitor difference
between groups in
therapy ingredients
and dosage

Receipt of Treatment

b

Enactment of Treatment b

In VERSE-TFc

Within VERSE RCT

Ability to perform
behavioural skills

Specify therapy
ingredients

Dosage of ingredients
(number of therapeutic
inputs and client acts)

Specify dosage
of ingredients
received
Figure 2. Thesis aims and conceptual frameworks
a

TIDieR Checklist (Hoffmann et al., 2014)

b

Bellg et al. (2004) treatment fidelity areas

c

VERSE-TF refers to this doctoral study
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2.5 Very Early Rehabilitation in SpEech (VERSE) Trial
The data for this PhD is drawn from the VERSE RCT. The context of the trial is important in
understanding the content of this work. The VERSE RCT was the largest, and first international
clinical trial to assess the effectiveness of aphasia therapy in the early post stroke recovery period
(Godecke et al., 2016). It was prospective, randomised, open-label, blinded trial with an endpoint at
12 weeks post stroke (PROBE design) and funded by the National Health and Medical Research
Council (NHMRC). The primary aim was to investigate whether intensive aphasia therapy was more
effective and cost saving than usual care training in very early aphasia recovery after stroke (Godecke
et al., 2016). The secondary hypothesis was that a prescribed intensive intervention would be more
effective than non-prescribed intensive intervention. The trial aimed to provide evidence for the
provision of early intensive therapy and for the specific VERSE treatment, helping to address areas in
the Cochrane Review that indicate there is “insufficient evidence within this review to establish the
effectiveness of one SLT theoretical approach over another” (Brady et al., 2016, p. 51). Details of the
VERSE protocol are provided in the method section and throughout the publications in this thesis.
The main findings of the VERSE RCT add to the context of this PhD. Communication
outcomes were equivalent for usual care therapy and early intensive therapy at 12 and 26 weeks post
stroke (Godecke et al., 2018). That is, the outcomes of early aphasia therapy, commenced within 15
days post stroke and completed within 50 days post stroke, was equivalent across all arms of the trial
when measured at 12 and 26 weeks post stroke. Specifically the outcomes of therapy within the usual
care arm, which provided an average of 9.5 hours of therapy across the intervention period, was
equivalent to therapy provided in the intensive arms which provided an average at 21 hours of therapy
across the intervention period. Usual care was documented to be two to three SLP therapy sessions
per week for approximately thirty minutes and this resulted in improved communicative ability after
stroke as measured by the outcome on the Western Aphasia Battery Revised – Aphasia Quotient
(WABR-AQ) (Kertesz, 2006). Intensive intervention did not cause harm but did not provide a
statistically significant or clinically meaningful benefits to patients. This provides valuable evidence
that intensive aphasia intervention does not enhance aphasia recovery in the early post stroke period.
Additionally, the findings suggest that models are needed to explain language recovery during this
period of recovery, as language recovery in the early phase post stroke, appears to be different to both
chronic aphasia recovery and motor recovery models.
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Foreword to Chapter 3
Title of publication: ‘Treatment fidelity in aphasia randomised controlled trials’
Hinckley and Douglas’s seminal paper in 2013 reported that of the 149 studies reviewed, 14%
reported on treatment fidelity. During the period of their review (2002-2011) significant progress was
made in guiding treatment fidelity methodology (Hildebrand, 2018). Recommendations were
developed by the treatment fidelity workgroup of the National Institutes of Health Behaviour Change
Consortium (Bellg et al., 2004). Bellg et al.’s (2004) recommendations provided a comprehensive
way to address treatment fidelity within intervention. Additionally, since Hinckley and Douglas
published in 2013 the TIDieR checklist (Hoffmann et al., 2014) has been released. Both of these
encourage more complete reporting and transparency of treatment fidelity elements. The paper
presented in this chapter provides an update on the reporting and implementation of treatment fidelity
practices in aphasia RCTs since 2012.
This chapter is published in Aphasiology:
Brogan, E., Ciccone, N., and Godecke, E (2019): Treatment fidelity in aphasia randomised controlled
trials, Aphasiology, 33(7), 759-779: 10.1080/02687038.2019.1576442
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Chapter 4: Methodological Overview
4.1 Design
This observational study utilised video recorded therapy sessions collected as part of the
VERSE RCT. Hereafter, the labels Very Early Rehabilitation of SpEech-Randomised Controlled Trial
(VERSE RCT) and Very Early Rehabilitation of SpEech, Treatment Fidelity study (VERSE TF) refer
to the VERSE trial and this study respectively.

4.2 VERSE RCT
The VERSE RCT provides the broader setting for VERSE TF which is detailed here. The
VERSE RCT was undertaken by Godecke et al. (2016) and was an international, multicentre RCT that
complied with the CONSORT statement (Schulz, Altman, & Moher, 2010) for non-pharmaceutical
trials. VERSE RCT was a prospective, randomised, single-blinded trial conducted across 17 acutecare hospitals across Australia/New Zealand. Participants were randomised to one of three groups:
Usual Care, Usual Care-Plus and VERSE. Therapy commenced within 15 days post stroke and was
completed within 50 days post stroke. All participants received usual care while the participants
randomised to the Usual Care-Plus and VERSE arms received usual care and an additional 20
sessions of direct aphasia therapy completed over four weeks. A description of the three intervention
arms of the trial is provided below.
4.2.1 Therapy
The interventions provided in the trial were as follows:
i)

Usual Care: Participants randomised to this group received intervention that was typical for
aphasia management and was at the discretion of the treating SLP. Usual care treatment may
also have included management of other speech pathology impairments such as dysphagia,
dysarthria and/or dyspraxia. However, only direct aphasia therapy time was included in the
analysis for the primary VERSE RCT result. Usual care therapy was recorded over a period
of 20 working days.

ii) Usual Care-Plus: Participants received treatments typical of direct aphasia therapy, at the
discretion of the treating SLP, but with a defined therapy regimen of daily sessions for 45-60
minutes duration over 20 sessions. Direct aphasia therapy included 1:1 impairment based
therapy, impairment based computer training, social training, group impairment based
therapy, group social training or Augmentative and Alternative Communication (AAC)
training.
iii) VERSE intervention: The intensity of this arm of therapy matched that of the Usual Care-Plus
arm but the intervention was prescribed and standardised according to a specific VERSE
intervention protocol. As per treatment fidelity recommendations, significant consideration was
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given when planning the prescribed intervention to highlight theoretical underpinnings,
allowing these to be monitored and evaluated. This intervention was founded on principles of
promoting neurorecovery through targeted early intensive language therapy. The main
principles that guided the VERSE prescribed intervention were: i) massed practice, ii) errorfree learning, iii) task complexity, iv) salience, and v) maximising communicative success. The
therapy protocol contained target goal levels based on aphasia severity to encourage output
from single word to conversation level.
4.2.2 Trial therapists
Therapists for usual care were qualified SLPs or therapy assistants employed by the
participating facility. In the Usual Care-Plus and VERSE arms of the trial SLPs were hired
specifically for the trial and were required to be eligible for membership to Speech Pathology
Australia. All usual care, Usual Care-Plus and VERSE treating SLPs underwent training (three hours)
and received procedural and training manuals relevant to the arm of therapy they were providing.
Clinical support was provided by trial clinical staff as required throughout the trial. VERSE therapists
were then given additional training (two hours) to administer the prescribed therapy.
4.2.3 Participants
Individuals were recruited to the VERSE RCT if they had aphasia secondary to an acute
ischaemic stroke or intracerebral haemorrhage, were 18 years of age or over, had corrected hearing
and vision, were medically stable at or before 14 days post stroke and could participate in aphasia
therapy in English without the need for an interpreter. Exclusion criteria included pre-existing aphasia
on admission to hospital, a history of progressive neurological disease, neurosurgery or major
depression, subdural or subarachnoid haemorrhage, and an inability to maintain alertness for 30
consecutive minutes at 14 days post stroke. VERSE RCT recruited 246 participants, 81 in Usual Care,
82 in Usual Care-Plus and 83 in VERSE. Recruitment was completed in February 2018 and the last
participant visit was undertaken in August 2018.
4.2.4 Setting
Within the VERSE RCT, participants were recruited from one of 17 sites across Australia and
New Zealand. These sites included Joondalup Health Campus, Fremantle Hospital, Cairns Hospital,
Royal Melbourne Hospital, The Alfred Hospital, Albury-Wodonga Health, St Vincent’s Hospital,
Concord Repatriation General Hospital, St George Hospital, the Prince of Wales Hospital, Sir Charles
Gairdner Hospital, Fiona Stanley Hospital, Gold Coast Hospital, Royal North Shore Hospital, Royal
Price Alfred Hospital and Christchurch and Taraunga Hospitals in New Zealand. Therapy occurred at
hospital if the participant was an inpatient, their residential facility or personal home once the
individual was discharged from hospital.
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4.2.5 Randomisation
Once recruitment and baseline assessments were completed, participants were randomised to
either the Usual Care, Usual Care-Plus or VERSE arms of the trial using the Research Electronic Data
Capture (REDCapTM ) system (Harris et al., 2009). REDCapTM is a secure web based application
designed to support data capture for research studies. This system complied with regulatory
requirements such as the FDA Code of Federal Regulations Title 21 CFR part 11 (electronic records).
Randomisation involved a computer generated block pattern and stratification for aphasia severity
based on the baseline Aphasia Quotient (AQ) component of the revised Western Aphasia Battery
Revised (WABR) (Kertesz, 2006) score. Participants were allocated a participant number and all data
were de-identified. All participants were required to commence therapy within 24 hours of
randomisation.
4.2.6 Outcome measures
Participants were assessed at baseline, 12 and 26 weeks post stroke on a range of impairment
based, psychosocial and economic outcome measures as seen in Table 6. Assessments at 12 and 26
weeks were performed by an independent blinded assessor at the hospital site or participants’
residential address. The primary outcome measure for the VERSE RCT was the WABR-AQ at 12
weeks. Secondary outcome measures include the Boston Naming Test (BNT)(Kaplan, Goodglass, &
Weintraub, 2000), discourse analysis (Nicholas & Brookshire, 1995), Stroke and Aphasia Quality of
life questionnaire (SAQOL-39) (Hilari, Byng, D.L, & Smith, 2003) and the Aphasia Depression
Rating Scale (ADRS) (Benaim, Cailly, Pelissier, & Perennou, 2004). All baseline, 12 and 26 week
assessment data, information regarding Usual Care clinical management and all treatment data (Usual
Care-Plus and VERSE therapies) was entered into REDCapTM (Harris et al., 2009).
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Table 6. VERSE outcome measures
Assessment Measure

Time post stroke Days (weeks)

Data collection/Outcome

Baseline Assessment

1 to 14 (0-2)

Demographic and stroke information,
WABR-AQ, BNT, discourse
collection.

Primary end point

84 (12)

WABR-AQ, BNT, Discourse
collection, ADRS, SAQoL-39,
Participant Diary (for cost
evaluation)

Follow up

182 (26)

WABR-AQ, BNT, Discourse
collection, ADRS, SAQoL-39,
Participant diary (for cost evaluation)

4.2.7 Therapy fidelity
To ensure treatment fidelity a number of processes were included within the VERSE RCT.
Therapists from both the Usual Care-Plus and VERSE arms of the trial participated in standardised
therapist training and were required to log therapy sessions and video record sessions. The therapy
fidelity monitor checked that therapy for both groups was commenced on or before day 15 post stroke
and the intervention period did not exceed 50 days post stroke. The duration and frequency of each
session was also monitored to ensure it was 45-60 minutes of direct aphasia therapy, for a maximum
of five sessions per week for 20 sessions within a maximum of 25 working days after baseline
assessment. VERSE intervention therapists received a specific therapy manual and received one on
one support in order to implement the therapy as prescribed. VERSE and Usual Care-Plus therapists
were required to video record one therapy session per week, resulting in four to five recordings per
participant. For practical reasons it was suggested to therapists to video record session numbers five,
ten, 15 and 20 however, therapy videos for any session were accepted. Video recording of usual care
sessions was optional for therapists. The therapy fidelity monitor reviewed videos of the treatment
sessions to ensure the prescribed VERSE protocol targets were met. The therapy fidelity monitor and
therapy fidelity co-ordinator were responsible for providing feedback to the therapists about any
deviations from the VERSE protocol and to respond to any general questions that had arisen about the
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treatment procedures. A summary of the areas of TF investigated by the broader VERSE RCT is
provided in Appendix C.

4.3 VERSE TF
4.3.1 Randomisation and selection of videos
For VERSE TF therapy videos were selected at random to comprise the sample for these
analyses. Each participant in the intensive arms of VERSE RCT (Usual Care-Plus and VERSE) had
videoed therapy sessions that were added to the pool for randomisation. Participants from the VERSE
RCT were eligible to be included in VERSE TF if they had a primary outcome measure (12 week
dependent outcome measure score), had completed the full treatment protocol (completed 20 therapy
sessions) and did not contain the present author as the therapist. Microsoft Excel (2016) was used for
the selection of a block randomisation sample of videos with randomisation stratified by aphasia
severity (WABR-AQ) and group (VERSE or Usual Care-Plus). The randomisation was completed by
the therapy fidelity monitor who was not involved in VERSE TF. As the VERSE RCT trial continued
to receive videos throughout the VERSE TF study, randomisation for the VERSE TF study was
completed in blocks of six videos (one from each therapy group and severity) to ensure that recent
VERSE RCT trial videos were included. A total of 9 randomisations were completed. The sample was
balanced for therapy group and aphasia severity as determined by the WABR-AQ at baseline.
Following the completion of the VERSE TF randomisation process selected video recordings
were transferred from the VERSE RCT database to an external hardrive. All video recordings were
stored securely, in a locked filing cabinet when not in use, supplied by Edith Cowan University, in
accordance with their data management policy (policy code PL049 [ac076]).
After randomisation, videos were screened to ensure they were at least 40 minutes in duration
and playable on Windows Media Player. In total, 66 videos were screened and 13 videos were
eliminated for the reasons outlined in Figure 5. The final sample comprised 53 randomly selected
therapy videos across 44 different participants. Of the 53 videos selected through randomisation seven
participants had two videos in the sample (total 14 videos), one participant had three videos in the
sample (total 3 videos) and the remaining 36 participants had one video each (total 36 videos). This
resulted in the inclusion of 44 different participants. Forty-eight videos were balanced for aphasia
severity at baseline and therapeutic group and used in conjunction with their dependent outcome
measures for the correlational analysis outlined in Chapter 6. The remaining five videos did not have
both a three and six month outcome measure and so were included in all analyses other than
correlational. This study analysed the treatment delivered to 44 (27%) of the total participants
included in the intensive arms of the VERSE RCT trial (Usual Care-Plus and VERSE) and 53 (12%)
of the total available 434 therapy videos received through the trial. Further videos were not analysed
due to the time consuming nature of the analysis and the constraints of the project timeline.
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Figure 5. Exclusion of videos
4.3.2 Participants

4.3.2.1 Participants
As outlined previously this study involved the analysis of videotaped treatment sessions for
44 participants from the VERSE-RCT. Demographic information of the participants in VERSE TF is
presented in Table 7. The participants’ WABR aphasia (type) classifications at baseline, three months
and six months post stroke are presented in Table 8. The evolution of the participants’ WABR-AQ
scores based on classification at baseline and then corresponding scores at the three assessment time
points is shown in Table 9. Table 10 outlines the number of participants who had fluent compared to
non-fluent aphasia at each assessment time point and Table 11 provides further information on the
change in classification across these time points.
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Table 7. Participant demographic and stroke characteristics
Demographic

Whole group

VERSE

Usual Care-Plus

(n = 44*)

(n = 25)

(n = 19)

72.0 (14.8)

75.0 (14.2)

68.0 (14.7)

19 (43)

12 (48)

7 (37)

3 (7)

2 (8)

1 (5)

PACs (%)

34 (77)

18 (72)

16 (84)

PoCs (%)

1 (2)

0 (0)

1 (5)

TACs (%)

6 (14)

5 (20)

1 (5)

Mild

15 (34)

8 (32)

7 (37)

Moderate

13 (30)

7 (28)

6 (32)

Severe

16 (36)

10 (40)

6 (32)

2 – Slight

6 (14)

5 (20)

1 (5)

3 - Moderate

17 (39)

7 (28)

10 (53)

4 – Moderate Severe

11 (25)

7 (28)

4 (21)

Age, Mean (SD)

Female (%)

Oxford Stroke Classification

Haemorrhagic (%)

Baseline WABR-AQ Severity

Modified Rankin Scale Score
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5 - Severe

National Institutes of Health Scale Score,

10 (23)

6 (24)

4 (21)

9.1 (7.1)

9.4 (7.5)

8.7 (6.5)

Mean (SD)
Note. PACs= Partial Anterior Circulation syndrome; PoCs= Posterior Circulation syndrome; TACs=
Total Anterior Circulation syndrome. *53 videos were selected through randomisation. Eight
participants had more than one video and 36 participants had one video in the sample. Therefore, 44
different participants are included in the table.

Table 8. Western Aphasia Battery Revised - aphasia classifications
WABR Aphasia Classification

Baseline

12 weeks

26 weeks

(n = 44)

(n = 42)

(n = 40)

Broca’s

15 (28%)

6 (11%)

5 (9%)

Global

9 (17%)

1 (2%)

2 (4%)

Anomic

7 (13.2%)

23 (43%)

26 (49%)

Wernicke’s

5 (9%)

3 (6%)

2 (4%)

Conduction

3 (6%)

5 (9%)

1 (2%)

Transcortical motor

2 (4%)

0 (0%)

1 (2%)

Isolation

1 (2%)

1 (2%)

0 (0%)

Transcortical sensory

1 (2%)

0 (0%)

0 (0%)

Unclassifiable

1 (2%)

3 (6%)

3 (6%)

Note. Classifications as per WABR Aphasia classification criteria in manual.
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Table 9. Evolution of WABR-AQ scores mean (SD) based on baseline severity classification
WABR-AQ Score

Whole Group

VERSE

Usual Care-Plus

(n = 44)

(n = 25)

(n = 19)

Mild (62.6-100)

72.5 (9.1)

73.1 (8.3)

71.91 (10.5)

Moderate (62.5-32.3)

44.2 (10.3)

45.8 (12.4)

42.4 (7.8)

Severe (0-31.2)

15.0 (8.6)

12.6 (8.2)

17.9 (8.7)

Mild (62.6-100)

94.6 (6.2)

93.2 (8.2)

96.0 (3.2)

Moderate (62.5-32.3)

81.8 (11.0)

87.8 (6.2)

75.9 (11.9)

Severe (0-31.2)

53.8 (29.6)

50.0 (20.1)

57.5 (37.8)

Mild (62.6-100)

95.0 (4.6)

94.5 (4.9)

95.6 (4.5)

Moderate (62.5-32.3)

86.9 (9.7)

91.7 (5.4)

82.1 (10.9)

Severe (0-31.2)

59.4 (30.5)

54.6 (23.3)

64.2 (37.4)

Baseline AQ Score

12 Week AQ Score

26 Weeks AQ Score
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Table 10. Fluency status at baseline to six months post stroke
Fluency

Baseline

12 weeks

26 weeks

(n = 43)

(n = 42)

(n = 38)

Non-fluent

27 (63%)

8 (19%)

9 (24%)

Fluent

16 (37%)

34 (81%)

29 (76%)

Note. Fluency status determined as per WABR Aphasia classification. Classifications of Global,
Broca’s, Isolation, and Transcortical Motor were labelled as non-fluent. Classifications of Wernicke’s,
Transcortical Sensory, Conduction and Anomic were labelled as fluent.

Table 11. Evolution of fluency baseline through to six months post stroke
Fluency evolution

Remained in original fluency category

n = 37

20 (54%)

Evolved from fluent to non-fluent

1 (3%)

Evolved from non-fluent to fluent

16 (43%)

Note. Fluency status determined as per WABR Aphasia classification. Classifications of Global,
Broca’s, Isolation, and Transcortical Motor were labelled as non-fluent. Classifications of Wernicke’s,
Transcortical Sensory, Conduction and Anomic were labelled as fluent.

4.3.2.2 Therapists
Included within the videos were 27 different SLPs (16 in Usual Care-Plus and 11 in VERSE).
The Usual Care-Plus therapists were employed at 11 different hospitals (all in Australia) and the
VERSE therapists were employed at 8 different hospitals (7 in Australia and 1 in New Zealand). The
average years clinical experience working with people with aphasia for the Usual Care-Plus group (n
= 14) was 5.5 years (median 3.5 years, range 1-16 years) and 3.7 years (median 2.5 years, range 1- 12
years) for the VERSE therapists (n = 10).
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4.3.3 Procedure

4.3.3.1 Transcription
Each video was transcribed verbatim following the guidelines provided within the Systematic
Analysis of Language Transcripts (SALT) (Miller, 2008) software and as per SALT guidelines
(available at http://saltsoftware.com/resources/tranaids). Utterances were segmented as per the SALT
guidelines for Communication units (C-units). C-units are defined as ‘an independent clause and its
modifiers’(Loban, 1963). It is an utterance that cannot be further divided without the disappearance of
its essential meaning. Subordinate clauses are separated only if they can stand-alone. Subordinate
causes that depend on the main clause to make sense are included in a C-unit. SALT transcription
conventions were adhered to including ending punctuation, utterance segmentation, unintelligible
segments, spelling conventions, bound morphemes, mazes and overlapping speech. For
comprehensive information on C-units and SALT conventions please see the SALT User Guide
(Miller, 2008). Customised codes are able to be used in the SALT software. A methodological
framework and coding system relating specifically to the aims of VERSE TF, was developed for this
study to allow the behaviours of interest to be assessed. These are explained in the sections below.

4.3.3.2 Methodological framework
A key element of VERSE TF was the examination of therapy sessions to explore treatment
integrity and differentiation within VERSE RCT. In order to analyse the treatment sessions a
framework to guide the analyses was developed based on published recommendations for the
reporting of research. The TIDieR checklist was chosen for adaption as an overall framework for both
intervention and control groups (Hoffmann et al., 2014). It contains a number of relevant
categories/items related to the aims of this study and is recommended by the Cochrane Systematic
Review for intervention reporting for aphasia following stroke (Brady et al., 2016). The TIDieR
checklist includes 12 items that have been detailed in Key Frameworks 2.4.1.
The checklist was adapted within VERSE TF in order to better address the aims of the
research, specifically items that were kept constant across both VERSE and Usual Care-Plus arms, or
did not alter session to session, were excluded from the coding framework. These items were: i) ‘Item
6 How Therapy is Delivered’ as all recorded therapy sessions were individual 1:1 therapy, ii) ‘Item 10
Modifications’ as the therapy was not modified at a protocol level, and iii) ‘Item 11 How Well –
Planned’ as planned aspects of treatment fidelity were described elsewhere and did not vary within
each individual session. It should be noted that although group therapy sessions could be included as
part of Usual Care-Plus therapy within the VERSE-RCT, only individual therapy sessions were
observed in the current study. This resulted in the Adapted (TIDieR) Checklist for Describing Care
(ACDC) seen in Table 12. The remaining Items from the TIDieR Checklist were expanded to include
specific codes, developed for this study, to reflect key concepts from the VERSE RCT interventions
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in order to examine treatment fidelity and to capture the therapeutic inputs and the client acts within
the session (Baker, 2012). Section 8 ‘When and How Much’ has been adapted to describe the dosage
or number of client acts, that occur in a session. The dose of number of therapeutic inputs from the
therapist is captured in Section 9 ‘Tailoring’.

Table 12. Adapted (TIDieR) Checklist for Describing Care (ACDC) in VERSE TF
Participant Number:
Video:
Session:
SPSS Row Number:
Session Duration (min)
TIDieR Elements
1. Name of therapy
2. Rationale, theory or task
discussion
3. Materials Used

4. Type of task

5. Therapist
7. Location

8. When and How Much
(Dosage)

Quantity
☐1.0 Specific therapy regimen
(VERSE)a
☐Rationale discussion [rd] 0 No 1
Yes
☐Task explanation [te] 0 No 1 Yes
☐0 No materials [om]
☐1 Visual stimuli [vs]
☐2 Electronic stimuli [es]
☐3 Functional items [fs]
☐Impairment based [ibt] 0 No 1
Yes
☐Social Training [stt] 0 No 1 Yes
☐Compensatory [ct] 0 No 1 Yes
Therapist code:
☐1 Inpatient in Hospital
☐2 Personal home
☐3 Nursing home
☐4 Other
Error free therapy adherent [ef]
Total error free verbal ([ef]+[efd][ges])
Error free therapy deviant [efd]a
Error free therapy deviant verbal
([efd]-[ges]) a
Total error free [ef]+[efd] a
Errors therapy adherent [e]
Error therapy deviant [ed] a
Error total [e]+[ed] a
Verbal errors (error total – [re])
Accurate repetitions [rep]
Spontaneous verbal (error free
verbal – [rep]-([ef][read])
Non-verbal responses [ges]
Reading [read]
Error free reading [ef][read]
Above goal level [goalup] a
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9. Tailoring

% utterances above goal level a
Not at target goal level [efd]+[ed] a
% utterances at correct goal level a
Social utterances [soc]
Self-Corrections [sc]
% errors self-corrected
Metalinguistic comments [met]
Humour [hu]
Error type
☐Filled pause [fp]
☐Unfilled pause [ufp]
☐Close phonological error [phec]
☐Distant phonological error
[phed]
☐Neologism [phen]
☐Stuck in set perseveration [pers]
☐Recurrent perseveration [per]
☐Circumlocution [circ]
☐Related error [seer]
☐Unrelated error [seeu]
☐ Irrelevant error [irre]
☐ Pronoun error [pro]
☐ Repetition fluency error [repf]
☐Grammatical error [gre]
☐Receptive error [re]
☐Unintelligible XX
MLU (words)
MLU (morphemes)
Total turns
Total verbal utterances
Average errors per utterance
(errors/utt.)
Average utterances per error
(utt/errors)
Total words
% total words with errors
UPM
WPM
Mean turn length (words)
Cues used with success [cs]
Amount

Success

Cue Type
☐Phonological [phc]
☐Semantic [sec]
☐Orthographic [orc]
☐Visual gestural [vic]
☐F/A [fac]
☐Sentence completion [scc]
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☐Articulatory placement cue [arc]
☐Direct model [mod]
Total number of cues used
% Cues used that are successful
Feedback
☐Supportive Positive [supf]
☐Supportive Elaboration [supfb]
☐Supportive clarification [supfc]
☐Supportive requests [supfd]
☐Problem solving yes/no [prof]
☐Problem solving explains error
[profb]
☐Conceptual focus [conf]
Humour [hu]
12. Adherence to protocol
Total therapist utterances
Protocol deviant utterances (same
cue) [pdbs] a
Protocol deviant utterances – x 3
errors [pdbe] a
Total deviant utterances
[pdbe]+[pdbs]+[pdne] a
Protocol adherent behaviours a
% Utterances that adhere to
protocol a
Therapist MLU (words)
Therapist MLU (morphemes)
Therapist Total words
Therapist UPM
Therapist WMP
Mean turn length (therapist)
a
Note. marked for VERSE arm videos only

4.3.3.3 Coding
The investigation of client acts and therapeutic inputs in aphasia therapy sessions required the
specification of ingredients to measure. Codes relating to these ingredients were developed and
coding was completed during transcription at the end of each utterance or word as applicable. The
development and rationale of codes and their definitions are expanded on below according to the
broad categories of participant dosage, therapist tailoring, treatment integrity and intervention
description. Appendix D provides further expanded definitions of all the codes used in transcription.

4.3.3.3.1 Dosage- client act codes
4.3.3.3.1.1 Rationale for client act codes
Item 8 ‘When and How Much’ of the Adapted TIDieR Checklist for Describing Care
(ACDC) (Appendix E) contains measures of participant dosage. Of particular note was the amount
that a PWA was saying (number of words and utterances and the mean length of utterance) and the
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number of errors they were making and self-correcting. These therapy principles relate to
neuroscience literature. The rationale for examining how much the participants talked i) that
improvement in therapy is experience dependent and ii) a lack of experience of practicing a task may
result in learned non-use (Pulvermuller & Berthier, 2008). Therapy should practise tasks, in this case
the use of language, and talking to avoid a lack of experience causing atrophy in the network (Varley,
2011). Aphasia treatment approaches are often described as ‘error full’ or ‘error free’ referring to
whether patients are encouraged to attempt target attainment irrespective of the error quantity or
whether errors are minimized to avoid strengthening of associated negative neural networks.
Reducing errors in therapy relates to Hebbian theory surrounding coactivation of neurones and that a
mistake occurring while producing a word may wire together these two behaviours (Hebb, 1949;
Varley, 2011). It aims to avoid therapy being the practice of errors (Varley, 2011). Error-less learning
may reflect implicit learning techniques that may be suited to the motor learning required in speech
production (Page, Wilson, Norris 2006). As such the measures of focus reflected the quantity and
accuracy of utterances.
4.3.3.3.1.2 Description of client act codes
Table 13 details the four different accuracy codes used for each participant utterance. Error
responses were marked at the word level for both treatment groups as utterances frequently contained
multiple errors. Within the Usual Care-Plus arm of the trial an error free response was one which was
appropriate for the context and not corrected or modified by the therapist. An error included
inaccurate productions within the context that required modification, correction or negative feedback
from the therapist. Within the VERSE arm error free and error responses were coded with the addition
of whether they were adherent to the goal level at which the therapy was being delivered to monitor
treatment integrity. A summary of the goal level requirements is presented in Appendix F. Error codes
were followed by the type of error as per the codes in Table 12. Boundaries of therapy tasks were not
always clear and social conversation was often a target of therapy. Therefore, every utterance from the
participant within the therapy session was coded and used as a measure of dosage. In some videos the
stimulus could not be seen in the recording and so it was difficult to mark participant responses as
correct or incorrect. In the event that the response could not be assessed as correct by the transcriber,
it was marked as correct if the therapist did not provide correction or negative feedback.
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Table 13. Error free and error codes
Code

Condition

Level

Definition

[ef]

VERSE, Usual

Utterance

A correct verbal response from the participant. If in the

Care-Plus

level

VERSE condition it must be at the target goal level of
the session (as per goal summaries Appendix F).

[efd]

VERSE

Utterance

Within the VERSE condition a correct verbal response

level

from the participant but below the target goal level for
the session.

[e]

VERSE, Usual

Word level

Care-Plus

An error at the word level with the exception of
circumlocutory and irrelevant errors which were
marked at the utterance level.

[ed]

VERSE

Utterance

An error at the word level but below the correct goal

level

level for the participant for the session (as per goal
summaries Appendix F). Can only be marked once for
utterance. If multiple errors are present in an utterance
then the [e] code was used for subsequent errors.

4.3.3.3.2 Dosage – Therapeutic input codes
4.3.3.3.2.1 Rationale for therapeutic input codes
Cueing and feedback are the key therapeutic inputs that were coded in this study and are core
therapy techniques used within behavioural based therapy. Cues are used by the therapist to promote
accuracy and participation by assisting word retrieval and/or accurate speech production. Feedback
serves to increase monitoring of production and may alter language and/or motor neural
representations to encourage self-correction and improved accuracy. Turkstra et al., (2016) suggested
investigating ingredients such as handling of errors and their effect on target attainment more
generally rather than looking at the efficacy of methods separately for each activity. This has been
addressed in the investigation across the entire sessions of therapist tailoring cues and how often they
were successful as well as the feedback given. Cues and feedback given by the therapist result in
tailoring of the patient’s utterances in the therapy session and were of interest in accurately describing
therapy sessions within both conditions.
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4.3.3.3.2.2 Description of therapeutic input codes
If a cue was given by the therapist prior to the correct target response from the participant the
type of cue was coded. Feedback from the therapist after a participant response was also coded.
Definitions of the cues and feedback types can be seen in Appendix D. The totals were recorded in
Section 9, Tailoring, in the ACDC (Appendix E).

4.3.3.3.3 Treatment integrity codes
4.3.3.3.3.1 Rationale for treatment integrity codes
Treatment integrity was measured through the therapist’s adherence to the VERSE condition
protocol. Treatment integrity is of vital importance in establishing whether the treatment was
delivered as it was intended by the researchers. By reporting treatment integrity in this sample, overall
trial results can be interpreted with greater confidence.
4.3.3.3.2.2 Descriptions of treatment integrity codes
The transcriptions for the VERSE intervention group were coded according to therapist
behaviours that adhered to VERSE elements and those that did not. The definition of a VERSE
element was developed in the pilot stage of this project by reviewing the VERSE RCT protocol
manual, training package and two Usual Care-Plus and two VERSE intervention recordings. The main
VERSE elements were then identified, allowing deviations to be coded and counted. Protocol
deviations can be seen in Table 14. This gave a percentage of therapist behaviours at the utterance
level that adhered to VERSE elements for each session.

Table 14. VERSE protocol deviations
Code

Definition

Protocol Deviant Behaviour –

The utterance was marked as [pdbs] if the therapist used the

Same Cue [pdbs]

same cue twice for a stimulus.

Protocol Deviant Behaviour –

The utterance was marked [pdbe] if the participant made more

Error [pdbe]

than three errors on the same stimulus. A cue must be given by
the therapist within three errors or a model after the third error.
If a fourth error is made regardless of whether a cue was given
the therapist utterance was marked deviant. Every subsequent
cue (not model) and utterance following this for the same
stimulus was marked as a deviation.
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4.3.3.3.4 Description of the intervention
4.3.3.3.4.1 Rationale for description of the intervention
Other elements that contribute to therapy and are of interest in this study include therapy
materials, a description of the treatment task / activity (e.g. picture naming) along with the desired
output level (i.e. single word, sentence or conversation level) and the location of therapy. These relate
to the environment that therapy occurs in. The descriptive elements of intervention were not included
in statistical analyses but did provide an overall context to the sessions and assisted in interpreting
therapy decision making.
4.3.3.3.4.2 Description of codes for intervention description
Usual care and VERSE practices relating to information on the materials, procedures, location
of therapy and adaptions were recorded. This information in particular gives a snapshot of usual care
practices across Australia and NZ in regards to their content. The intensity of usual care therapy was
not captured within the videos as most recordings were sourced from the Usual Care-Plus arm of the
VERSE RCT, where therapy had a prescribed frequency that is 20 sessions within 4 weeks of
baseline.
A list of all codes used during transcription can be seen in Table 15. The counts of codes were
used to complete the Adapted TIDieR Checklist for Describing Care (ACDC) for each therapy session
as per Table 12.

Table 15. List of codes used in transcriptions
TIDieR Item

Area

Meaning

Code

Participant

Response

Error free therapy adherent

[ef]

Error free therapy deviant a

[efd]

Error therapy adherent

[e]

Error therapy deviant a

[ed]

Non verbal

[ges]

Above goal level a

[goalup]

Self-Correction

[sc]

Repetitions

[rep]

Dosage
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Error

Therapist

Cues

Metalinguistic comment

[met]

Humour

[hu]

Reading

[read]

Filled pause

[fp]

Unfilled pause

[ufp]

Close phonological error

[phec]

Distant phonological error

[phed]

Neologism

[phen]

Stuck in set perseveration

[pers]

Recurrent perseveration

[per]

Circumlocution

[circ]

Related error

[seer]

Unrelated error

[seeu]

Irrelevant error

[irre]

Pronoun error

[pro]

Repetition fluency error

[repf]

Grammatical error

[gre]

Receptive error

[re]

Unintelligible

XX

Cue used with Success

[cs]
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Tailoring

Phonemic cue

[phc]

Semantic Cue

[sec]

Orthographic Cue

[orc]

Visual Cue

[vic]

Forced alternative Cue

[fac]

Sentence Completion Cue

[scc]

Articulatory placement cue

[arc]

Model

[mod]

Supportive- Positive

[supf]

Supportive- Elaboration

[supfb]

Supportive- Clarification

[supfc]

Supportive - Requests

[supfd]

Problem solving- Yes/No

[prof]

Problem solving – explains error

[profb]

Conceptual focus

[conf]

Protocol

Protocol Deviant Behaviour – same

[pdbs]

Adherence

cue a

Feedback

Treatment

Protocol Deviant Behaviour – x 3

Integrity

[pdbe]

errors a
Other

Task Explanation

[te]

Rationale Discussion

[rd]
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Intervention

Materials

Description

Type of Task

Location

Visual stimuli (non electronic)

[vs]

Electronic stimuli

[es]

Functional item

[fs]

Other

[om]

No materials

[ns]

Impairment based

[ibt]

Social Training

[stt]

Compensatory

[ct]

Social utterance

[soc]

Inpatient

[is]

Personal Home

[ph]

Nursing Home

[nh]

Other

[os]

Note. a denotes a code for the VERSE arm of the trial only.

4.3.3.4 Pilot
The ACDC was piloted on two VERSE and two Usual Care Plus video recordings by the
primary researcher. After piloting, codes were added in the cueing and error categories to increase the
specificity of the data collected. A code relating to the therapist using an incorrect cue in the VERSE
condition for protocol adherence was eliminated as it was too difficult to practically identify.
Additionally, the format of the tool was adjusted to make it more user-friendly for data entry.
4.3.4 Analysis

4.3.4.1 Transcription analysis
Following transcription, calculations were performed by the SALT software for both
participant and therapist behaviours. These were mean length of utterance (MLU) in both words and
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morphemes, total verbal utterances, total words, words per minute (WPM), utterances per minute
(UPM) and mean transcription turn length in words. In addition, calculations based on the transcribed
codes were made manually and their formulas can be seen in Table 16. All of this information was
recorded on the ACDC. An example completed ACDC can be seen in Appendix C.

Table 16. Formulas for measures calculated
Calculation

Formula

% utterances at correct goal level a

100 - (Not at goal level) / (total utterances) x 100

% errors self-corrected

(self-corrections) / (total errors) x 100

Average no. of errors per utterance

(verbal errors) / (verbal utterances)

Average no. of utterances per error

(verbal utterances) / (verbal errors)

% total words with errors

(errors) / (total words) x 100

Protocol adherent behaviours (utterance

(Total therapist utterances) – (Total deviant utterances)

level) a
% Utterances that adhere to protocol a

(Protocol adherent behaviours / total utterances) x 100

Total Turns

Total utterances

Verbal utterances

Total utterances – gestures ([ges])

Note. a denotes a code for the VERSE arm of the trial only.

4.3.4.2 Statistical analysis
VERSE TF participant numbers were provided to the VERSE RCT Trial Manager and
dependent measures and demographic characteristics were requested. The trial manager provided this
de-identified data. These data along with the data from the ACDC were entered into the statistical
software program SPSS (IBM Corp, 2015). Descriptive statistics were used to address the aims of this
research related to treatment integrity to the VERSE protocol and the description of Usual Care-Plus
practices. Statistical tests were used for the aims related to treatment differentiation and dosage
analysis as per below.
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4.3.4.2.1 Treatment fidelity – treatment differentiation
One of the primary aims of this research was to statistically investigate treatment
differentiation between the Usual Care Plus and VERSE treatment conditions. Client acts and
therapeutic inputs were selected as possible key points of difference between treatments based on the
theoretical underpinnings of the VERSE therapy protocol. For example, the quantity and accuracy of
the participant’s production was a key consideration as the VERSE protocol was developed with error
free therapy principles. Participant related variables of interest for differentiating treatments were total
error free utterances, total errors, spontaneous verbal output, total self-corrections, percent errors selfcorrected, MLU (words and morphemes), total verbal utterances, average errors per utterances,
average utterances per error, total words, utterance level errors, word level errors, percent total words
with errors, UPM, WPM, mean turn length. Therapist related variables of interest were total cues used
with success, percent successful cues used, total utterances, UPM and total words. As the session
length of the videos was not equal, the length of the session was included in the analysis to provide a
standardised measure across participants for some measures with the following formula usedmeasure / session time (mins). This formula was used for the following measures: total error free
utterances, total errors, spontaneous verbal output, total self-corrections, total verbal utterances, total
words, utterance level errors, word level errors, total cues used with success, total therapist utterances
and total therapist words. A Welch’s t-test for non-equal variances was performed using the above
measures to determine whether Usual Care-Plus and VERSE conditions were sufficiently different
enough. A Bonferroni correction was applied for multiple comparisons and significance was set at
<0.001.

4.3.4.2.2 Dosage – correlation with participant response
Of interest in this study was whether certain key ingredients of dosage (therapeutic inputs or
client acts) would be correlated with overall participant outcomes at 12 and 26 weeks post stroke.
Participant related dosage variables of interest for the correlation analysis were total error free
utterances, total errors, spontaneous verbal output, total self-corrections, percent errors self-corrected,
MLU (words and morphemes), total turns taken, total verbal utterances, average errors per utterances,
average utterances per error, total words, utterance level errors, word level errors, percent total words
with errors, UPM, WPM, mean turn length. Therapist related variables of interest were total cues used
with success, percent successful cues used, total utterances, UPM and total words. As the session
length of the videos was not equal, the length of the session was included in the analysis to provide a
standardised measure across participants for some measures with the following formula usedmeasure / session time (mins). The following measures were adjusted: total error free utterances, total
errors, spontaneous verbal output, total self-corrections, total turns taken, total verbal utterances, total
words, utterance level errors, word level errors and total cues used with success. To relate measures of
dosage with overall participant response, a General Linear Regression model was used across both
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groups with the participant’s primary outcome measure, the WABR-AQ score at 12 weeks and then at
26 weeks being the dependent measures in separate models. Baseline severity on the WABR and the
overall amount of intervention received were included as predictors in the model to account for these
factors.
4.3.5 Reliability
Six videos (one from each severity in Usual Care-Plus and VERSE) were re-coded for inter
and intra rater reliability. This comprised 11% of the total sample. Reliability was established using
the intra-class correlation coefficient (ICC) in SPSS (IBM Corp, 2015) with a consistency 2-way
mixed effects model. The ICC was established on the four key coded measures of interest in the study
- error free utterances, total errors made, total self-corrections and the total number of cues used with
success by the therapist. These were the main measures that were coded and then used in statistical
analysis. Koo and Li’s (2016) guidelines for reporting the ICC have been adhered to. As per Table 17,
three of the measures had ICCs in excess of 0.90 and therefore, inter-rater reliability can be said to be
excellent. The self-corrections measure was lower however, ICCs in the range of 0.75-0.90 remain in
the good reliability range (Koo & Li, 2016).

4.3.5.1 Inter-rater reliability
Table 17. Inter-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.993

.949

.999

273.752

5

5

.000

Errors

.949

.686

.993

38.369

5

5

.001

.807

.134

.971

9.350

5

5

.014

.937

.621

.991

30.538

5

5

.001

Selfcorrections
Successful
Cues
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4.3.5.2 Intra-rater reliability
As the ICCs are all in excess of 0.90 as per Table 18, intra-reliability can be said to be
excellent.

Table 18. Intra-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.993

.950

.999

281.238

5

5

.000

Errors

.988

.916

.998

162.171

5

5

.000

.993

.949

.999

270.621

5

5

.000

.993

.954

.999

300.417

5

5

.000

Selfcorrections
Successful
Cues

4.3.6 Ethical considerations
Research participants and therapists in the broader VERSE RCT gave consent for the video
footage to be used for therapy fidelity purposes and were aware that these data were re-identifiable.
All data collected from the video footage such as transcriptions and measures was de-identified. The
VERSE RCT received National Ethics approval HREC/13/Austin/101. Ethics approval for this project
was received from the Edith Cowan University Human Research Ethics Committee using the online
System for Tracking Research Ethics Applications and Monitoring (STREAM) approval number
16390. A waiver of consent was obtained as the project contained no additional risk for the
participants who had consented to the broader VERSE RCT.
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Foreword to Chapter 5
Title of publication: ‘Treatment integrity and differentiation in the Very Early Rehabilitation in
SpEech (VERSE) Trial’
At a fundamental level, treatment fidelity is concerned with how well the intervention was
implemented as per protocol and whether it was different from the control condition in the trial.
Treatment fidelity is needed to assist in the interpretation of study outcomes and to increase the
scientific confidence in the relationship between components and outcomes (Rixon et al., 2016). This
paper demonstrates a method for measuring treatment integrity and differentiation in a complex
behavioural intervention using a subset of the data from the VERSE RCT to assist research consumers
with their interpretation of the overall trial results.
This article will be submitted for publication in the journal of Clinical Rehabilitation once the
main VERSE trial results are published.
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Chapter 5: Treatment Integrity and Differentiation in the Very
Early in SpEech (VERSE) Trial
Abstract
Objective: To investigate treatment fidelity in the Very Early Rehabilitation in SpEech
(VERSE) trial by establishing treatment integrity and differentiation. While the VERSE trial
established treatment fidelity at the macro level for key components of therapy, this study aimed to
complete a fine grained analysis of therapy adherence and differentiation with a focus on the utterance
level of therapeutic interaction. Design: Observational study of therapy videos collected as part of the
VERSE trial. VERSE was a multicentre randomised control trial (n = 246) that reported equivalent
communication outcomes for usual care and early intensive therapy at 12 and 26 weeks post stroke.
Participants: People with aphasia in the very early phase of recovery post stroke (n= 44) and speech
language pathologists (n= 27). Methods: Participants in the VERSE trial were randomised to one of
two intensive therapy arms (VERSE-prescribed therapy, or Usual Care Plus) or the non-intensive
Usual Care arm. Therapists video recorded therapy sessions in the intensive arms and 53 therapy
videos were randomly selected for analysis in this study, comprising 12% of the total received in the
trial. Therapy sessions were transcribed and coded for measures of interest related to the aims of
treatment integrity and differentiation. A descriptive analysis and a Welch’s t-test for non-equal
variances were used to analyse the sessional data. Main Measures: Utterance level protocol
adherence within the prescribed VERSE condition was measured for treatment integrity. Key
measures reflective of therapeutic inputs and client acts were coded in both conditions for statistical
analysis to determine treatment differentiation. Results: Therapists, in the VERSE (prescribed
intervention) arm of the study, were highly adherent to the treatment protocol at the utterance level (M
= 97%). There was no significant difference in key measures of differentiation between the intensive
(VERSE, prescribed intervention and Usual Care Plus) conditions. Conclusion: Within this sample,
treatment adherence to the prescribed condition was maintained however, there was not significant
differentiation in the therapy provided in the two arms of the trial. This result supports the null finding
in effectiveness between the two intensive arms of the treatment as potential key measures were not
different in dosage.
Keywords: aphasia, fidelity, RCT, rehabilitation, dosage
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5.1 Introduction
5.1.1 Treatment fidelity concept
Assessing and monitoring treatment fidelity is an important component of intervention
studies, however a single, widely agreed upon definition has not been developed (O’Shea et al.,
2016). Most definitions, at a fundamental level, describe treatment fidelity as the degree to which the
administration of a treatment corresponds to the specified protocol for the implementation of that
treatment (Kaderavek & Justice, 2010). However, the definition of treatment fidelity has widened
over the last twenty years to incorporate the concepts of treatment integrity, treatment differentiation
and treatment receipt (Borrelli et al., 2005). Treatment integrity or adherence refers to the extent to
which the treatment is given as intended, while treatment differentiation determines if the therapy
provided in the intervention and control groups is sufficiently different in relation to the key or
‘active’ ingredients of the therapy provided (Moncher & Prinz, 1991). Treatment receipt is the
processes implemented to monitor and improve the participant’s ability to comprehend and perform
the behaviours targeted in the treatment (Bellg et al., 2004). This broader definition of treatment
fidelity reflects the increased complexity of research and the demand for an evolving evidence base to
guide clinical practice. To address this, there is a need to reliably report on elements of intervention
that are regularly omitted in treatment studies (Walton, Spector, Tombor, & Michie, 2017).
Strengthening processes for the planning, implementation, monitoring and reporting on treatment
fidelity in clinical trials helps to ensure that interventions are delivered as per the study protocol, and
the integrity of the treatment is preserved.
Addressing treatment fidelity can help to explain study findings, minimise errors in
interpreting study outcomes and inform future modifications to the intervention (Hoffmann et al.,
2014). Monitoring and evaluating treatment fidelity within studies assists in the interpretation of study
outcomes and may increase confidence in the relationship between intervention components and the
outcomes of a trial (Rixon et al., 2016). While treatment fidelity is broached with caution by some,
due to the real world applicability of strict treatment protocol procedures (Karas & Plankis, 2016),
implementation of thorough treatment fidelity procedures has the aim of building a robust body of
evidence for interventions. If the scientific basis for clinical practice is built on studies that have not
effectively investigated treatment fidelity then systematic reviews, meta analyses and clinical practice
guidelines may be skewed (Wheeler et al., 2006). Additionally, studies with high fidelity monitoring
and reporting have increased external and internal validity and are more likely to be replicable. High
levels of fidelity reporting also allow comparisons to be made between treatments (Hildebrand et al.,
2012; Moncher & Prinz, 1991; Resnick et al., 2005; Schlosser, 2002). While the importance of
planning for and assessing treatment fidelity has been highlighted, treatment fidelity processes are not
always incorporated within intervention studies (Bellg et al., 2004). For example, Borelli et al., (2005)
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evaluated 342 behaviour change articles between 1990 and 2000 and found that overall, 54% of
studies did not report intervention fidelity.
5.1.2 Treatment fidelity in complex interventions
Complex interventions are “health service interventions that are not drugs or surgical
procedures but have many potential active ingredients” (Oakley et al., 2006, p. 413). Complex
interventions are used in a wide range of practice areas from psychotherapy to physiotherapy.
Behavioural interventions, such as those used in speech language pathology (SLP), are complex and
treatments implemented have been described as “black boxes” referring to the fact they may contain
many potential active ingredients that shape patient outcomes (DeJong, Horn, Conroy, Nichols, &
Healton, 2005; Walker et al., 2017). Additionally, due to the inherent complexity of behavioural
interventions, there may be more variation when different sites and providers are involved in
intervention studies (O’Shea et al., 2016) resulting in potential issues with training of providers and
delivery of treatment such as contamination between conditions or therapist drift. Treatment fidelity is
especially relevant to behavioural change interventions due to this complexity (O’Shea et al., 2016).
Investigating therapy fidelity measures encourages researchers to deconstruct and make explicit what
is inside the “black box” of rehabilitation intervention (Hand, Darragh, & Persch, 2018). Processes for
how treatment fidelity can be applied in specific fields are being developed. Currently, the
incorporation of treatment fidelity processes is more established in the field of psychotherapy research
compared to medical rehabilitation research (Hildebrand et al., 2012). Treatment fidelity has been
made of such value in the psychotherapy literature that only research that includes substantial
attention to this is considered as reliable evidence for the efficacy of a treatment. In 2008 it was
recommended that psychotherapy sessions should be videotaped and a random selection of 20%
should be rated for treatment adherence and therapy competence (Öst, 2008). Although not as
established as the psychotherapy literature increasing attention is being given to treatment fidelity in
rehabilitation interventions in stroke. Similar to psychotherapy, stroke interventions are often
behavioural in nature, delivered via a therapist and are likely to have a range of potential active
ingredients.
Treatment fidelity processes should be incorporated when designing a study, when
implementing the study and also when reporting the findings (Brogan et al., 2019). The importance of
assessing treatment fidelity has been emphasized in recent guidelines and recommendations for
evaluating complex interventions (Rixon et al., 2016) however, guidelines are needed to define
treatment fidelity concepts and to provide standardisation regarding key aspects of treatment fidelity
(Gearing et al., 2011). The Treatment Fidelity Workgroup of the National Institutes of Health
Behaviour Change Consortium (Bellg et al., 2004) reviewed treatment fidelity practices used within
identified literature and developed recommendations to embed treatment fidelity practices within
intervention studies. Recommendations for addressing treatment fidelity in behaviour change studies
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were outlined across five main areas: study design, training providers, delivery of treatment, receipt of
treatment and enactment of treatment skills (Bellg et al., 2004). Additionally, Gearing (2011)
provided a treatment fidelity guide, identifying four core components from the treatment fidelity
literature with less of an emphasis on treatment enactment, the fifth category in the Bellg et al. (2004)
framework. Gearing’s (2011) guide provides a chronological outline incorporating study design,
training, monitoring intervention delivery and monitoring intervention receipt. The guide encourages
researchers to address some broader areas of study design such as the overall framework. The
elements included in both the Bellg et al. (2004) framework and Gearing’s (2011) guide are very
similar with Bellg et al. (2004) being the most widely up taken in research (O’Shea et al., 2016).
Documenting fidelity involves investigating therapy effectiveness including key ingredients
and the dosage delivered of these (Kaderavek & Justice, 2010). Specification of therapy ingredients is
central to all areas of Bellg et al.’s (2004) framework and dosage is important for determining whether
the therapist adhered to the protocol and whether the intervention groups received different amounts
or types of the intervention. Warren, Fey and Yoder (2007) proposed a comprehensive model for
defining dosage and calculating cumulative intervention intensity. The model included the term ‘dose
form’ which is defined as the task or activity within which the teaching episodes are delivered and it
may contain the important active ingredients of the intervention. Potential active ingredients may
involve therapeutic inputs and client acts (Baker, 2012). It is important when designing a treatment
that researchers give significant consideration to the theoretical underpinnings of the treatment so that
the potential active ingredients and the required dosage are identified and then adequately monitored
and evaluated. As such the planning of treatments may be as complex and detailed as the treatment
itself. If researchers fail to recognise potential factors that may facilitate change in the participants at
the design stage, the appropriate data may not be collected, evaluated and reported (Walker et al.,
2017). Specification of ingredients in the study design allows therapists to be trained in delivering
those ingredients and decisions on the monitoring of implementation of the ingredients in therapy can
be made. How to monitor treatment delivery presents a challenge as there are few validated tools to
use for the investigation of treatment fidelity in behavioural interventions (Borrelli et al., 2005).
In order to assess treatment integrity a range of methods can be applied. Treatment integrity is
commonly investigated by measuring the therapist’s adherence to the treatment protocol. Checklists
for rating treatment adherence are mainstay using direct, structured observation of treatment sessions
either in person or via recording. The checklist should be developed using a priori coding categories
which reflect the potential factors that are identified during the development of the study design
(Kaderavek & Justice, 2010). This method for assessing treatment adherence is considered the gold
standard and most thorough and objective way of measuring treatment integrity (Kaderavek & Justice,
2010). It also allows for the collection and analysis of data for treatment differentiation (Hildebrand et
al., 2012). The use of checklists has been demonstrated in a number of behavioural intervention
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studies (Damschroder et al., 2016; Hildebrand et al., 2012; Seng & Lovejoy, 2013; Thomas et al.,
2016) and stricter protocol adherence has been linked to improved outcomes (O'Donell, 2008;
Perepletchikova & Kazdin, 2005). One criticism is that direct observation may be more prone to bias
because the treatment variable is predefined and an observer might report what the therapist is
supposed to do rather than what actually happened (Schlosser, 2002).
Treatment fidelity information should be included in detailed treatment descriptions and in
the reporting of trial results (Moher, 2018). Currently papers may limit their investigation and
reporting of treatment fidelity to protocol adherence only (O’Shea et al., 2016) not addressing the five
areas of treatment fidelity (Bellg et al., 2004). Several guidelines now exist to help authors include
important intervention details including information on treatment fidelity (Moher, 2018). For example
checklists such as the Template for Intervention Description and Replication (TIDieR) (Hoffmann et
al., 2014) were established to encourage more complete reporting of treatments and to address the
“remarkably poor” (p. 1) intervention description quality. While the TIDieR checklist includes
general items related to the therapy such as task selection, therapy location and dosage it also includes
treatment fidelity specific items related to planned (item 11) and actual (item 12) treatment fidelity
(Hoffmann et al., 2014). These items go beyond simple receipt of the intervention and refer to how
well the intervention was received or delivered (Hoffmann et al., 2014). With the recent emphasis on
treatment fidelity, publications addressing this area specifically within clinical trials have been
published (Carragher et al., 2019; McLennon et al., 2016; Resnick et al., 2011) providing exemplars
for the reporting of treatment fidelity analyses. This has included the specific quantitative reporting of
protocol adherence.
5.1.3 Treatment fidelity in aphasia
The adequacy of SLP Randomised Controlled Trials (RCT) intervention descriptions, across
all SLP practice areas not just within aphasia trials, was assessed against the TIDieR checklist
(Hoffmann et al., 2014) with 46% of studies included reporting on treatment fidelity (Ludemann et al.,
2017). The reporting of treatment fidelity within the aphasia literature specifically has been
investigated twice. Hinckley and Douglas (2013) outlined the findings of an investigation into the
frequency of treatment fidelity reporting in the aphasia literature over a ten year span between 20022011 with all study designs and not just RCTs included in the review. Of the 149 studies reviewed,
14% reported on treatment fidelity. No apparent upward trend was identified towards an increase in
reporting over the ten years. As a result of their findings the authors called for journals to firm up
guidelines of treatment fidelity as a requirement for publication. More recently Brogan et al. (2019)
investigated treatment fidelity reporting in aphasia RCTs published from 2012-2017. Of the 42
included studies, nine (21%) articles explicitly reported on treatment fidelity processes. One article
addressed every recommended element of treatment fidelity and 37 (88%) articles addressed the study
design aspect of treatment fidelity by investigating therapy dosage. The least addressed aspect of
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treatment fidelity was ensuring participants used the skills gained in treatment in appropriate life
settings, with only two (2%) articles including this. The authors acknowledged that many trials
currently underway are placing emphasis on treatment fidelity and reflected that future reviews will
likely publish higher figures due to this (Brogan et al., 2019).
At the time of writing, 119 registered aphasia trials are currently underway or were recently
completed according to the International Clinical Trials Registry Platform. Many have published
research protocols and are using the current gold standard technique of video recording therapy
sessions and assessing these according to a priori criteria. These studies include the Aphasia Action
Success Knowledge (ASK) trial (Worrall et al., 2016), The Very Early Rehbailitation in SpEech
(VERSE) trial (Godecke et al., 2013), Predicting and Promoting Sub-acute Aphasia Recovery
(PAPAR) (Copland, 2017), SUpporting well-being through PEeR-Befriending (SUPERB) trial (Behn
et al., 2018) and the COMPARE trial (M. Rose et al., 2017). Other studies such as BIG CACTUS
(Palmer et al., 2015) have advantages with computerised therapy in obtaining fidelity data via logs
without relying on therapist report or monitoring therapist participant interactions. An additional level
of therapy fidelity is the monitoring of recorded sessions and providing feedback to the therapist to
change aspects of their therapy delivery and increase protocol adherence while treatment is still being
delivered. ASK, COMPARE and VERSE have incorporated this element. Some trials have published
therapy fidelity protocols as standalone articles (Behn et al., 2018; Carragher et al., 2019) or have
presented their processes at conferences (see Godecke et al. (2015)). This reflects an increased focus
on reporting treatment fidelity in aphasia and incorporating more rigorous procedures into the study
design and evaluation.
5.1.4 Very Early Rehabilitation in SpEech (VERSE) trial
This study involved the analysis of a subset of data from the VERSE trial, which aimed to
address gaps in the aphasia literature by investigating whether intensive aphasia therapy is more
effective and cost saving than usual care in very early aphasia recovery after stroke (Godecke et al.,
2016). The trial aimed to provide evidence for the provision of early intensive therapy, therapy
commencing with 15 days post stroke, and for the specific VERSE treatment. By doing so it
addressed areas in the Cochrane Review that indicate there is “insufficient evidence within this review
to establish the effectiveness of one SLT theoretical approach over another” (Brady et al., 2016, p.
51).
VERSE was a multicentre RCT with the interventions outlined in the trial as follows
(Godecke et al., 2016):
i)

Usual Care: Participants randomised to this group received care that is typical for aphasia
management and at the discretion of the treating SP. It also included management of other
speech pathology impairments such as dysphagia, dysarthria and/or apraxia of speech. Only
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direct aphasia therapy time was included in the analysis for the primary VERSE result. Usual
Care therapy was recorded over a period of 20 working days.
ii) Usual Care Plus (Usual Care-Plus): Participants received treatment that is typical of direct
aphasia therapy, at the discretion of the treating SP as per the Usual Care group, but with a
defined intensity therapy regimen of daily sessions for 45-60 minutes duration over 20
sessions. Direct aphasia therapy included 1:1 impairment based therapy, impairment based
computer training, social training, group impairment based therapy, group social training or
Augmentative and Alternative Communication (AAC) training.
iii) VERSE intervention: The intensity of this arm of therapy matched that of the Usual Care-Plus
arm but the intervention was impairment based, prescribed and standardised according to a
specific VERSE intervention protocol. As per treatment fidelity recommendations, when
planning the prescribed intervention the theoretical underpinnings of the treatment were
highlighted, allowing these to be monitored and evaluated. This intervention was founded on
principles to promote neurorecovery: i) massed practice, ii) error-free learning, iii) task
complexity, iv) salience, and v) maximising communicative success.
The findings of the VERSE trial indicated that communication outcomes were equivalent for
usual care therapy and early intensive therapy at 12 and 26 weeks post stroke (Godecke et al., 2018).
Usual care was documented to be therapy provided an average of two to three times per week for
approximately forty minutes (9.5 hours in total in the first 50 days after stroke) and this resulted in
improved communicative ability after stroke as measured by the outcome on the Western Aphasia
Battery Revised – Aphasia Quotient (WABR-AQ) (Kertesz, 2006). Intensive intervention (22 hours in
total in the first 50 days after stroke) provided within the Usual Care-Plus and the prescribed VERSE
intervention arms of the trial did not cause harm but did not provide a statistically significant benefit
to participants over and above the usual care regimen.
5.1.5 The current study
Treatment fidelity processes were developed and implemented within the VERSE trial.
Treatment integrity and differentiation were established in the main study, at the broad level, between
treatment conditions. However, with a trial of this size, including 8915 completed therapy sessions,
fine grained analysis of therapy sessions was not feasible. The researchers placed importance on
investigating a proportion of the sample at the fine grained level of analysis. In this treatment fidelity
study we investigate the dose form, as per Warren et al. (2007), given in the two arms of the trial to
establish treatment integrity and differentiation. In the VERSE trial the intensity was prescribed for
the two intervention arms at twenty sessions however, the dose form given and received within a
session was not prescribed. This therefore provides an opportunity to investigate treatment integrity
and differentiation. According to Baker (2012) dose form involves both the therapeutic inputs and
client acts of a task and so integrity and differentiation results have been framed according to these
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elements within the current study. As the interventions provided within the VERSE RCT were
behavioural and interactional in nature, treatment integrity and differentiation was investigated at the
utterance level in this study, with the following aims:
i)

To determine treatment integrity (protocol adherence) for the task and therapeutic inputs to
the VERSE intervention protocol.

ii) To determine the level of treatment differentiation (dose form given within sessions) for the
task, therapeutic inputs and client acts, between the intensive conditions (Usual Care Plus and
VERSE) at the utterance level.

5.2 Method
5.2.1 Participants
This study utilized therapy videos collected as part of the VERSE RCT. Participants were
recruited to the VERSE trial if they had aphasia secondary to an acute intracerebral haemorrhage or
ischaemic stroke; were 18 years of age or over; had corrected hearing and vision; were medically
stable at or before 14 days post stroke; and could participate in aphasia therapy in English without the
need for an interpreter. Exclusion criteria included pre-existing aphasia prior to admission into
hospital; a history of progressive neurological disease, neurosurgery or major depression, subdural or
subarachnoid haemorrhage; and an inability to maintain alertness for 30 consecutive minutes at 14
days post stroke. VERSE recruited 246 participants, 81 in Usual Care, 82 in Usual Care-Plus and 83
in VERSE, across Australia and New Zealand. Participants were assessed at baseline, 12 and 26
weeks post stroke on a range of impairment, psychosocial and economic based measures. The primary
outcome measure and dependent variable for VERSE was the WABR-AQ (Kertesz, 2006) at 12
weeks post stroke.
The participants for the current study represent a subset of participants from the broader
VERSE RCT. As part of the treatment fidelity processes embedded within the VERSE RCT, VERSE
and Usual Care-Plus therapists were required to video record one therapy session per week, resulting
in four or five recordings per participant (please see below for more details on the VERSE RCT
treatment fidelity processes). For practical reasons it was suggested to therapists to video record
session numbers five, ten, 15 and 20 however, therapy videos for any session were accepted.
A research assistant not involved with the current project used a computer generated block
randomisation sample of videos stratified for aphasia severity to select therapy videos for all
participants. This process was stratified for aphasia severity (mild, moderate and severe aphasia as
determined by the WABR-AQ at baseline). For the videos to be included within the study participants
were required to have outcome scores at 12 weeks (primary outcome) and twenty-six weeks on the
WABR-AQ and have completed the full treatment protocol. Additionally their videos needed to be at
least forty minutes in length, not contain the present author as the therapist and be playable on
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Windows Media Player. The sample comprised 53 videos which was 12% of the 434 therapy videos
received through the trial. See Table 19 for participant demographics included in this study. Of the 53
randomly selected videos seven participants had two videos in the sample (total 14 videos), one
participant had three videos in the sample (total 3 videos) and the remaining 36 participants had one
video each (total 36 videos). This resulted in the inclusion of 44 different participants. Twenty-seven
SLPs are also included in the videos. SLPs were hired specifically for the trial and were required to be
eligible for membership to Speech Pathology Australia. All treating SLPs underwent training (three
hours) and received procedural and training manuals relevant to the arm of therapy they were
providing. Clinical support was provided by trial clinical staff as required throughout the trial.
VERSE therapists were then given additional training (two hours) to administer the prescribed
therapy.

Table 19. Participant demographic and stroke characteristics

Whole group
Demographic
(n = 44)a

Age, Mean (SD)

Usual Care-

VERSE High

Plus

Intensity cohort

(n = 19)

(n = 164)b

VERSE
(n = 25)

72.0 (14.8)

75.0 (14.2)

68.0 (14.7)

75 (18)

19 (43%)

12 (48%)

7 (37%)

80 (49%)

3 (7%)

2 (8%)

1 (5%)

13 (8%)

PACs

34 (77%)

18 (72%)

16 (84%)

110 (67%)

PoCs

1 (2%)

0 (0%)

1 (5%)

6 (4%)

TACs

6 (14%)

5 (20%)

1 (5%)

35 (21%)

15 (34%)

8 (32%)

7 (37%)

47 (29%)

Female

Oxford Stroke Classification c

Hemorrhagic

Baseline WABR-AQ Severity

Mild

72

Moderate

13 (30%)

7 (28%)

6 (32%)

49 (30%)

Severe

16 (36%)

10 (40%)

6 (32%)

68 (41%)

Low disability (mRS 0-2)

6 (14%)

5 (20%)

1 (5%)

16 (10%)

High disability (mRS 3-6)

38 (86%)

20 (80%)

18 (95%)

148 (90%)

National Institutes of Health

9.1 (7.1)

9.4 (7.5)

8.7 (6.5)

9 (6)

Modified Rankin Scale Score
(mRS)

Scale Score, Mean (SD)
Note. a Within this substudy, 53 videos were selected through randomisation with 8 participants
having more than one video in the sample. Therefore, 44 different participants are included in this
demographics table. b This column represents the VERSE high intensity cohort as a whole from the
primary study for comparison purposes. c PACs= Partial Anterior Circulation syndrome; PoCs=
Posterior Circulation syndrome; TACs= Total Anterior Circulation syndrome.
5.2.2 Treatment fidelity within VERSE
All therapists within the trial completed standardised therapist training, including the
provision of a manual and logged session data. Additionally therapists in the intensive arms of the
trial (Usual Care-Plus and VERSE) were required to video record a set number of sessions across the
intervention period. The Therapy Fidelity Monitor (TFM) checked that therapy for participants in the
intensive arms of the study was commenced on or before day 15 post stroke and that it did not
continue beyond 50 days post stroke. The duration and frequency of each session within the intensive
arms of the trial were also monitored to ensure it was 45-60 minutes of direct aphasia therapy, for a
maximum of five sessions per week for 20 sessions within a maximum of 25 working days after
baseline assessment. For the prescribed VERSE intervention arm, key therapy ingredients were
identified within the study design. This guided therapist training and the monitoring of therapy
delivery. VERSE intervention therapists received a specific therapy manual and received one on one
support in order to implement the therapy as prescribed. The TFM monitored that prescribed targets
as per the protocol were met such as the target goal level for the session and that treatment was
predominately conversation based. They also monitored major VERSE protocol elements broadly
such as the timing and type of cueing used by the therapist and scaffolding of correct productions.
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This resulted in an overall rating of the session as adherent or non-adherent to VERSE protocol. The
TFM and Therapy Fidelity Co-ordinator were responsible for feeding back to the therapists about any
deviations from the VERSE protocol or any general questions that arose about the treatment
procedures.
5.2.3 Procedure

5.2.2.1 Transcription
In this study, each video was transcribed verbatim and utterances segmented following the
guidelines provided within the Systematic Analysis of Language Transcripts (SALT) (Miller, 2008)
software and as per SALT guidelines (available at http://saltsoftware.com/resources/tranaids).

5.2.2.2 Coding
During transcription, codes developed specifically for this research were applied at the word
and utterance level of the transcript for both therapeutic inputs and client acts. Variables of interest
were selected as possible key points of difference between treatments based on the theoretical
underpinnings of the VERSE therapy protocol. For example, the quantity and accuracy of the
participant’s production was a key consideration as the VERSE protocol incorporated the principle of
maximising communicative success through the use of salient communication based tasks and error
minimisation strategies. Rationales for the coding systems are explained in the relevant sections
below.

5.2.2.2.1 Treatment integrity – protocol adherence
5.2.2.2.1.1 Task (dose form)
Integrity or adherence to the VERSE prescribed treatment required therapists to implement
conversation based tasks aimed at eliciting an accurate phrase structure at the appropriate level for the
participant. This appropriate level is called a ‘goal level’. The rationale for verbal conversation tasks
in the VERSE protocol was i) that improvement in therapy is experience dependent; ii) a lack of
experience of practicing a task may result in learned non-use; and iii) conversation is salient to the
person with aphasia, a key neuroplasticity principle (Pulvermuller & Berthier, 2008).
A summary of the goal levels of the prescribed treatment and subsequent coding is presented
in Table 20. For example, if goal two was chosen as the starting point for the participant based on
baseline data, the therapist was trained to facilitate the production of verbal output at a minimum of
single word level. If the participant independently achieved 80% success during the session, they
progressed to the next goal. Utterances from the participant were coded as either at, above or below
the targeted goal level. The target goal level of each session was coded, to account for incremental
improvement throughout the treatment period. These codes were then counted to allow a calculation
of the percentage of utterances that were at or above the target goal level. The mean length of
utterance (MLU) during the therapy session, as per the SALT analysis, was also used to determine
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protocol adherence to see whether it matched the predetermined goal level of the session. This
measure is an average and broader than the utterance by utterance analysis. The MLU analysis
provides an overall measure of the mean length of utterance for the entire session whereas the
utterance analysis was a point to point count.

Table 20. Summary of coding for task adherence
Goal level

Definition

Utterance level coding

Minimum MLU
Expected in
Session

1a

1b

Receptive: Identification of verb

Any verbal output is

pictures from spoken words

appropriate. Cannot mark as

Receptive: Identification of
noun pictures from spoken
words

being below goal level. Can

0

0

mark as above goal level for
any verbal output that is not
an error.

1c

Receptive: Identification of

0

adjectives pictures from spoken
words
2

Verbal production of single
words

If not responding verbally

1

then mark as below the
appropriate goal level. Can
mark as above goal level if
above this level.

3

Verbal production of two
element phrases or clauses

If responding at single word

2

level including yes/no
responses then mark as
below the appropriate goal
level. Can mark as above
goal level if above this level.
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4

Verbal production of three

If responding below three

element phrases or clauses

element clause then mark as

3

below the appropriate goal
level. Can mark as above
goal level if above this level.
5

Verbal production of complex

If responding with three

clauses and/ or phrases

element clauses or less then

4

mark as below the
appropriate goal level. Can
mark as above goal level if
above this level.
6

Verbal production of complex

If responding below a

phrases (verb and noun) and

complex phrase mark as

clauses

below the appropriate goal

5

level. Can mark as above
goal level if above this level.
7

8

Verbal conversation about

Cannot mark as above goal

familiar topics

level. At conversation level

Verbal conversation about
unfamiliar topics

utterances must be above a

>5

>5

complex phrase otherwise
they will be marked as below
the appropriate goal level.

Note. MLU= Mean Length of Utterance
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5.2.2.2.1.2 Therapist inputs
The video transcriptions for the VERSE intervention group were coded according to
therapeutic inputs that adhered to VERSE treatment elements and those that did not. There was a
specific focus on how the therapist responded to participant errors with cueing. Cues are used by the
therapist to promote accuracy and participation by assisting in word retrieval and/or accurate speech
production. After coding and counting, a percentage of therapeutic inputs that adhered to VERSE
treatment elements for each session was established. Table 21 provides definitions of each of the
VERSE treatment elements that were coded.

Table 21. Definitions of adherence to protocol by the therapist
Type

Definition

Protocol deviant utterances (same cue)

Therapists are required to establish the type of cue that is
most effective for the participant. Therefore, therapists were
encouraged not to repeat cues that were ineffective. An
utterance would be marked as a protocol deviation if the
therapist used the same cue type for the same stimulus and
it was unsuccessful.

Protocol deviant utterances – x 3 errors

VERSE therapy incorporated the principle of error-less
practice. Therefore, therapists were encouraged to limit the
participant to no more than three errors on a stimulus. The
utterance was marked as a protocol deviation if the
participant made more than three errors for one stimulus
and a model was not given after the third error. Every
subsequent cue and utterance for the same stimulus by the
therapist which allowed the participant to continue making
errors was marked as a protocol deviation.

Protocol adherent behaviours

All therapist utterances that did not meet the above criteria
were deemed adherent to the therapy protocol.
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5.2.2.2.2 Treatment differentiation
5.2.2.2.3.1 Task (dose form)
Tasks were coded with a description of the activity (e.g. picture naming), the target language
process (i.e. expressive verbal, expressive written, receptive auditory or receptive written) and the
target phrase level (i.e. single word level, sentence or conversation) to enable dose form
differentiation. For conversation to be included as a task it needed to be the target of therapy including
therapeutic inputs such as cueing and feedback. Filler conversation and rapport building at the
beginning or end of session was not included.
5.2.2.2.3.2 Therapist inputs
Measures related to therapeutic inputs were coded in order to assess whether the treatment
provided in the two intervention groups were significantly different. A list of these codes is provided
in Table 22. Turkstra et al., (2016) suggested investigating ingredients, such as handling of errors and
their effect on target attainment, more generally across a therapy session rather than looking at the
impact of these ingredients separately for each activity. This approach was used within this study and
so the treatment sessions were examined as a whole to analyse therapist tailoring of cues and whether
the use of the cues resulted in successful participant/client performance. Codes were then counted to
provide totals and percentages for each session. In addition calculations were performed by the SALT
software (total therapists utterances, total therapist words and utterances per minute) and used in the
analysis.

Table 22. Therapist inputs for differentiation treatments
Code

Definition

Cue

Coded if a cue was used by the therapist. Also coded for cue type
including phonemic, semantic, orthographic, visual, forced alternative,
sentence completion, articulatory placement and direct model cues.

Cue used with success

Marked if a therapist utterance used a cue that successfully elicited an
appropriate response from the participant.

5.2.2.2.3.3 Client Acts
Measures related to client acts were coded in order to assess whether the participants’
response to the treatment provided in the two intervention groups were significantly different. A list
of these codes is provided in Table 23. Aphasia treatment approaches are often described as ‘error
full’ or ‘error free’ referring to whether patients are encouraged to attempt target attainment
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irrespective of the error quantity or whether errors are minimized to avoid strengthening of associated
negative neural networks. Reducing errors in therapy relates to Hebbian theory surrounding
coactivation of neurones and that a mistake occurring while producing a word may wire together these
two behaviours (Hebb, 1949; Varley, 2011). It aims to avoid therapy being the practice of errors
(Varley, 2011). Error-less learning may reflect implicit learning techniques that may be suited to the
motor learning required in speech production (Page, Wilson, Norris 2006). As such the codes of focus
reflected the quantity and accuracy of utterances. The codes were then counted to provide totals and
percentages for each session. In addition calculations were performed by the SALT software and used
in the differentiation analysis. These were mean length of utterance (MLU) in both words and
morphemes, total verbal utterances, total words, words per minute (WPM), utterances per minute
(UPM) and mean turn length in words.

Table 23. Client acts for differentiating treatments
Code

Definition

Error free utterances

Total number of utterances without an error.

Error

Total number of errors produced. An error made by the participant was
marked at the word level. Further coded for error type including filled and
unfilled pauses, phonological, perseverations, circumlocutions, semantic,
grammatical, repetition fluency, receptive and unintelligible errors.

Self-Correction

Errors that have been self-corrected prior to intervention from the therapist

Additionally, calculations were performed manually according to the formulas in Table 24
and used in the analysis.
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Table 24. Client act calculations for differentiating treatments
Calculation

Formula

Spontaneous verbal utterances

The number of verbal utterances that were generated
spontaneously. e.g. not a repetition of a model or a gesture.
(verbal utterances) – (repetitions + gestures)

Utterance Level Errors

Total of the number of errors that occur at the utterance level
based on codes in the transcript.

Word Level Errors

Total of the number of errors that occurred at the word level
based on codes in the transcript.

% errors self-corrected

Self-corrections / Total errors x 100

Average no. of errors per utterance

Verbal errors / Verbal utterances

Average no. of utterances per error

Verbal utterances / Verbal errors

% total words with errors

Errors / Total words x 100

Verbal utterances

Total utterances – Gestures

5.2.2.4 Pilot
The transcription and coding procedure was piloted on two VERSE and two Usual Care Plus
video recordings prior to completion of the full analyses. After piloting, codes were added in the
cueing and error category to increase the specificity of the data collected. The code relating to the
therapist using an incorrect cue in the VERSE condition for protocol adherence was eliminated as it
couldn’t be consistently identified.
5.2.4 Statistical analysis
Descriptive statistical analyses for treatment integrity and differentiation measures were
completed. As the session length of the videos was not equal, the time of the session was used to
standardise the data [measure / session time (mins)] for the following measures: total error free
utterances, total errors, spontaneous verbal output, total self-corrections, total verbal utterances, total
words, utterance level errors, word level errors, total cues used with success, total therapist utterances
and total therapist words. A Welch’s t-test for non-equal variances was performed using the above
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measures to determine whether Usual Care Plus and VERSE conditions were significantly different.
This test was used as it is robust to unequal sample sizes. A Bonferroni correction was applied for
multiple comparisons and significance was set at p<0.001.
5.2.5 Reliability
Six videos (one from each aphasia severity in Usual Care Plus and VERSE groups) were recoded for inter and intra rater reliability. This comprised 11% of the total sample in this study.
Reliability was established using the intra-class correlation coefficient (ICC) in SPSS (IBM Corp,
2015) with a consistency 2-way mixed effects model. The ICC was established on the four key
measures of interest in the study - error free utterances, total errors made, total self-corrections and the
total number of cues used with success by the therapist. Koo and Li’s (2016) guidelines for reporting
the ICC have been adhered to in the tables below.

5.2.4.1 Inter-rater reliability
As per Table 25, three of the measures had ICCs in excess of 0.90 and therefore, inter-rater
reliability can be said to be excellent. The self-corrections measure was lower however, ICCs in the
range of 0.75-0.90 remain in the good reliability range (Koo & Li, 2016).

Table 25. Inter-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.993

.949

.999

273.752

5

5

.000

Errors

.949

.686

.993

38.369

5

5

.001

.807

.134

.971

9.350

5

5

.014

.937

.621

.991

30.538

5

5

.001

Selfcorrections
Successful
Cues
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5.2.4.2 Intra-rater reliability
Intra-reliability is rated as excellent, given the ICCs are all in excess of 0.90 as per Table 26.

Table 26. Intra-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.993

.950

.999

281.238

5

5

.000

Errors

.988

.916

.998

162.171

5

5

.000

.993

.949

.999

270.621

5

5

.000

.993

.954

.999

300.417

5

5

.000

Selfcorrections
Successful
Cues

5.3 Results
5.3.1 Treatment integrity

5.3.1.1 Protocol adherence- task (dose form)
Within the VERSE condition participants took on average 511 turns (SD = 170.3) per session
including verbal and non-verbal responses. Non-verbal responses occurred on average 29 times per
session (5.6%) and verbal responses 482 times (94.4%). The majority of participant utterances within
tasks were at the target goal level with an average 67% of utterances at the target goal level within a
session. On average, 8% of utterances by the participant in a session were above the target goal level
of the session. Table 27 provides descriptive statistics for the therapists’ adherence to the target goal
level for the VERSE condition as measured at the utterance level.

82

Table 27. Measures of central tendency for protocol adherence to task
Measure

VERSE (n = 28 videos)

Error free and at appropriate goal level
Mean (SD)

197.2 (124.6)

Median

172.5

IQR

161

% total utterances

38.6%

Error free not at appropriate goal levela
Mean (SD)

128.4 (87.6)

Median

122.0

IQR

114.0

% total utterances

25.1%

Contains an error and at the appropriate goal level
Mean (SD)

185.7 (123.9)

Median

149.0

IQR

129

% total utterances

36.4%

Contains an error and not at appropriate goal level a
Mean (SD)

64.0 (56.3)

Median

48.0

IQR

55.0
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% total utterances

12.5%

Above goal level
Mean (SD)

36.2 (31.7)

Median

31.0

IQR

63.0

% total utterances

7.0%

% utterances above goal level
Mean (SD)

8.2 (8.5)

Median

6.1

IQR

12.1

Not at target goal level
Mean (SD)

192.4 (124.3)

Median

159.0

IQR

175

% utterances at correct goal level
Mean (SD)

67.2 (24.4)

Median

66.3

IQR

38.2

Note. a Not at appropriate goal level includes utterances that were below the target goal level only.
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A higher level of dosage adherence was seen using the MLU analysis compared to the
utterance by utterance dosage adherence measures above. The MLU analysis provides an overall
measure of the mean length of utterance for the entire session whereas the dosage adherence measures
above were a point to point count. Of the 28 VERSE sessions analysed, 24 (86%) had an MLU at or
above the target goal level for the session. This represents a high level of protocol adherence.

5.3.1.2 Protocol adherence – therapeutic inputs
Therapists produced on average 671 utterances (SD = 278.1) per session in the VERSE
condition. There were on average 15 protocol deviant utterances per session (inclusive of same cue
and error deviations) with 97.6% of utterances by the therapist being adherent to the VERSE
intervention protocol. Where deviations were observed, allowing the participant to make more than
three errors was observed most frequently, occurring on average ten times per session (1.5%). Table
28 summaries the protocol adherence data with descriptive statistics.

Table 28. Means and standard deviations for protocol adherence – therapeutic inputs
Measure

VERSE (n = 28 videos)

Total deviant utterances Mean (SD)

14.9 (17.3)

Protocol deviant utterances (same cue)

4.3 (7.5)

Protocol deviant utterances – x 3 errors

10.0 (12.5)

Protocol adherent behaviours

656.3 (273.6)

% Utterances that adhere to protocol

97.6

(3.2)

5.3.2 Treatment differentiation

5.3.2.1 Task (dose form)
Descriptive statistics for the tasks completed in this study are presented in Table 29. The
prescribed protocol was designed to focus on verbal language output and encourage conversation. The
VERSE therapy group had a greater percentage of verbal and conversation level tasks.
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Table 29. Tasks for treatment differentiation
Measure

Whole group

VERSE

Usual Care-Plus

(n = 53)

(n = 28)

(n = 25)

Total number of tasks

152

56

96

Total number of verbal tasks (%)

114 (75%)

48 (86%)

66 (69%)

Total verbal tasks at single word level (%)

53 (46%)

13 (27%)

40 (61%)

Total verbal tasks at conversation level (%)

16 (14%)

12 (25%)

4 (6%)

5.3.2.2 Therapist inputs
Descriptive statistics for therapeutic inputs are presented in Table 30. To maintain context the
means and standard deviations are presented in raw format prior to time adjustment [measure / session
time (mins)]. After statistical analysis, the groups were not found to be significantly different with p >
0.001.

Table 30. Descriptive and t-test statistic for treatment differentiation – therapeutic inputs
Measure

a

VERSE

Usual Care-Plus

p value

(n = 28 videos)

(n = 25 videos)

Therapist total utterances Mean (SD)

671.1 (278.1)

679.6 (226.0)

.577

Cues used with success by therapist

29.6 (27.4)

38.5 (48.5)

.424

Total cues used by therapist

77.3 (72.3)

86.6 (74.8)

.631

% Cues that were successful

41.5 (20.0)

38.2 (26.9)

.625

Therapist total words

2687 (948.5)

2848.6 (857.9)

.518

Therapist UPM a

12.5 (4.9)

14.5 (7.6)

.283

Utterances Per Minute
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5.3.2.3 Client acts
Descriptive statistics for client acts are presented in Table 31. To maintain context the means
and standard deviations are presented in raw format prior to time adjustment (measure / session time
(mins)). After statistical analysis, the groups, Usual Care Plus and VERSE were not found to be
significantly different with p > 0.001.

Table 31. Descriptive and t-test statistic for treatment differentiation – client acts
Measure

VERSE

Usual Care-Plus

(n = 28 videos)

(n = 25 videos)

474.2 (213.7)

483.4 (225.1)

.651

Error free utterances*

311.8 (135.5)

302.5 (139.6)

.979

Errors*

242.9 (134.6)

211.9 (135.7)

.521

Spontaneous verbal*

250.0 (161.0)

257.3 (144.5)

.661

Self-Corrections*

49.2 (64.0)

22.0 (22.0)

.040

% errors self-corrected

17.6 (18.1)

12.6 (14.4)

.276

Total words*

1847.4 (1460.7)

1511.6 (1128.2)

.402

MLU (words) a

3.5 (2.1)

2.9 (1.4)

.230

MLU (morphemes) a

3.9 (2.3)

3.2 (1.5)

.212

Average errors per

0.5 (0.3)

0.4 (0.2)

.115

2.4 (1.3)

2.8 (1.3)

.349

24.3 (27.2)

23.4 (34.0)

.854

Total Verbal Utterances

p value

Mean (SD)*

utterance (errors/utt.)
Average utterances per
error (utt/errors)
Utterance Level Errors
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Word Level Errors*

232.4 (162.0)

227.4 (162.3)

.997

% total words with

33.5 (52.1)

22.5 (25.5)

.326

UPM b

9.7 (3.1)

9.8 (3.6)

.892

WMP c

35.7 (27.7)

29.5 (19.8)

.355

Mean turn length

6.5 (6.2)

4.8 (3.5)

.223

errors

(words)
Note. a Mean Length of Utterance, b Utterances per minute, c Words per minute * Variables that were
adjusted for time as the session length of the videos was not equal (measure / session time (mins).

5.4 Discussion
This study sought to establish treatment integrity and treatment differentiation for the VERSE
trial in a fine grained transcript analysis of the therapy sessions. VERSE was the largest RCT into
early aphasia recovery completed to date. The analysis of the wealth of treatment fidelity data
collected in the trial is imperative to further analyse and interpret the trial outcomes.
5.4.1 Treatment integrity
Results suggest therapists, providing therapy in the intensive VERSE arm of the trial, were
adherent to the prescribed treatment protocol. This was established by measuring the therapists'
adherence to the target task level. On average, the target level of verbal output was achieved in 67%
of participant utterances in this sample of sessions from the VERSE arm, as per protocol. When
looking at a broader session view the target phrase structure was achieved 86% of the time when
measured by mean length of utterance. Protocol adherence for the therapeutic inputs was high at 98%
with minimal deviations. Therefore, the key VERSE elements of minimising errors and encouraging
verbal output were delivered by the therapist and it is possible to establish treatment integrity to the
dose form within this sample. There is no research that indicates the minimum level of integrity that is
required in an complex, behavioural RCT however, it is important to report what was intended
compared to what was received (Brogan et al., 2019). Additionally, adherence to the intensity of the
protocol is more commonly reported than adherence to key therapeutic elements within sessions
(Bakheit et al., 2007; Resnick et al., 2011). However, this study has shown that it is possible for
aphasia studies to monitor adherence to key therapeutic elements within therapy sessions and report
quantitative values for this. Behn et al. (2018) have also reported preliminary results with high fidelity
at 93.8% for their peer befriending wellbeing trial for people with aphasia. A current therapy fidelity
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protocol for the Action Success Knowledge (ASK) trial has set integrity at 100% adherence to
essential therapeutic criteria in a session and 80% overall adherence to protocol to deem therapists as
meeting criteria (Carragher et al., 2019).
5.4.2 Treatment differentiation
At the broader task level the VERSE treatment arm contained more verbal output, less single
word tasks and more conversation based task as per protocol. However, when the therapeutic inputs
and client acts were examined, at the utterance level, the treatments did not differ significantly. As
expected the tasks completed in the prescribed VERSE therapy were different to the treatment
provided in Usual Care Plus, however the therapist input, related to the amount of cueing provided to
support participant success as well as the amount of language produced by the therapist, was similar
for therapists in both arms of the trial. It may be that even if different therapy tasks were used, the
manner in which clinicians supported the participants within the treatment sessions was similar. This
may reflect clinicians’ perspectives around best practice for supporting patients in treatment sessions
or their understanding of facilitating neural recovery through limiting errors and providing individual
opportunities to produce verbal output. A related explanation concerns the underlying theoretical
mechanism underpinning language therapy. As hypothesized previously, the underlying therapeutic
mechanism at work in language therapy may be irrespective of task or therapeutic inputs (Godecke et
al., 2016).
In exploring treatment fidelity it is important to consider the way in which the therapy is
delivered as well as the role of the person who receives the therapy, the person with aphasia in this
case (Bellg et al., 2004). People with aphasia are a heterogeneous population (Brady et al., 2016),
with considerable variation in relation to how aphasia may present. Even within the same aphasia
classification such as Broca’s or Wernicke’s aphasia, the number of errors made or the types of cues
that are helpful may be very different from one person to the next. However, homogeneity can be
observed within PWA during therapy. The tasks used between therapy groups and between therapists
were different however, the interaction frequently elicited the same behaviour from people with
aphasia. It is possible that people with aphasia were reasonably predictable once their individual error
pattern and response to cues was established. Therefore, regardless of the assigned therapy group, the
presence or absence of a protocol, the therapist’s attempts to manipulate a session, minimise or
maximise errors, PWA responded in a particular pattern. And so, another possible explanation for the
lack of treatment differentiation in client acts is that regardless of the therapy provided, the response
of PWA was similar across the intervention groups. This may relate to the reinforcement of error
patterns by PWA regardless of the approach taken by the therapist (Conroy, Sage, & Lambon Ralph,
2009b).
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5.4.3 Interpretation of main trial results
Therapy fidelity data is vital to support the interpretation of the main trial outcomes,
especially in behavioural research (Walton et al., 2017). The main VERSE trial results found that
there was not a main effect for treatment intensity (Godecke et al., 2018). The participants in the
intensive therapy groups did not perform better on language testing outcome measures at 12 and 26
weeks post stroke compared to participants receiving Usual Care. VERSE established clearly that the
intensity with which the therapies were provided, when comparing Usual Care and the two intensive
arms was statistically different. This enabled their main hypothesis to be answered, confirming that
early aphasia therapy is important to enhance recovery but therapy is not required to be intensive
(greater than 3 times per week) (Godecke et al., 2018). Additionally the VERSE trial found that
results for the prescribed therapy arm of the trial were not different to usual care provided at the same
intensity.
This study aimed to investigate treatment integrity and differentiation for therapy provided in
the VERSE- RCT. Clinicians within in the VERSE and Usual Care Plus arms of the trial were
required to record 20% of their treatment sessions and this study provided a detailed, fine grained
examination of 12% of the videos received through the trial. As this is only a small percentage of the
total number of therapy sessions completed we cannot say with certainty whether this sample is
representative of all therapy given, however, feel the analyses completed and results found provide
important insight into the therapy provided within this trial. If the results from this study are
extrapolated to the broader VERSE RCT the findings suggest that therapists were adherent to the
therapy protocol for the prescribed VERSE arm of the trial and that while the therapies, provided in
the VERSE and Usual Care plus arms of the trial, contained different tasks and target language levels,
how the therapists interacted with participants was not different. Specifically the amount of cues used
by therapists to support participants, the success of these cues and the amount of verbal output from
the therapist, and the PWA, were not significantly different. We are cautious with extrapolating this
result to the entire VERSE RCT sample, however it could provide one potential explanation for why
the prescribed VERSE therapy arm and Usual Care-Plus did not perform differently in statistical
analyses for the primary outcome measures. It is likely that both conditions share the key elements of
aphasia therapy, that is therapists within the Usual Care Plus condition provided treatment elements at
the micro level that share the key elements of the VERSE intervention. It is unlikely that this is due to
contamination between conditions as the VERSE intervention was shown to be statistically different
at the task level of intervention prescription.
5.4.4 Recommendations for future trials
We would encourage researchers to undertake fine grained analyses of treatments provided
within complex, behavioural interventions. These fine grained analyses may reveal important
underlying factors in the way the intervention is provided or received by participants that require
90

further investigation and understanding in order to interpret trial results. Examining differentiation in
the treatments provided may not be sufficient if participant behaviour or acts have the potential to
impact clinician behaviour as the therapy session progresses. It will be important to consider this
relationship further in complex behavioural trials.
This study established that reviewing aphasia therapy videos from a RCT and coding these for
key measures is feasible, however data analysis was lengthy due to the in-depth nature of the analyses
completed. Further research is needed to develop a greater understanding of the behaviours that
should be investigated in establishing treatment integrity and differentiation and the most efficient
ways of evaluating these components. As this study was the first undertaken of this nature, a scoping
process was used. If a pilot study is utilized and the researcher has confidence that all key measures
have been identified resulting in a more targeted approach, the practicability may be increased.
5.4.5 Limitations
This study is the first of its kind to provide a detailed analysis of speech pathology therapy
sessions within an aphasia based RCT. However, it is acknowledged that a small number (12%) of the
available, trial videos were analysed and so there is a limit to the extrapolation of results to across the
trial as a whole. It is also possible that the study was underpowered to find differences between the
groups. The primary rater for the videos was not blinded to the treatment condition however,
unblinding was necessary for monitoring protocol adherence and treatments were also easily
distinguishable based on task selection. We do acknowledge the potential for bias.

5.5 Conclusion
Aphasia RCTs are encouraged to routinely report therapy fidelity data to assist research
consumers with their interpretation of trial results. We report high treatment integrity within the
VERSE trial. Determining the active ingredients and dosage level to ensure treatment differentiation
is an ongoing goal for aphasia trials. Micro level analysis of therapy sessions may reveal important
underlying factors for further investigation and it is only once the treatments are determined to be
sufficiently different and the target dosage achieved that the efficacy question can be answered.
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Foreword to Chapter 6
Title of publication: ‘An exploration of aphasia therapy dosage in the first six months of stroke
recovery’
Treatment fidelity is concerned with specifying theoretical underpinnings and potential active
ingredients in treatments to assist in drawing conclusions about treatment efficacy. It is not only
important for research to specify treatment ingredients but also to investigate the dosage level
delivered. Dosage in behavioural rehabilitations is frequently reported in units of time such as minutes
however, the content of a therapy minute and the way in which it may impact the rehabilitating brain
is frequently unidentified. The optimal treatment dosage in aphasia rehabilitation is unknown
(Dignam 2015) and there is a dearth of literature on optimal intervention intensity across many areas
in speech language pathology including aphasia (Baker, 2012; Off et al., 2016). Investigating how
therapists handle errors and cueing and the effect this has on the behaviour elicited in the treatment
session is a goal for aphasia research (Turkstra et al., 2016). This chapter is presented as an article
providing a thorough dosage analysis of the VERSE RCT and an attempt at furthering the theoretical
debate on dosage analysis within complex behavioural interventions.
This article has been submitted to Neuropsychological Rehabilitation for review.
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Chapter 6: An Exploration of Aphasia Therapy Dosage in the
First Six Months of Stroke Recovery
Abstract
Aphasia research uses the length of time within rehabilitation sessions as the main measure of
dosage. Few papers detail therapeutic ingredients or outline the number of times these were delivered
or received within a session or over the treatment period. The present observational study identified
therapeutic ingredients in the Very Early Rehabiltiation in SpEech (VERSE) trial and explored the
dosage provided using a model of cumulative intervention intensity (CII). Therapists video recorded
one therapy session per week and 53 randomly selected therapy videos were analysed. The videos
were coded for dosage related measures including number of error productions, self-corrections and
type and frequency of therapist cueing. The Western Aphasia Battery Revised-Aphasia Quotient
(WABR-AQ) was used as the dependent variable for measuring participant outcome with total verbal
utterances (p<0.001) and cues used with success (p<0.001) being independent positive predictors of
WABR-AQ score at six months post stroke and hypothesized as key therapeutic ingredients. The CII
was calculated by counting identified therapeutic ingredients and multiplying this by the number of
sessions completed. Collectively, the key ingredients occurred on average 504 times per session and
over 10,000 times per participant during the treatment period. This paper reports a novel approach for
identifying key treatment ingredients and detailing the dosage delivered within an early aphasia
rehabilitation trial.
Keywords: aphasia, dosage, rehabilitation, language, stroke
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6.1 Introduction
6.1.1 The rehabilitating brain and dosage
Rehabilitation has progressed from a focus on rheumatic diseases in the 19th century, through
war time needs, to the present day. More people are surviving brain injury than ever before, resulting
in greater demands placed on rehabilitation services (van de Sandt-Koenderman et al., 2012). For
rehabilitation to be successful, the brain relies on complex chemical and neuronal mechanisms to
induce permanent adaptation in cognitive processes. Learning is a cognitive process essential to
successful rehabilitation. Behavioural therapy for impairments after a brain lesion do not aim to
provide a cure but to maximise the capacity of the damaged networks to re-learn with experience and
for learning to alter the neural functioning at a synaptic level (Murphy & Corbett, 2009; Varley,
2011). Identifying the optimal treatment and its dosage is highly complex given the myriad of factors
that may influence the effect of treatment (Kamhi, 2012). Important components of the rehabilitation
jigsaw may include dosage, therapeutic relationship, medium of therapy delivery, client motivation,
cognitive ability, neurological stability (Whitworth, Webster, & Howard, 2014) as well as taskspecific practice (Lang, Lohse, & Birkenmeier, 2015). Developing an understanding of the key
elements of therapy needed and the dosage with which these should be delivered are likely to be an
important piece of the rehabilitation jigsaw.
Learning within neurorehabilitation sessions is concerned both with client acts and inputs
from the therapist (Kleim & Jones, 2008). The dosage at which these are delivered is crucial.
Treatment sessions aim to capitalise on and enhance the brain’s natural inherent plasticity that
underpins learning (Crosson et al., 2019). Neurorehabilitation focuses largely on practice dependent
learning that occurs when an individual repeatedly uses a skill to induce lasting neuronal change
(Robbins et al., 2008). This focus is grounded largely in Hebbian learning theory which is a
neuroscientific theory that proposes learning occurs by connections that develop through inputs that
co-occur and can be summarized by ‘neurons that fire together wire together’ (Hebb, 1949). It
requires repetition to induce lasting cellular changes that add stability to the network (Pulvermuller &
Berthier, 2008). Neuronal assemblies must be repeatedly active at the same time when forming links
(Pulvermuller & Berthier, 2008). Increased repetition of a newly learned behaviour may be required
to induce lasting neural changes (Kleim 2008) and so, in theory, the more frequently two relevant
brain events occur together, the more the critical connections will be strengthened (Pulvermuller &
Berthier, 2008). Assuming that therapy can induce coincidental learning, it has been hypothesized that
more training will help improve learning and may change behaviour (Pulvermuller & Berthier, 2008).
It is also hypothesised that there is a point of diminishing return to increasing the amount of therapy
and so the dosage associated with a therapeutic ‘sweet spot’ is yet to be discovered (Yoder, Fey, &
Warren, 2012). Additionally, there is the term ‘reaction range’ indicating that the response to therapy
varies depending on the individuals brain functioning (Gottesman, 1963; Yoder et al., 2012). Both of
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these concepts need to be considered in neurorehabilitation as increasingly, particularly with aphasia
therapy, intense may not be better (Godecke et al., 2018).
6.1.2 Defining dosage
There is no consensus for a definition of dosage within the stroke rehabilitation literature.
Dosage has been more widely investigated in the pharmacological literature and is of vital importance
as over-dosing is commonly associated with serious health problems (Baker, 2012). Dosage has been
defined as the amount of the active ingredient delivered at any one time, the frequency with which the
active ingredient is delivered and time duration or length of time across which the active ingredient
needs to be delivered in order to produce the desired effect (Lang et al., 2015). Frequently, in the
stroke rehabilitation literature, the terms intensity and dosage are used interchangeably. There has
been a call for consistent distinct terminology as the terms intensity and dosage have been used to
refer to a greater number of therapeutic events occurring in a shorter amount of time, greater number
of hours in therapy massed or distributed, or a greater number of total hours of therapy (Harnish et al.,
2014). A lack of definition consensus has implications for the synthesis of evidence and making
decisive statements about therapy. Definitions of dosage vary in the physical therapy literature with
some defining dose as the amount of time actively spent in practice and others as the number of
repetitions of a movement. However, the concept of repeated episodes of intervention over a period of
time is common across the different definitions of dosage (Baker, 2012). In a meta-analysis of doseresponse relationships in stroke rehabilitation, the dosage measure of therapy time was used as this
was the most consistently reported measure in studies (Lohse, Lang, & Boyd, 2014). The authors
acknowledged that ideally active time in movement practice or movement repetitions would be
reported and used in subsequent meta-analyses. Although the measurement of limb movements or
repetitions is different to the measurement of repetition in language based activities, the same
challenges associated with measuring dosage are present. This paper uses the definitions of dose and
intensity outlined by Warren et al. (2007) which is explained further. Regardless of how dosage is
defined, increasing the dose of rehabilitation interventions is a major challenge for therapists
(Vratsistas-Curto, Sherrington, & McCluskey, 2019).
6.1.3 Measuring dosage
The measurement of dosage is complex in behavioural interventions however needs to be
considered in planning and monitoring interventions. In planning an intervention it is not only
important for researchers to specify a therapy type but also whether an intended level of dosage
(amount in the session) is a key component of the therapy. In the implementation of the intervention
the level of dosage provided should be measured and then reported within publications. These
processes are needed in order to develop a greater understanding of the impact of the dosage within
the interventions being trialled. Implementing a treatment at an ineffective dose may be a waste of
therapy resources, harmful, ineffective or produce no effect and so be equivalent to providing no
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intervention (Baker, 2012). However, it is not yet clear how dosage should be measured in all
complex behavioural interventions or whether the measurement itself may be detrimental. Too much
attention on the process of quantifying dose might detract from the interaction between the therapist
and client that might ultimately determine the success or failure of therapy (Kamhi, 2012).
Additionally therapy dose may be expressed too simplistically if dosage is considered in a traditional
way such a time spent in therapy (Nelson & Butler, 2009). Frequently, the only reported dimension of
dosage is one or more units of time (Harnish et al., 2014; Warren et al., 2007). However, not all
therapy minutes are of equal value and understanding the contents of a therapy minute is essential.
Despite the potential challenges to measuring dosage it is vitally important to make sure the
minimum required dosage level is planned for and achieved in treatment efficacy research. Specifying
dosage will allow for improved treatment fidelity, facilitate the completion of replication studies and
better therapy delivery to patients (Harnish et al., 2014). As an example, Bakheit et al., (2007)
reported that only thirteen of the fifty one participants received the intensive aphasia intervention as
planned. The study cited that it was likely the amount of therapy received by the intensive therapy
group was below the threshold that is required to significantly enhance recovery of language function
(Bakheit et al., 2007; Robey, 1998). This issue is not limited to aphasia-focused research. For
example, in an investigation of whether patients with chronic stroke, who underwent task oriented
treadmill training, could motor learn and improve cardiovascular fitness, Resnick et al. (2011)
reported that only 48% of the sample reached the study goal of exercising at 60-70% of their
maximum heart rate. The study reported the low dosage level achieved by participants which helped
to interpret the treatment outcomes.

6.1.3.1 A formula for dosage
While it is acknowledged that is important to measure the dosage of an intervention, a
definition of dosage and a method of measuring dose is not yet well accepted. Warren et al., (2007)
called for behavioural scientists to adopt a similar approach to the pharmacological studies and
investigate therapeutic effects for different dosage levels. They proposed a comprehensive model of
intervention intensity and this was adapted and applied by Baker (2012). The model provides a
method of determining the dose of a treatment, or the Cumulative Intervention Intensity, across an
intervention period by first considering the task in which the teaching episode takes place. The
concept has been praised for encouraging researchers to develop a quantitative model of interactive
factors to describe a treatment approach. Figure 6. outlines Baker’s (2012) application of Warren et
al., (2007) dosage concepts visually.
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Figure 6. Parameters involved in determining the optimal intensity of intervention, based on Warren
et al. (2007). Reproduced with permission from Taylor & Francis Ltd and Baker (2012),
http://www.informaworld.com.
The application of most of these parameters appears straight forward for aphasia research. However,
even the simplest treatments are multifaceted (Warren 2007) and identifying the teaching episodes
that contain the active ingredients is the most difficult aspect of implementation. It is unclear which
factors contribute to cumulative intervention intensity and whether these will influence treatment
outcome in aphasia (Crosson et al., 2019). Even a picture naming task in therapy involves many
cognitive processes that could contain a number of active ingredients such as the cueing or feedback
used by the therapist, and whether the task is at the correct challenge point for the people with aphasia
(PWA). There is the additional complexity of whether the accuracy of production counts or discounts
a teaching episode. For example, an error made during stimulus production may exclude that attempt
in the dosage calculation, depending on the underlying theory of the treatment. Warren et al (2007)
suggest that this is one of the benefits of the model in that it requires clinicians and researchers to
think about and specify what their active ingredients are as well as the theory underpinning them.
More broadly, researchers need to consider whether interventions could be
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examined to identify the active ingredient/s in order to measure these and prescribe a dose (Baker,
2012).

6.1.3.2 Active ingredients in aphasia therapy
While efficacy studies exist, research into why and how aphasia therapy works is virtually
absent (Ratner, 2006). Aphasia and other complex interventions can be viewed as a ‘black box’
containing therapeutic inputs and clients’ outputs with little understanding of how the components of
therapy work. Dissecting the ‘black box’ of treatments, in order to identify the active ingredients and
explain how they work, is a challenge for researchers and practitioners. One explanation for why we
lack more detailed understandings of therapies is that rehabilitation practice is frequently not theory
driven (Dijkers, Hart, Tsaousides, Whyte, & Zanca, 2014). This is true in that many studies have aims
and hypotheses around therapy effectiveness not the theory behind the treatment. If researchers were
able to disaggregate interventions to test theory driven hypotheses about potential active ingredients
we may have more knowledge about the individual and joint effects of our treatments not just whether
they work or not (Dijkers et al., 2014).
Behavioural interventions are thought to have one or more active ingredients. Articles about
complex treatments often don’t provide information on active ingredients (Behn, Marshall, Togher, &
Cruice, 2019; Ludemann et al., 2017; Yamato et al., 2016) or their corresponding dosage because it
hasn’t been investigated, possibly due to the challenges associated with measuring these components
(Cherney, 2012). When the targeted goals are complex, defining teaching episodes becomes very
challenging (Hoffman, 2009). Baker (2012) has highlighted that dosage can only be determined
accurately when active ingredients within teaching episodes have been identified. In doing this it is
important to consider how the underlying theory is applied in the development of the treatment. For
example, neuroplasticity principles state that accurate, error-free practice of a skill is beneficial for
rehabilitation outcomes (Biernaskie & Corbett, 2001; Nudo, 2013; Raymer et al., 2008). Therefore,
investigations of therapy may focus on the quantity and accuracy of language produced by PWA. The
rationale for examining how much PWA say is that i) improvement in therapy is experience
dependent and ii) a lack of experience of practice may result in learned non-use (Pulvermuller &
Berthier, 2008; Pulvermuller et al., 2001). Therapy should involve practising tasks, involving an error
minimisation approach, to avoid a lack of experience causing atrophy in the network as well avoiding
the strengthening of negative neural networks (Varley, 2011). If recovery depends both on the
quantity and accuracy of PWA production then therapist behaviours, including cueing to facilitate
successful outputs from the PWA, together with the PWA’s production or output within therapy, are
key to recovery. This is in line with Baker’s (2012) view that active ingredients can involve
therapeutic inputs or client acts.
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6.1.4 Aphasia rehabilitation and dosage
According to the most recent Cochrane review, speech therapy is beneficial for people with
aphasia (Brady et al., 2016). However, there is a dearth of literature on the optimal intervention
intensity and the dose with which intervention should be delivered (Baker, 2012; Off et al., 2016). As
such, the optimal treatment regimen in aphasia rehabilitation is unknown (Dignam 2015). Despite the
existence of definitions for intensity and dosage (Baker, 2012; Warren et al., 2007), operational
definitions of treatment intensity and dosage have not been agreed upon and are not applied
consistently within aphasia research. Additionally, when time in therapy is used as a definition on
treatment intensity and/ or dosage, there is inconsistency in the description of what constitutes high
and low dose therapy provision. For example dosage is described, within the Cochrane review (Brady
et al., 2016), as hours of therapy provided reflecting the way in which dosage is most commonly
reported in studies in the review. The number of therapy hours in the ‘high dose’ Speech Language
Pathology (SLP) intervention varied from twenty seven hours up to 208 hours whereas ‘low dose’
received five hours to 78 hours. It has been reported that therapy is generally considered to be
intensive when participants receive at least nine hours of therapy per week (Cherney et al., 2008) with
efficacy for intensive therapy regimens being shown at 8.8 hours of therapy per week (Bhogal,
Teasell, & Speechley, 2003). The inconsistency in terminology presents a challenge for researchers
and clinicians.
When intensity has been investigated as a key factor in the outcome of therapy it is unclear if
the impact of therapy is due to the intensity with which the therapy was provided or what was
contained within the therapy (Sage, Snell, & Lambon Ralph, 2011). While many aphasia studies, as
per the Cochrane review, report intervention dosage using time, they give little insight into active
ingredients or within session therapy dosage. When Cherney (2012) compared eleven studies across
195 participants for high and low intensity aphasia they found that only 3 studies provided
information on the dosage level delivered within the session, or the number of times a teaching
episode containing an active ingredient occurred per session. It is not only that intervention studies are
not reporting optimal intensity, but the dosage of a ‘typical’ aphasia therapy session is also unknown
as benchmarking studies are rarely undertaken (Enderby, 2012). This means many therapists are
therefore unaware of the dosage they are providing in usual care, or the active ingredients of the
therapy, so it is also important to establish normative data prior to dosage manipulation (Dignam et
al., 2015).
Efforts have been made more recently to specify key therapeutic ingredients and report the
dosage of these within trials. Dignam (2015) provided the cumulative treatment intensity as per
Warren et al.,’s (2007) model for the treatment delivered in the first dosage controlled, parallel-group
design study to compare the short and long term therapeutic outcomes of massed versus distributed
comprehensive aphasia program in participants with chronic aphasia. Distributed over massed
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practice was favoured in which therapy in the distributed arm involved 6 hours per week for 8 weeks
days whereas participants in the intensive practice arm received 16 hours per week for 3 weeks. All
participants received Aphasia LIFT therapy (Rodriguez et al., 2013), a combination of impairment,
functional, computer based and group therapy. Over the treatment period the semantic feature analysis
component delivered 118.3 teaching episodes and the phonological component analysis delivered
114.3 teaching episodes. This represents a high level of dosage analysis for an aphasia trial. Another
attempt at measuring the dosage of active ingredients is a case series study from Harnish (2014) who
used a targeted cueing program for aphasia rehabilitation. Eight participants attempted to name fifty
target pictures, eight times during each session for a total of 400 attempts per session. The reported
cumulative intervention intensity was 3200 teaching episodes and the treatment resulted in significant
gains in reacquiring problematic words (Harnish, 2014). This study has been praised for its wellconstructed theory driven protocol that provides the foundation for continued and deliberate dosage
investigations (Off et al., 2016). It is plausibly easier to conceptualise measuring dosage in single
word treatments as opposed to conversational treatments and this presents a challenge for discourse
rehabilitation.
6.1.5 Very Early Rehabilitation in SpEech (VERSE) Trial
This study is part of a broader treatment fidelity analysis of the VERSE trial. VERSE aimed
to address some of the gaps in the aphasia literature by investigating whether intensive prescribed
aphasia therapy (VERSE treatment) and intensive non-prescribed usual care therapy were more
effective and cost saving than non-prescribed usual care training in very early aphasia recovery after
stroke (Godecke et al., 2013). The trial aimed to provide evidence for the provision of early intensive
therapy helping to address areas in the Cochrane Review that state there is “some indication that
therapy at high intensity or high dose… may be beneficial” (Brady et al., 2016, p. 9). The VERSE
trial findings indicated that communication outcomes were equivalent for usual care therapy and early
intensive therapy at 12 and 26 weeks post stroke (Godecke et al., 2018). Usual care was documented
to be therapy provided two to three times per week for 30-36 minutes, on average, or 9.5 hours of
direct aphasia therapy within the first 50 days post stroke. This resulted in improved communicative
ability after stroke as measured by the Western Aphasia Battery Revised- Aphasia Quotient (WABRAQ) (Kertesz, 2006), equal to that of the high intensity groups (total mean time of 21.7 hours of direct
aphasia therapy within the first 50 days post stroke). This provides valuable evidence that aphasia
intervention provided at 21 hours is not necessary in the defined early post stroke recovery period.
The goal of the VERSE prescribed treatment, one of the two intensive therapy arms of the
VERSE trial, was to facilitate and improve verbal output with therapists using a targeted cueing
hierarchy to promote successful, independent verbal production. Therapists were instructed to use
cues that were most likely to be successful once participants produced an incorrect response.
Participants were encouraged to repeat the target for practice in connected speech. The rationale
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behind the treatment postulated that correct production of the target as quickly as possible would
strengthen the networks responsible for language production and that high repetition of output with
reduced error production would lay the foundations for improved language and communication
outcomes in early stroke recovery. In this way, cueing was thought to be a key ingredient as well as
the dosage level of error free productions achieved by the participant in a session. As the Usual CarePlus condition in the trial did not include a prescribed treatment type, specified active ingredients or
dosage schedule, there is a unique opportunity for measurement of a ‘typical’ aphasia session.
6.1.6 Study Aims
This study investigated the dose form and dose frequency (Warren et al., 2007) provided within
the VERSE trial (Godecke et al., 2016) sessions with the following aims:
i)

Analyse the dosage level provided within a session for:
a. The two intensive therapy groups (Usual Care-Plus and VERSE)
b. Aphasia severities (mild, moderate and severe)

ii) Identify key ingredients in the intervention that are correlated with the primary outcome at 12
and 26 weeks post stroke.
iii) Calculate the cumulative intervention intensity for both intensive therapy groups (Usual CarePlus and VERSE) (Warren et al., 2007).

6.2 Method
6.2.1 VERSE Trial
VERSE was a RCT with the interventions offered in the trial as follows:
i)

Usual Care: Participants randomised to this group received care that is typical for aphasia
management and at the discretion of the treating SLP. It also included management of other
speech pathology impairments such as dysphagia, dysarthria and/or apraxia of speech,
however only aphasia specific hours were included as therapy hours within the primary study
analysis.

ii) Usual Care-Plus: Participants received treatments typical of direct aphasia therapy, at the
discretion of the treating SLP, but with a defined therapy regimen of daily (5 days per week)
aphasia therapy sessions for 45-60 minutes duration over 20 sessions. Direct aphasia therapy
included 1:1 impairment based therapy, impairment based computer training, social training,
group impairment based therapy, group social training or Augmentative and Alternative
Communication (AAC) training.
iii) VERSE intervention: The intensity of this intervention arm matched that of the Usual Care
Plus arm but the intervention was prescribed and standardised according to a VERSE
intervention protocol. As per treatment fidelity recommendations, significant consideration
was given when planning the prescribed intervention to highlight theoretical underpinnings,
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allowing these to be monitored and evaluated. This impairment based intervention was
founded on principles of promoting neuroplasticity through targeted early intensive language
therapy. The main principles that guided the VERSE prescribed intervention were i) massed
practice ii) error-free learning iii) task complexity iv) salience and v) maximising
communicative success through interactive functional tasks.

6.2.1.1 Participants
Participants were recruited to VERSE if they had aphasia secondary to an acute intracerebral
haemorrhage or ischaemic stroke, were 18 years of age or over, had corrected hearing and vision,
were medically stable at or before 14 days post stroke and could participate in aphasia therapy in
English without the need for an interpreter. Exclusion criteria included pre-existing aphasia prior to
hospital admission, a history of progressive neurological disease, brain injury, neurosurgery or major
depression, and an inability to maintain alertness for 30 consecutive minutes at 14 days post stroke.
Following baseline assessment, participants were randomised using a computer-generated, block
randomisation sequence, stratified for aphasia severity via the REDCAP web-based program (Harris
et al., 2009). VERSE recruited 246 participants, 81 in usual care, 82 in Usual Care-Plus and 83 in the
VERSE condition (Usual Care-Plus and VERSE conditions being the intensive conditions).
Participants were recruited from sites across Australia and New Zealand and were assessed at
baseline, 12 and 26 weeks post stroke on a range of impairment, psychosocial and economic based
measures. The primary outcome measure and dependent variable for VERSE was the WABR-AQ
(Kertesz, 2006) at 12 weeks post stroke. Please refer to the VERSE protocol paper (Godecke et al.,
2016) for full study details.

6.2.1.2 Therapists
In the Usual Care-Plus and VERSE conditions SLPs were contracted specifically for the trial
and were qualified SLPs. All Usual Care, Usual Care-Plus and VERSE treating SLPs underwent
training (five hours) and received procedural and training manuals relevant to the arm of therapy they
were providing. Clinical support was provided by the trial Treatment Fidelity Coordinator (VERSE)
or trial clinical staff as required.
6.2.2 Therapy fidelity dosage sub-study

6.2.2.1 Video recording and randomisation
This study examined therapy videos collected as part of the VERSE trial (Godecke et al.,
2016). Therapists from the two intensive therapy arms VERSE and Usual Care-Plus were required to
record four therapy sessions over the 20 sessions completed. Therapists were encouraged to record
one session a week. Of the 246 participants included in the VERSE trial (81 in Usual Care, 82 in
Usual Care-Plus and 83 in the VERSE condition), 434 therapy videos were recorded. To be included
in the current study videos had to be at least forty minutes in length and not contain the present author
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as the therapist, the participants shown in the video had to have completed the full treatment protocol
and have the 12 and 26 week dependent outcome measure score, WABR-AQ (Kertesz, 2006)
available and the video needed to be playable on Windows Media Player. A research assistant not
involved with the current project used a computer generated block randomisation sample of videos
stratified for aphasia severity to select therapy videos for all participants. The sample comprised 53
randomly selected videos representing 12% of the total recorded sample.

6.2.2.2 Procedure
6.2.2.2.1 Transcription
The selected videos were transferred and stored in a secure cloud based service. Each therapy
video was then transcribed verbatim using transcription conventions as outlined in the Systematic
Analysis of Language Transcripts (SALT) Transcription guidelines and software (Miller, 2008)
(available at http://saltsoftware.com/resources/tranaids). This included segmenting utterances in
Communication Units or C-Units. Each transcription was then coded according to a pre-determined
set of measures (see Table 32) that were based on the theoretical construct of the intervention and
believed to represent key therapeutic ingredients.

6.2.2.2.2 Coding
Word and utterance level codes, related to the aims of this research, were developed. Of
particular note were the number of error free utterances and utterances containing errors. The
investigation of client acts in this study focused on the quantity and accuracy of speech from PWA
and was grounded in a neuroscience perspective of experience dependent plasticity, learned non-use
and Hebbian theory (Hebb, 1949; Pulvermuller & Berthier, 2008; Varley, 2011). Aphasia treatment
approaches are often described as ‘error full’ or ‘error free’ referring to whether the PWA is
encouraged to attempt target attainment irrespective of the error quantity or whether errors are
minimized to avoid strengthening of associated negative neural networks. For this reason the
production and management of errors and participant self-correction of errors was an area of focus
within the coding with frequency of errors and self-corrections viewed as potential active ingredients.
An error free response was defined as one which was “appropriate and accurate for the
context and not corrected or modified by the therapist”. Frequently, the stimulus materials were
visible in the therapy video and the transcriber was able to evaluate the response. In the event that the
response could not be assessed as correct by the video reviewer, it was defined as a response that did
not receive correction or negative feedback from the therapist. Error free responses were coded at the
C-unit/ utterance level. Errors were defined as “inaccurate productions at the word or sentence level
that required modification, correction or negative feedback from the therapist”. Error responses were
marked at the word level and utterance level and utterances could contain multiple errors. If an error
was corrected by the PWA, without intervention from the therapist, it was coded as a self- correction
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with the initial mistake coded as an error. Boundaries of therapy tasks were not always clear and
social conversation was often a target of therapy. Therefore every utterance from the participant
within the therapy session, from the beginning to the end of the session, was coded and used as a
measure of dosage. Table 32 outlines the codes used in transcription.

Table 32. Dosage related measures and possible active ingredients
Measure

Definition

Error free utterances

Total number of utterances without an error.

Errors

Total number of errors produced.

Non-verbal responses

Responses that are non-verbal (e.g. gestures).

Self-Corrections

Errors that have been self-corrected prior to intervention
from the therapist

Cues used with success*

The number of times a cue was used by the therapist and
the participant responded correctly following the cue.

Note. *Cues used with success may represent a client act or therapist input. For ease of interpretation,
it has been categorised as a therapist input within this paper.

6.2.2.2.3 Transcription analysis
6.2.2.2.3.1 Dose form
The dosage delivered within a session is highly dependent on the type of therapy task, or dose
form (Warren et al., 2007) being used. A task was judged by the primary author while watching the
videos and was defined as the medium through which therapy was taking place and reflective of a
specific therapy goal. For example, picture naming at the single world level would reflect a task. The
same stimuli used in a sequence to generate sentences would reflect a new task. Tasks usually
contained stimuli and task explanations although not always. Most sessions contained multiple tasks
and many tasks were seen multiple times in the therapy videos. The total number of different tasks
provides a value for the number of times therapists used a task that was unique i.e. had not been used
by any other therapists in the videos.
6.2.2.2.3.2 Session duration
Dosage is also dependent on the duration, or length of a session. To calculate the dosage rate
of active ingredients in the cumulative intervention intensity model, the session duration is needed
(Warren et al., 2007). Session duration was controlled for in the VERSE study as sessions had to be
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greater than forty minutes in length and twenty sessions were given in total. The session duration for
the specific 53 videos used in this study is reported.
6.2.2.2.3.3 Dose
Following transcription and coding, calculations were performed by the SALT software for
both the participant and therapist utterances. These were total number of verbal utterances, mean
length of utterance (MLU) in words and morphemes, total words, words per minute (WPM),
utterances per minute (UPM) and mean turn length in words. In addition, calculations based on the
codes error codes outlined previously were made manually and these formulas can be seen in Table
33. Counts of the codes and the calculations were entered into the statistical software program SPSS
(IBM Corp, 2015) together with demographic data and the WABR-AQ scores at 12 and 26 week post
stroke scores (dependent measures).
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Table 33. Formulas used for calculating measures
Measure

Formula

Spontaneous verbal utterances

The number of utterances verbally generated
spontaneously. e.g. not a repetition of a model or a
gesture. (verbal utterances) – (repetitions + gestures)

Utterance Level Errors

Total number of errors that occurred at the utterance
level.

Word Level Errors

Total number of errors that occurred at the word level.

% errors self-corrected

(self-corrections) / (total errors) x 100

Average no. of errors per utterance

(verbal errors) / (verbal utterances)

Average no. of utterances per error

(verbal utterances) / (verbal errors)

% total words with errors

(errors) / (total words) x 100

Total Turns (participant)

Total utterances

Verbal utterances (participant)

Total utterances – gestures

Total number of cues used

Total number of cues used by the therapist.

% Cues that were successful

Percentage of the total number of cues used by the
therapist that were successful in facilitating accurate
production.

Total therapist utterances

Total utterances produced by the therapist.

6.2.2.3 Statistical analysis
Descriptive statistics are presented for participant, session number and duration, recovery and
dose form data. A Welch’s t-test for unequal variances with p > 0.001 (as per Bonferroni correction)
was performed to establish significant differences in dose. Within VERSE and Usual Care-Plus arms
of the VERSE trial sessions were expected to be at least 45 minutes long. However, as session time
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was not controlled for exactly, session length usually ranged from 45- 60 minutes, longer therapy
sessions would naturally be higher in many measures. These measures (as per Table 39 and 40) were
adjusted by dividing the total by the session time. The resulting standardised data was used in the
statistical analyses. Descriptive statistics are presented according to therapeutic group and aphasia
severity is in unadjusted raw format to maintain context. An ANOVA was used for the between group
analyses, to examine differences between therapy group (Usual Care-Plus and VERSE) and aphasia
severity (mild, moderate, severe). Significance set at p < 0.05 for post hoc analyses.
A linear regression was used to explore the relationship between potential therapy active
ingredients, considering and client acts and therapeutic inputs. A linear regression model was used
across both therapy groups (VERSE and Usual Care-Plus) with the participant’s primary outcome
measure, their WABR-AQ score at 12 and 26 weeks being the dependent measure. The WABR-AQ
score at 26 weeks was used for measures to show longer term association with the dependent variable
to be suggestive of maintenance. A Bonferroni correction was used for multiple comparisons
according to the number of variables in the analysis and significance was set at p < 0.00277. Baseline
aphasia severity as per the WABR-AQ and the overall amount of direct aphasia therapy was included
as predictors in the model to account for these factors. To be identified as predictive of WABR-AQ
score at 26 weeks, measures had to be significant at 26 weeks post stroke, demonstrating longer term
association. The identified ingredients were used to calculate the cumulative intervention intensity
[dose (client acts and therapeutic inputs) x dose frequency x total intervention duration] (Warren et
al., 2007).

6.2.2.4 Reliability
Six videos (one from each of the three aphasia severity groupings in Usual Care-Plus and
VERSE) were re-coded for inter and intra-rater reliability by another SLP trained in the coding
methods for this study. This comprised 11% of the total sample in this study. Reliability was
established using the intra-class correlation coefficient (ICC) in SPSS (IBM Corp, 2015) with a
consistency 2-way mixed effects model. The ICC was established on the four key coded measures of
interest in the study - error free utterances, total errors made, total self-corrections and the total
number of cues used with success by the therapist. Koo and Li’s (2016) guidelines for reporting the
ICC have been adhered to in the tables below. As per Table 34, three of the measures had ICCs in
excess of 0.90 and therefore, inter-rater reliability is reported as excellent. The self-corrections
measure was lower with ICCs in the range of 0.75-0.90 which remain in the good reliability range
(Koo & Li, 2016). As the ICCs were all in excess of 0.90 as per Table 35, intra-reliability is reported
excellent.
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Table 34. Inter-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.99

.95

.99

273.75

5

5

.000

Errors

.95

.69

.99

38.37

5

5

.001

.81

.13

.97

9.35

5

5

.014

.94

.62

.99

30.54

5

5

.001

Selfcorrections
Successful
Cues

Table 35. Intra-rater reliability results using ICC calculation
95% Confidence Interval

F Test With True Value 0

Intraclass
Code
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Error free

.99

.95

.99

281.24

5

5

.000

Errors

.99

.92

.99

162.17

5

5

.000

.99

.95

.99

270.62

5

5

.000

.99

.95

.99

300.42

5

5

.000

Selfcorrections
Successful
Cues
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6.3 Results
6.3.1 Participants
The 53 videos presented therapy sessions of 44 different participants. This comprised 27% of
the total number of participants included in the intensive arms of the trial (Usual Care-Plus and
VERSE, 165 participants). Of the 53 videos selected through randomisation seven participants had
two videos in the sample (total 14 videos), one participant had three videos in the sample (total 3
videos) and the remaining 36 participants had one video each (total 36 videos). This resulted in the
inclusion of 44 different participants. Table 36 presents the demographic details of these participants.
Twenty-five different SLPs were included within the analysed videos.

Table 36. Participant demographic and stroke characteristics
Demographic

Whole group

VERSE

Usual Care-Plus

(n = 44)*

(n = 25)

(n = 19)

Age, Mean (SD)

72.0 (14.8)

75.0 (14.2)

68.0 (14.7)

Female, n (%)

19 (43)

12 (48)

7 (37)

Haemorrhagic, n (%)

3 (7)

2 (8)

1 (5)

PACS, n (%)

34 (77)

18 (72)

16 (84)

PoCS, n (%)

1 (2)

0 (0)

1 (5)

TACS, n (%)

6 (14)

5 (20)

1 (5)

Mild, n (%)

15 (34)

8 (32)

7 (37)

Moderate, n (%)

13 (30)

7 (28)

6 (32)

Oxford Stroke Classification

Baseline WABR-AQ Severity
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Severe, n (%)

16 (36)

10 (40)

6 (32)

2 – Slight, n (%)

6 (14)

5 (20)

1 (5)

3 - Moderate, n (%)

17 (39)

7 (28)

10 (53)

4 – Moderate Severe, n (%)

11 (25)

7 (28)

4 (21)

5 - Severe, n (%)

10 (23)

6 (24)

4 (21)

9.1 (7.1)

9.4 (7.5)

8.7 (6.5)

Modified Rankin Scale Score

National Institutes of Health Scale Score,
Mean (SD)

Note. PACS= partial anterior circulation syndrome; PoCs= posterior circulation infarct; TACs= total
anterior circulation infarct. Baseline WABR-AQ Severity Scores= mild (>62.6), moderate (32.3-62.5)
and severe (0-32.2). *53 videos were selected through randomisation. Eight participants had more
than one video and 36 participants had one video in the sample. Therefore, 44 different participants
are included in this sample.
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6.3.2 Session number
Figure 7. displays the most frequently analysed session numbers within this sample. Session
number fourteen, twenty and five were the most frequently viewed.

Figure 7. Frequency data of session number included in the sample
6.3.3 Recovery
Figure 8. provides an overall context to the recovery of the participants included in this study.
Based on their severity diagnosis at baseline and reassessment at 12 and 26 weeks on the WABR-AQ,
participants at each severity level on average made an improvement in their scores.

111

100
90

WABR-AQ Score

80
70
60
50
40
30
20
10
0
Baseline

12 Weeks

26 Weeks

Time post Stroke
Mild

Moderate

Severe

Figure 8. Recovery trend on the WABR-AQ based on baseline severity
6.3.4 Dose form
Table 37 provides a summary of the number of therapy tasks completed within the sessions
shown in the videos according to each therapeutic group within the trial. A list of all tasks completed
in each condition is provided in Chapter 7 (Usual Care-Plus) and Chapter 8 (VERSE).

Table 37. Tasks completed in therapy videos
Measure

Whole group

VERSE

Usual Care- Plus

(n = 53)

(n = 28)

(n = 25)

Total number of tasks across all sessions

152

56

96

Total number of different tasks across all

69

18

51

2.9

2

3.8

session

Average no. tasks per session

112

6.3.5 Session duration
Table 38 below provides a summary of session time to provide a context for the measures
reported in the results section.

Table 38. Session duration in minutes

Mean Session Time

Whole Group

VERSE

Usual Care-Plus

(n=53)

(n=28)

(n = 25)

51.9 (7.3)

52.8 (6.9)

50.9 (7.8)

(minutes)

6.3.6 Dose- all measured ingredients

6.3.6.1 Session dosage by therapy group
The dose of all client acts is presented in Table 39 as per the different therapy arms in the trial
and the group as a whole. The dose of all therapeutic inputs is presented in Table 40. The groups were
not found to be significantly different on any of the measures, using Welch’s t-test for unequal
variances with p > 0.001 (as per Bonferroni correction) indicating an equivalent dosage across the
different types of intensive treatment.

Table 39. Dosage (client acts) descriptive statistics
Measure

Whole Group

VERSE

Usual Care-Plus

(n = 53)

(n = 28)

(n = 25)

Mean (SD)

307.4 (136.2)

311.8 (135.5)

302.5 (139.6)

Median (IQR)

289.0 (220.0)

273.0 (225.0)

292.0 (186.0)

Mean (SD)

228.3 (134.7)

242.9 (134.6)

211.9 (135.7)

Median (IQR)

203.0 (155.0)

211.5(194.0)

202.0 (189.0)

Error free utterances*

Errors *
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Spontaneous verbal
utterances *
Mean (SD)

253.5 (152.1)

250.0 (161.0)

257.3 (144.5)

Median (IQR)

215.0 (220.0)

214.5(287.0)

267.0 (167.0)

Mean (SD)

23.3 (45.0)

28.6

17.4

Median (IQR)

3.0 (18.0)

6.0 (19.0)

2.0 (17.0)

Mean (SD)

36.3 (50.3)

49.2 (64.0)

22.0 (22.0)

Median (IQR)

18.0 (43.0)

24.5 (79.0)

13.0 (36.0)

Mean (SD)

15.2 (16.5)

17.6 (18.1)

12.6 (14.4)

Median (IQR)

11.6 (20.6)

13.1 (26.9)

6.9 (16.3)

Mean (SD)

3.2 (1.7)

3.5 (2.1)

2.9 (1.4)

Median (IQR)

3.0 (2.8)

3.4 (3.8)

2.8 (1.8)

Mean (SD)

3.6 (2.0)

3.9 (2.3)

3.2 (1.5)

Median (IQR)

3.3 (3.1)

3.7 (4.3)

3.1 (2.1)

506 (186.6)

510.7 (170.3)

500.8 (206.9)

Non-verbal responses *

Self-Corrections *

% errors self-corrected

MLU (words)

MLU (morphemes)

Total turns *
Mean (SD)
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Median (IQR)

510.0 (232.0)

520.5 (257.0)

485.0 (254.0)

Mean (SD)

478.5 (217.0)

474.2 (213.7)

483.4 (225.1)

Median (IQR)

495.0 (265.0)

509.0 (317.0)

477.0 (252.0)

Mean (SD)

0.5 (0.2)

0.5 (0.3)

0.4 (0.2)

Median (IQR)

0.4 (0.2)

0.4 (0.4)

0.4 (0.2)

Mean (SD)

2.6 (1.3)

2.4 (1.3)

2.8 (1.3)

Median (IQR)

2.3 (1.3)

2.3 (1.5)

2.4 (1.3)

1689.0 (1313.1)

1847.4 (1460.7)

1511.6 (1128.2)

1443.0 (1552)

1791.5 (2138)

1256.0 (1171.0)

Mean (SD)

28.3 (41.7)

33.5 (52.1)

22.5 (25.5)

Median (IQR)

16.5 (21.5)

18.4 (27.7)

15.4 (19.2)

Mean (SD)

23.9 (30.3)

24.3 (27.2)

23.4 (34.0)

Median (IQR)

13.00 (32)

20.0 (31)

11.0 (39)

Total Verbal Utterances *

Average errors per utterance

Average utterances per error

Total words *
Mean (SD)
Median (IQR)
% total words with errors

Utterance Level Errors *

Word Level Errors *
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Mean (SD)

230.0 (160.6)

232.4 (162.0)

227.4 (162.3)

200 (214)

182 (202)

249.0 (238)

Mean (SD)

9.7 (3.3)

9.7 (3.1)

9.8 (3.6)

Median (IQR)

9.3 (4.9)

9.2 (4.0)

9.5 (6.0)

Mean (SD)

32.8 (24.2)

35.7 (27.7)

29.5 (19.8)

Median (IQR)

29.5 (28.3)

33.7 (51.5)

29.4 (27.2)

Mean (SD)

5.7 (5.1)

6.5 (6.2)

4.8 (3.5)

Median (IQR)

4.0 (7.0)

4.6 (9.3)

4.0 (4.3)

Median (IQR)
UPM a

WMP b

Mean turn length (words)

Note. * These measures were standardised according to session length. Descriptive statistics are
presented in their raw score to maintain context. a Utterances per minute b Words per minute
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Table 40. Dosage (therapeutic inputs) descriptive statistics
Measure

Whole Group

VERSE

Usual Care- Plus

(n = 53)

(n = 28)

(n = 25)

33.8 (38.6)

29.6 (27.4)

38.5 (48.5)

18.0 (50)

19.5 (49)

15.0 (70)

Mean (SD)

81.7 (72.9)

77.3 (72.3)

86.6 (74.8)

Median (IQR)

52.0 (110)

46.0 (110)

71.0 (112)

Mean (SD)

39.9 (23.4)

41.5 (20.0)

38.2 (26.9)

Median (IQR)

40.4 (31.2)

40.8 (25.2)

33.3 (43.9)

675.1 (252.5)

671.1 (278.1)

679.6 (226.0)

642.0 (403)

639.5 (472)

656.0 (309)

Cues used with success *
Mean (SD)
Median (IQR)
Total number of cues used *

% Cues that were successful

Total therapist utterances *
Mean (SD)
Median (IQR)

Note. * These measures were standardised according to session length. Descriptive statistics are
presented in their raw score to maintain context. a Utterances per minute b Words per minute

6.3.6.2 Session dosage by aphasia severity
Dosage (client acts and therapeutic inputs) are outlined in Table 41 and Table 42 respectively
according to aphasia severity at baseline. Significant differences were found between the mild and
moderate aphasia severity groups on the measures of percentage of errors self-corrected and mean
length of utterance (words and morphemes). Significant differences between the mild and severe
severity group were seen in measures of spontaneous verbal utterances, non-verbal responses, selfcorrections, percentage of errors self-corrected, mean length of utterance (words and morphemes),
total words, percentage of total words with errors, words per minute, mean turn length (words), cues
used with success, total number of cues used and total therapist utterances. Significant differences
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between the moderate and severe severity groups were seen in measures of spontaneous verbal
utterances, non-verbal responses, percentage of errors self-corrected, mean length of utterance (words
and morphemes), total verbal utterances, total words, percentage of total words with errors, utterances
per minute, words per minute, mean turn length (words). The direction of the significance can be seen
in the means provided. All other variables did not meet significance in post hoc testing p > 0.05. For
full statistical sentences of each of the post hoc analyses please see Appendix G.

Table 41. Dosage (client acts) mean (SD) and group comparisons by aphasia severity
Measure

Mild

Moderate

Severe

ANOVA

(n = 16)

(n = 17)

(n = 20)

p value

340 (149.4)

354.3 (125.3)

Errors *

223.2 (152.9)

292.4 (147.0)

177.8 (81.4)

.086

Spontaneous verbal *

318.6 (139.8)

329.8 (136.9)

136.5 (94.3)

.000 b,c

4.7 (7.3)

2.8 (3.5)

55.7 (61.1)

.000 b,c

Self-Corrections *

68.2 (70.1)

40.5 (37.4)

7.4 (11.2)

.001 b

% errors self-corrected

30.8 (18.7)

14.0 (10.7)

3.9 (5.6)

.000 a, b, c

MLU (words)

4.7 (1.4)

3.5 (1.3)

1.8 (1.2)

.000 a, b, c

MLU (morphemes)

5.2 (1.6)

3.9 (1.5)

2.0 (1.4)

.000 a, b, c

503.9 (1.8)

604.5 (171.2)

351.1 (207.6)

.023 c

Average errors per utterance

0.5 (0.4)

0.5 (0.2)

0.5 (0.2)

.988

Average utterances per error

3.0 (1.8)

2.4 (0.9)

2.4 (1.0)

.242

2442.5 (1153.5)

2208.1 (1335.1)

645.0 (548.4)

.000 b,c

9.6 (6.4)

15.8 (8.8)

53.8 (59.5)

.001 b,c

25.8 (22.7)

34.4 (43.1)

13.5 (18.3)

.158

Error free utterances *

Non-verbal responses *

Total Verbal Utterances *

Total words *
% total words with errors
Utterance level errors *

241.5 (111.7)

.045
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Word level errors *

223.9 (180.5)

310.1 (168.3)

167.0 (105.1)

.057

UPM

9.8 (3.2)

11.3 (2.7)

8.4 (3.5)

.023 c

WMP

47.2 (20.0)

42.0 (24.3)

13.4 (12.2)

.000 b,c

9.3 (4.6)

6.5 (5.0)

2.2 (3.1)

.000 b,c

Mean turn length (words)

Note. * These measures were standardised according to session length. Descriptive statistics are
presented in their raw score to maintain context.a Significant difference between the mild and
moderate groups b Significant difference between mild and severe groups. c Significant difference
between the moderate and severe groups. MLU= Mean length of utterance. UMP= Utterances per
minute. WPM= Words per minute

Table 42. Dosage (therapeutic inputs) mean (SD) and comparisons by aphasia severity
Measure

Mild

Moderate

Severe

ANOVA

(n = 16)

(n = 17)

(n = 20)

p value

9.6 (8.5)

37.5 (35.7)

50.1 (46.7)

.004 b

Total number of cues used *

29.9 (31.6)

91.8 (69.6)

114.5 (78.8)

.001 b

% Cues that are successful

38.5 (26.8)

41.9 (22.7)

39.5 (22.1)

.914

Total therapist utterances *

506.1 (188.6)

696.4 (260.6)

792.4 (224.2)

.000 b

Cues used with success *

Note. * These measures were standardised according to session length. Descriptive statistics are
presented in their raw score to maintain context. b Significant difference between mild and severe
groups.
6.3.7 Dose - active ingredients
Table 43 shows the linear regression of within session dosage measures and the WABR-AQ
score at 12 weeks post stroke. A Bonferroni correction was set for multiple comparisons (0.05 / 18
measures) at p < 0.00277 and no measures met this criteria for 12 weeks post stroke. Measures that
were significantly predictive with the WABR-AQ score at 26 weeks post stroke, as per Table 44 were:
total verbal utterances, percentage of total words with errors and the number of cues used with
success. These were hypothesised as key therapeutic ingredients in the treatment and used in the
cumulative intervention intensity calculation.

119

Table 43. Linear regression of dose (client acts and therapeutic inputs) with participant
outcome at 12 weeks post stroke
Unstandardized
Measure

Beta (B)

Standardised

Standard

Standardised

t-test

Probability

error for

Beta (β )

statistic

(p)

Beta (SE

(t)

B)
Total error free utterances*

1.947

0.911

.194

2.138

0.038

Total Errors*

0.815

0.97

0.077

0.84

0.405

2.133

0.953

0.232

2.238

0.030

Self Corrections*

0.744

2.716

0.028

0.274

0.785

% Errors self corrected

0.108

0.198

0.069

0.546

0.588

MLU (words)

1.94

1.901

0.134

1.021

0.313

Total Turns taken *

1.437

0.664

0.191

2.165

0.036

Total Verbal Utterances *

1.502

5.72

0.235

2.627

0.012

Average errors per utterance

-6.23

9.514

-0.060

-0.655

0.516

Average utterances per error

-1.609

1.84

-0.081

-0.874

0.386

Total words*

0.164

0.126

0.150

1.305

0.198

Utterance level errors*

4.153

4.216

0.090

0.985

0.33

Word level errors*

0.708

0.763

0.085

0.928

0.358

Spontaneous verbal
utterances*
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% Total words with errors

-0.139

0.062

-0.231

-2.22

0.031

Utterances per minute

1.455

0.668

0.192

2.179

0.034

Words per minute

0.167

0.121

0.157

1.387

0.172

Mean Turn Length

0.576

0.572

0.115

1.007

0.319

Cues used with success*

7.274

3.115

0.219

2.335

0.024

Note. * denotes variables were adjusted for length of session time.

Table 44. Linear regression of dose (client acts and therapeutic inputs) with participant
outcome at 26 weeks post stroke
B

SE B

β

t

p

Total error free utterances*

2.332

0.934

0.249

2.498

0.016

Total Errors*

1.603

0.962

0.166

1.666

0.103

2.334

0.994

0.268

2.347

0.023

Self-Corrections*

1.006

2.809

0.042

0.358

0.722

% Errors self-corrected

0.053

0.205

0.037

0.26

0.796

MLU (words)

2.534

1.961

0.188

1.292

0.203

Total Turns taken *

1.937

0.687

0.268

2.82

0.007

Total Verbal Utterances *

2.077

0.577

0.337

3.598

0.001 a

Average errors per utterance

-2.989

-0.031

-0.031

-0.301

0.765

Average utterances per error

-3.075

1.874

-0.170

-1.641

0.108

Total words*

0.213

0.13

0.205

1.637

0.109

Measure

Spontaneous verbal
utterances*
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Utterance level errors*

5.024

4.381

0.118

1.147

0.258

Word level errors*

1.31

0.783

0.168

1.673

0.101

% Total words with errors

-0.21

0.06

-0.381

-3.479

0.001 a

Utterances per minute

1.961

0.691

0.270

2.837

0.007

Words per minute

0.213

0.125

0.212

1.707

0.095

Mean Turn Length

0.637

0.592

0.137

1.076

0.288

Cues used with success*

10.82

3.039

0.355

3.561

0.001 a

Note. * denotes variables were adjusted for length of session time. a denotes significance after
Bonferroni correction at p < 0.00277.
6.3.8 Cumulative intervention intensity
The dosage measures that were predictive of WABR-AQ score at 26 weeks post stroke were
considered to be key therapeutic ingredients for this treatment and population. Measures that were
predictive of participant response at 26 weeks post stroke were total verbal utterances, percentage of
total words with errors and cues used with success. Specifically the greater the number of total verbal
utterances that were produced per session (irrespective of errors), the better the WABR-AQ score was
at 26 weeks. The percentage of total words with errors in the session was negatively associated with
WABR-AQ score meaning that the lower the percentage of words with errors in the session, the
higher the WABR-AQ score. Cues used with success was positively associated, with WABR-AQ at
26 weeks post stroke. The percentage of total words with errors measure was a percentage calculation
[(errors) / (total words) x 100] and so the mean value is not representative of the number of times the
ingredient occurred during the session rather a percentage of two other measures. As such it was
problematic to use in the intensity calculation and not selected. Therefore, total verbal utterances and
cues used with success were selected as the key therapeutic ingredients in these treatments to use in
the calculation of cumulative intervention intensity.
Figure 9. presents the cumulative intervention intensity for both therapy groups as per the
sample used in this analysis. This figure is adapted from Baker (2012) which was based on Warren et
al. (2007) dosage concepts. When considering the number of verbal utterances produced and the
number of cues used with success per session, people in the Usual Care-Plus group averaged 522
active ingredient episodes each session with five sessions/ week taking place over four weeks. This
resulted in an average cumulative intervention intensity of 10,400 during the trial. For individuals in
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the VERSE arm of the trial an average of 504 active ingredient episodes occurred each session over
five sessions/ week for four weeks to give a cumulative intervention intensity of 10,080 during the
trial.

Calculation of cumulative
intervention intensity

Usual Care-Plus
Cumulative intervention
intensity
(522 x 5 x 4) = 10440

VERSE
Cumulative intervention
intensity
(504 x 5 x 4) = 10080

Total intervention duration
4 weeks

Total intervention duration
4 weeks

Dose frequency
5 sessions per week

Dose frequency
5 sessions per week

Session Duration (51 mins)
Dosage rate (522/51) = 10.2 per
minute

Session Duration (53 mins)
Dosage rate (504/53) = 9.5 per
minute

Active ingredients
1. Total verbal utterances (483)
2. Cues used with success (39)
Total = 522

Active ingredients
1. Total verbal utterances (474)
2. Cues used with success (30)
Total = 504

Figure 9. Calculation of cumulative intervention intensity as per Warren et al. (2007) concepts.
Numbers presented in parentheses are the mean values from the sample and sourced from Tables 39
and 40. Please read the figure from the bottom up.
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6.4 Discussion
This study aimed to provide insight into the dosage level provided within the intensive
intervention arms of the VERSE trial (Godecke et al., 2016). Specifically, we have provided i)
normative dosage data across the intervention groups and aphasia severities; ii) an exploration of
potential key therapeutic ingredients to explain recovery in this population; and iii) a specification of
the intervention according to the dosage and intensity theory of Warren et al. (2007). Our goal was not
to provide a therapy regimen for therapists to follow. Rather, we aimed to develop an increased
understanding of the key ingredients of the therapy provided in the VERSE trial and the dosage with
which theorised ingredients were provided. In doing so we have trialled a method of identifying
potential active ingredients and measuring dosage for this population. We hope to stimulate further
discussion and encourage the research agenda in the area in order to improve the methodology used
within intervention studies when considering the way in which therapies are delivered. In the long
term this will assist in uncovering the elements of treatment that are most likely to improve functional
outcomes and the dosage with which these elements, or ingredients, are delivered.
6.4.1 The therapy black box
On average, the participants within this study, who were from three aphasia severity groups,
made a clinically significant improvement in their recovery from aphasia as measured by the WABRAQ (Kertesz, 2006). Turkstra et al., (2016) proposed that any treatment be specified using three
elements of treatment theory: i) targets, ii) ingredients and iii) mechanisms of action. These elements
of treatment theory are likely to make up the as yet unknown “black box” of aphasia interventions
(DeJong et al., 2005; Walker et al., 2017). The main contribution of these results is to the ingredients
element of treatment theory (Turkstra et al., 2016). Whilst no single piece of research can establish
what, how and how much to do in therapy, we trialled a method of identifying key ingredients for
therapy provided within the VERSE trial and measured the dosage with which significant ingredients
occurred. Within this study three measures were identified that were associated with language
outcome at 26 weeks post stroke. These were increased verbal utterances (client act), reduced
percentage of words produced which contained errors (client act) and increased cues used with
success (likely represents both a client act and therapeutic input). Interestingly these measures
represented both therapeutic inputs and client acts (Kleim & Jones, 2008) in Baker’s (2012) model as
shown in Figure 10. and may be the evidence based kernels or the active ingredients of the treatment
within this intervention trial (Embry & Biglan, 2008). While the model shown in Figure 10. is focused
on the teaching episodes within tasks it is acknowledged that there are many other components of the
rehabilitation jigsaw that contribute to therapeutic success, in conjunction with the teaching episode,
and a few are listed here.
The results presented here support an error minimisation (not error-free) approach possible
through a targeted cueing program that aims to create successful verbal production. This is balanced
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with encouraging the person with aphasia to say as much as possible and to provide clinical support to
facilitate production which contains as few errors as possible. It should be highlighted that
intervention provided in the VERSE trial was provided during early aphasia recovery and so it is
unknown if these findings would be similar for people in the chronic phase of recovery. Within this
study a novel approach was used to determine key therapeutic ingredients of the treatment in an
attempt to explore how therapeutic ingredients may be identified. A regression model was used with
the WABR-AQ as the dependent variable and while this approach found predictions with three dosage
measures, caution is needed with interpretation. Measures that were predictive (specifically verbal
utterances and reduced percentage of words with errors) may logically be related to the WABR-AQ
score. That is, a person with aphasia who produces more utterances and less errors will have a better
score on the WABR which is by design a predominantly verbal accuracy test. However, of note, is
that the measures were taken within the first month post stroke, and were predictive at six months and
baseline aphasia severity and amount of intervention received was included in the model. This has
provided an attempt at identifying how the handling of errors, or other potential key ingredients such
as cueing, affected target attainment more generally (Turkstra et al., 2016). This predictive
relationship was observed from a snapshot of therapy sessions that involved sixty nine different
therapy tasks in early aphasia recovery.

Figure 10. Adapted from Baker (2012), the relationship between dose form, teaching episodes and
active ingredients.
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This figure is adapted from Baker (2012) and explores the relationship between key
components of dosage and speech language pathology interventions. The puzzle piece represents
other elements of rehabilitation that may contribute to therapeutic success.
Literature outlining complex treatments often lack information regarding specific active
ingredients and their corresponding dosage. This is largely due to difficulty investigating these
complex behavioural interventions and the impact of a myriad of factors including therapeutic
relationship, environment and client motivation (Cherney, 2012). We used a formula presented by
Warren (2007) to calculate the dosage and cumulative intervention intensity for a sample of therapy
delivered in the VERSE trial. Identifying the key therapeutic ingredients was challenging especially
as tasks were not controlled and were often greater than single word level. Potential ingredients were
identified in the design phase that linked to the theory underpinning the interventions. That is, the
measurement and handling of errors was thought to be key to neurorehabilitative learning and aphasia
therapy and so prioritised. Then in an exploratory manner these key ingredients were counted and
coded in the analysis phase, however we acknowledge that the active ingredients measured here do
not represent all possible key ingredients. The level of analysis undertaken in this study was time
consuming, however it provides a framework for this line of inquiry to develop further. We suggest
focusing on the theory behind the intervention to measure targeted ingredients only. That is, measure
a small number of ingredients thoroughly with the aim to draw conclusions about their role in therapy,
whilst embedding a larger rigorous fidelity monitoring process to establish treatment adherence and
differentiation. The detailed analysis of active ingredients should be included in all smaller pilot
studies with an aim to discover which ingredients are positively associated with outcome. These
intervention kernels should then be tested on a larger sample in feasibility and Phase-III studies.
6.4.2 Dosage
The optimal treatment dosage in aphasia rehabilitation is unknown with significantly more
research required (Baker, 2012; Dignam et al., 2015; Off et al., 2016). For this study the cumulative
intervention intensity is over 10,000 occurrences of the ingredients predictive of recovery within an
intervention block of twenty sessions. This means that, on average, approximately 500 of these key
ingredients were delivered and received each session. The VERSE trial’s primary hypothesis
investigated an intensive therapy schedule which demonstrated equivalent outcomes between
intensive therapy and standard care in early stroke recovery (Godecke et al., 2018). It should be
highlighted that only data from the intensive intervention arms of the trial were included in this study,
videos from therapy provided within non intensive usual care were not included and so we don’t
know the findings from therapy that may be delivered at a lower dose. It may be that the within
session dosage level that was delivered is necessary but not on an intensive schedule. In the overall
trial cohort sessions of longer duration were associated with better recovery than a larger number of
shorter sessions (Rai et al., 2019). Sessions of longer duration may result in an increased dosage of the
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key client acts and therapeutic inputs. Based on VERSE efficacy data, positive therapeutic results may
be achieved with less frequent sessions but this level of within session dosage. Alternatively, it may
be that the dosage level provided in the VERSE trial is not necessary and participants were
‘overdosed’. A further alternative is that the dosage provided to the participants in the VERSE trial,
and in this study, was insufficient to show benefit in communication and language. Harnish (2014)
measured the dosage of active ingredients in a cueing treatment for people with chronic aphasia and
found positive outcomes with 400 attempts per session for a total of 3200 teaching episodes.
Therefore, future studies may aim to determine a threshold at which these potential active ingredients
are associated with a positive outcome within a session in order to inform research consumers about
what was delivered in the trial and assist research translation.
This study outlines the findings of a detailed analysis of the intervention dosage provided
within the VERSE study however, while the length of the sessions was set, a minimum target for
repetitions was not set in either the prescribed or Usual Care-Plus conditions. We have provided an
analysis of a ‘typical’ 45-60 minute aphasia therapy session using usual care data, possibly providing
a benchmark to be used as normative data in the future. Usual Care-Plus therapists were not given a
prescribed therapy. Therefore, we believe that the results presented here are representative of therapy
provision within Australia and the dosage level seen within a sessions of this length. This, combined
with the information from the main trial (usual care was two to three times per week for 30-36
minutes or 9.5 hours of direct aphasia therapy within the first 50 days post stroke), provides an
unprecedented level of information on usual care aphasia therapy within Australia and New Zealand.
It is interesting to note that there was not treatment differentiation for dosage between the prescribed
intervention (VERSE) and Usual Care-Plus on the analyses completed as part of the current study.
And so, even when a treatment was prescribed to the therapists, the measures examined in this study
did not differ significantly. This may be because Usual Care-Plus therapists were using the same
principles as the prescribed therapy, or that there is a homogeneity in the way that people with aphasia
respond to tasks.
There were statistically significant differences in the measured dosage variables across
aphasia severities as expected. This demonstrated that classification of severity at baseline remained
relevant to the performance of PWA during therapy sessions within the subsequent month. Of note,
people with severe aphasia had significantly less spontaneous verbal utterances, percentage of errors
self-corrected and words spoken compared to people with mild and moderate aphasia. They were
consistently lower on verbal efficiency measures such as utterances per minute, words per minute and
mean length of utterance. As this fits the common picture of aphasia severity it may also be expected
that they would make more mistakes in a session. People with moderate aphasia produced the most
errors (total errors) but also more utterances without errors and more total verbal utterances than
people with severe aphasia. This may reflect a trade-off of attempting to say more but making more
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errors in the process. As a proportion of the total words produced people with severe aphasia made
errors over fifty percent of the time. This was consistent even in the prescribed VERSE condition that
aimed for an error free approach. People with mild aphasia produced more self-corrections and were
able to produce more words across less utterances reflected in a higher MLU. As expected, many of
the participants with mild aphasia at baseline approached ceiling level on the WABR-AQ by 12 and
26 weeks post stroke.
6.4.3 Clinical significance
Investigating dosage in aphasia research is important in the clinical realm. An inaccurate dose
may be a waste of precious resources, harmful, ineffective or equivalent to no intervention (Baker,
2012). Since many therapists implement ‘third wave therapies’ or therapy cocktails they may not
provide the required dosage of therapy to be effective (Waller, 2009). In addition, the dosage level
decided on by a therapist may be influenced by all areas of the evidence based practice triad,
including patient values and clinical expertise (Sackett, Rosenberg, Gray, & Hayens, 1996). If
researchers can provide clinicians with the evidence of a threshold dose for a treatment then therapists
can more accurately manipulate treatments according to clinical results and patient related factors. If a
specific dose can be determined then services can be utilised at their optimum level and resources can
be reallocated where necessary.
6.4.4 Limitations
This study aimed to explore dosage, as provided in the VERSE study, and trialled a method
for analysing the therapy provided. Although the findings give an important insight into therapeutic
dosage, as provided in the videos analysed through this study, the method for identifying key
ingredients should be interpreted with caution as detailed above. The values used in the cumulative
intervention intensity model are averages attained in the analysis. The drawbacks of using average
scores as a measure is acknowledged. This study analysed 12% of the available videos in the VERSE
trial. This represents a small sample and so there is a limit to the extrapolation of these results to
represent the dosage within the trial as a whole. Additionally this means the current study may have
been underpowered. The primary rater for the videos was not blinded to the treatment condition as
unblinding was necessary for monitoring protocol adherence and treatments were also easily
distinguishable based on task selection and the potential for bias exists.

6.5 Conclusion
This study demonstrated it is feasible to analyse the dosage of therapy in aphasia
rehabilitation. Overall, these results suggest that an error minimization but verbal maximisation
strategy using a targeted cueing program is beneficial for people with aphasia in the early stroke
recovery period. There is, of course, great difficulty in determining what our therapy consists of and
the way in which this acts on the brain to facilitate recovery. Regardless of the intensity regimen, we
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have demonstrated that this cumulative intervention intensity and within session level dosage
contributes to positive outcomes for people with aphasia in early stroke recovery.

129

Foreword to Chapter 7
Title of publication: ‘Behind the therapy door: What is ‘usual care’ aphasia therapy in acute stroke
management?’
Treatment fidelity is concerned with complete intervention descriptions as delivered and
received in reality in the trial. This comprises all intervention given, including the control group. The
TIDieR framework (Hoffmann et al., 2014) is designed to be used in the control condition as well as
the main intervention under investigation. The specifics for what usual care aphasia therapy entails
have not been clearly documented. Surveys of current practice (Guo, Togher, & Power, 2014; Katz et
al., 2000; Verna et al., 2009) have been conducted and provide insight into therapists’ choices and
decisions. However, little is known about what happens behind the therapy door and trial control
group data consisting of videotaped therapy sessions provides a unique opportunity to further
knowledge. This study provides an unprecedented level of detail about the type of therapeutic
practices that occur in usual care aphasia treatment by investigating an aphasia RCT control group.
Thorough, detailed documentation of this aspect of treatment fidelity allows greater understanding of
everyday treatment practices and how they differ from proposed interventions.
This chapter contains an article about usual care therapy in the intensive control arm of the
VERSE RCT.
This article has been submitted to Aphasiology for review.
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Chapter 7: Behind the Therapy Door: What is ‘Usual Care’
Aphasia Therapy in Acute Stroke Management?
Abstract
Background: Usual care is the term used to describe everyday practice in the management of
a client within a profession. The knowledge of the tasks used in therapy and key therapeutic processes
used within these treatments, provides critical information about if and how the therapy works. The
Very Early Rehabilitation in SpEech was a three-armed Randomised Controlled Trial (VERSE RCT)
with therapists within the intensive Usual Care arm (UC-Plus) providing daily direct aphasia therapy
at their discretion for 20 sessions. Aims: To describe usual care aphasia treatment provided in the
Usual Care-Plus arm of VERSE RCT. Methods and Procedures: One in four intensive Usual CarePlus treatment sessions were video-recorded (N=187) within the main trial. Twenty-five of these
(13%) were transcribed, coded and analysed for therapeutic inputs to describe usual care aphasia
therapy using the Template for Intervention Description and Replication (TIDieR) checklist as an
overriding framework. Outcomes and Results: Therapy predominantly took place in an inpatient
setting (52%) with an average session duration of 51 minutes (SD 7.8). Across the sessions 96
different tasks were used and 57% of these focused on verbal expression at the single word level.
Visual materials were most frequently used compared to the use of technology during sessions.
Therapists (n=16) did the majority of the talking during sessions and most frequently provided models
as cues or problem solving accuracy feedback. Models (55%), sentence completion (51%) and
orthographic cues (44%) were the most successful at eliciting the target response. Conclusions:
Considerable variability in task selection was seen in the sample which may be a hallmark of usual
care. Therapists may have a preference for single word tasks and appear to produce the majority of
verbal utterances during sessions, potentially creating an unequal communication environment. This
study provided a comprehensive description from the Usual Care-Plus data of the VERSE RCT and
may establish a baseline of therapy type for future research.
Keywords: aphasia, usual care, rehabilitation, therapy, stroke
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7.1 Introduction
Usual care is the term used to describe everyday practice in the management of a client or
group, within a profession. Documenting usual care is challenging and the specifics of what usual care
entails for speech language pathology (SLP), in the management of people with aphasia (PWA), has
not been clearly documented (Godecke et al., 2014). The recent Cochrane review indicates the
provision of SLP treatment is favoured, in comparison to no treatment, however no treatment type is
superior to another (Brady et al., 2016). There is no consensus on the best treatment provided or the
ideal timing for therapy during recovery, although treatment in the early phase (within one month of
aphasia onset) is noted to achieve greater gains than that provided in chronic recovery (after six
months post stroke) (RELEASE Collaborators, 2019). Consequently, clinicians may wonder how the
intervention they provide compares to evidence-best practice. Surveys of current aphasia management
have provided some insight into this however, survey data alone is insufficient to develop a thorough
understanding of what underpins current aphasia therapy (Foster, Worrall, et al., 2016). More recently
rigorous trial design control groups that deliver usual care have provided a unique and valuable
opportunity to establish what everyday aphasia therapy looks like (Godecke et al., 2016; M. Rose et
al., 2017).
When describing usual care therapy, many elements have been considered such as the amount
and frequency of therapy provided (Verna et al., 2009), the theoretical approach or nature of the
treatment sessions (Guo et al., 2014; Kong & Tse, 2018; Verna et al., 2009), and the way in which
outcomes are measured (Verna et al., 2009). These elements constitute a broad look at usual care
therapy and aim to reflect current practice and therapists’ clinical decision-making. Currently
implementation is a priority for aphasia research and a moderate to high evidence practice gap has
been identified concerning the timing of therapy, the amount of therapy that should be completed and
the intensity with which therapy is provided (Shrubsole, Worrall, Power, & O'Connor, 2018). This
current study looks behind the therapy door using observational rather than self-report data, to
describe the therapy provided in the intervention group of a randomised controlled trial with a
particular focus on the type, amount and frequency of therapy. This detailed description of task
selection, materials used and the number of client acts and therapeutic inputs (dosage) delivered
within a typical aphasia therapy session provides a baseline example for manipulation of intensity
variables in future studies.
7.1.1 The therapeutic process
In general, therapy focuses largely on practice dependent learning that occurs when an
individual repeatedly uses a skill to induce lasting neuronal change (Robbins et al., 2008). Learning
within therapy sessions is concerned both with the client acts and the clinician initiated therapeutic
inputs (Baker, 2012; Kleim & Jones, 2008). The teaching episodes that occur in a session can be
investigated to isolate and evaluate the quality and quantity of client acts and therapeutic inputs
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(Baker, 2012). Therapist inputs may include components such as cueing, feedback and/or recasting.
Client acts can include factors such as the quantity of errors made, number of self-corrections or how
much the language system is challenged (Guadagnoli & Lee, 2004). Typically, treatment tasks are
used by therapists to implement the planned therapy. While it is acknowledged that a broad range of
factors facilitate and support neural and communication recovery, within a therapeutic context it is
expected that the tasks used, together with the client’s engagement within the tasks, are the foundation
of communication change in the patient. However, there is little research evidence available
investigating the mechanism of change behind therapies (Ratner, 2006). Critical variables for aphasia
therapy are thought to include the intensity and dosage, therapeutic relationship, medium of therapy
delivery, client motivation to engage, cognitive ability and neurological stability (Whitworth et al.,
2014) and the active ingredients that promote an individual’s recovery may lie within these variables.
While a wide range of active ingredients may be important to facilitate change in the
communicative ability of a person with aphasia, measurement of the active ingredients for therapy
first requires the specification of key client acts or therapeutic inputs (Baker, 2012). It is also then
important to determine the dosage with which these are delivered. Dosage in this study is
conceptualised as the number of times these ingredients occur within a session (Warren et al., 2007).
Therapist inputs that are of interest in this current study of aphasia usual care are cueing techniques
and the provision of feedback as therapists are concerned with accuracy of responses and the strength
of their praise and encouragement (Horton, 2006). Cueing and feedback encourage a point of
interaction between the person with aphasia and the therapist and are crucial to the therapeutic process
(Byng, 1995). Cues are used by the therapist to promote accuracy and participation by assisting in
word retrieval and/or accurate speech production (Abel, Schultz, Radermacher, Willmes, & Huber,
2005). Feedback serves to increase monitoring of production and possibly alter language and/or motor
neural representations to encourage self-correction and improved accuracy (Byng & Black, 1995). A
specific cueing or feedback strategy may be an active agent in facilitating change in the language
system because it is a therapist input that promotes the desired client act of word retrieval. In addition
to cueing and feedback techniques, there are other elements of therapy that provide insight into the
therapeutic process. Therapists are in control of the session using task introductions and explanations
to direct sessions. These may reflect the “business” of the session and the nature of the interaction
between the in control therapist and more passive patient (Horton, 2006). Therapists may highlight the
rationale behind treatment decisions or not highlight their reasoning to maintain an expert status
(Horton, 2006). Analysis at the utterance level of the therapy session can afford information about the
technique of therapy as well as the social processes, both of which may be active ingredients within
sessions (Horton, 2006).
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7.1.2 Usual care in aphasia therapy
SLPs manage different communication and swallowing related disorders in clinical practice
creating unique caseload and clinical decision making demands. A previous incidence study on usual
care aphasia intervention cited that caseload demands were the primary reason why aphasia therapy
was not provided to all (Lalor & Cranfield, 2004) with SLPs predominantly managing dysphagia
within Australian hospitals (M. Rose, Ferguson, Power, Togher, & Worrall, 2014). This may reflect
the priority placed on dysphagia management in acute hospitals leaving reduced time for the
management of other speech pathology related disorders (Foster, Worrall, Rose, & O'Halloran, 2013)
and/or the focus on assessment in the acute setting (Foster, O’Halloran, Rose, & Worrall, 2016).
Foster, Worrall, et al. (2016) concluded that the most striking finding from in-depth interviews with
fourteen Australian SLPs was there was no standardisation in the management of PWA in the acute
setting. It is argued here that this treatment heterogeneity is a hallmark of usual care SLP practice in
stroke recovery. Interestingly, a survey of usual care dysphagia practice identified great variability in
the choices made by clinicians with minimal use of evidence based intervention types (Carnaby &
Harenberg, 2013). Clinicians reported ninety different combinations of therapy techniques that they
would use to treat a single case. The authors concluded that there was no ‘usual care’ for dysphagia
management.
Surveys have been used to gain insight into aphasia therapy provision clinical decision
making and determine an evidence practice gap. Usual care practice surveys have targeted areas
including education provision (T. Rose et al., 2018), intensity of therapy provision (Katz et al., 2000;
Verna et al., 2009) intensive comprehension aphasia programs specifically (M. Rose, Cherney, &
Worrall, 2013) and rehabilitation practices (M. Rose et al., 2014). In a broad review of aphasia
management practices Verna (2009) reported on a survey of 70 Australian SLPs. This revealed that
80% of SLPs working in the acute setting provide therapy at a low to moderate intensity of one to
three therapy sessions per week. Therapy was delivered on average of just over two hours of direct
aphasia therapy each week for PWA. It was not captured within the survey if some PWA did not
receive aphasia therapy. Individual therapy was the most frequent medium despite other methods of
delivery appearing not to affect efficacy (Wenke, Cardell, Lawrie, & Gunning, 2018). Therapists
reported themselves to be evidence based (82.9%) however, they frequently reported using
combinations of therapy approaches (61.4%) (Verna et al., 2009).
Australian therapists reported the functional approach was most widely used in aphasia
therapy (M. Rose et al., 2014; Verna et al., 2009). Functional approaches seek to reduce the activity
limitation and participation restriction associated with aphasia and have a focus on enhancing
communicative ability in everyday life (Patterson & Chapey, 2008). Consistent with the Australian
research, international surveys of aphasia management in Singapore and Hong Kong revealed
therapists rated their knowledge and confidence with functional and participation approaches and
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neuroplasticity principles most highly and subsequently these approaches were also the most
frequently used (Guo et al., 2014; Kong & Tse, 2018). This survey data is helpful in identifying some
aspects behind clinical decision making however, it lacks detail of what happens within the session
behind the therapy door.
Clinicians report clinical guidelines are the main source of research evidence they use to
guide their aphasia management (Verna et al., 2009). It might seem logical to conclude that if
guidelines are readily available, usual care would consist of the straight forward implementation of
these guidelines. However, clinical guidelines frequently lack specification about what to do behind
the therapy door. Many clinicians have the knowledge of the broader evidence but do not know how
to implement it within their clinical setting (Lynch, Chesworth, & Connell, 2018). Even if guidelines
were specific and more ‘recipe’ based for a given clinical setting there are many barriers to
implementing guidelines in practice such as time constraints and therapist beliefs about consequences
and capabilities (Shrubsole, Worrall, Power, & O’Connor, 2018). Additionally, reasons for this poor
uptake of research evidence include the poor representations of complex patients in research and
under representation of the everyday clinician within clinical trials (Lynch, Chesworth, et al., 2018).
Therefore, despite the number of guidelines available and the content of these, much remains
unknown about the state of current aphasia practice in Australia (Foster, Worrall, et al., 2016). Selfreported surveys and interviews give unique insight into the decision making of clinicians but have
obvious bias which may skew understanding of the reality behind the therapy door. Observing a RCT
therapy type usual care group creates a unique opportunity to describe aphasia therapy usual care
practices. It is acknowledged that there is a limit to the extrapolation of results to all of usual care as
not all data can be captured. Many eligible participants are not recruited to trials and trial eligibility
criteria may exclude key groups for aphasia service provision such as culturally and linguistically
diverse PWA. Nevertheless observational data of usual care practice is the gold standard for
determining the everyday decisions and habits of therapists.
7.1.3 Trial control groups
When designing a clinical trial one of the fundamental requirements is to ensure that the
control group receives genuine usual care as would be reflective of everyday practice (Smelt, van der
Weele, Blom, Gussekloo, & Assendelft, 2010). This means thorough investigation of treatment
fidelity is not simply concerned with the delivery of the specific therapy provided within the
intervention arm(s) of the trial. All intervention received, including the treatment in the control group,
needs to be sufficiently monitored and described (Hoffmann et al., 2014) so that therapy provided in
all arms of a trial, including that provided to the control group is understood. This is important for
treatment differentiation as administering two (or more) interventions that are similar may affect the
internal validity of the study (Hinckley & Douglas, 2013) potentially affecting the results of a trial and
the interpretation of trial findings. For example a lack of difference between group outcomes has been
135

observed in an aphasia study, which compared cognitive linguistic treatment and communicative
treatment (De Jong-Hagelstein et al., 2011). One potential explanation for the non-significant study
results was that the therapies were not sufficiently differentiated (De Jong-Hagelstein et al., 2011).
Treatment fidelity analysis would have helped to show whether this or another explanation was could
be provided for the study result.
Research protocols completed in acute care settings frequently describe their control group as
receiving usual care and this refers to clinical management that is at the discretion of the hospital site
and their treatment protocols (Worrall et al., 2016). This can mean there is a high degree of variability
in care delivery (National Stroke Foundation, 2016) in the control group between participating sites
and represents issues for treatment fidelity. Retrospective analysis of the control group can provide
valuable insight into usual care practices. Palmer et al. (2018) used the clinical and cost effectiveness
of computer treatment for aphasia post stroke (Big CACTUS) control group data to describe usual
care provided within their study. Big CACTUS used a computerised approach to long term aphasia
therapy post stroke. Usual care recorded for all 278 participants provided data on practice between
2014-2016 for UK SLPs. Therapy goals were recorded during the trial and coded. A quantitative
content analysis was conducted to identify the frequency of goal categories, the average therapy time
received, the length and frequency of therapy sessions, the personnel involved and mode of delivery.
Six goal categories (rehabilitation, enabling, review, assessment, supportive and activity to support
therapy) were identified within the usual care therapy that was delivered within the trial. The median
amount of therapy received was one sixty minute session every two weeks and mainly functional
goals were addressed (Palmer et al., 2018). Palmer et al., (2018) published these results in a
standalone paper dedicated to describing the usual care control group. This paper adds not only to our
understanding of aphasia therapy provision but additionally highlights the increasing priority given to
describing intervention across all intervention arms of a RCT. However, detail into what happened
within the therapy sessions within the trial was not outlined and would add further value to the
interpretation of the trial results.
7.1.4 Intervention reporting
The care received in usual care is supposed to reflect the wide range of care as usually
received by patients in daily practice, whether it is adequate or not (NIH Rockville, 2002). In a review
of 73 pragmatic primary care trials not specific to aphasia, most of the clinicians providing therapy in
the control groups were not given any instruction on how to provide care, heightening the external
validity of the study. A few trials provided a prescription of what standard care should constitute
exerting more control over the control group, but being less reflective of true usual care. This
prescription may also reflect an unclear perception of what usual care would entail and therefore more
instruction was given to standardise the control group. To increase our understanding of usual care
provided within trials, guidelines have been developed on the reporting of the control group within
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trials. Smelt et al., (2010) recommended an extension to the CONSORT statement that requires
authors to specify details of the usual care control group. Shortly after, in 2014, the CONSORT
statement was extended through the Template for Intervention Description and Replication (TIDieR)
checklist (Hoffmann et al., 2014) which provides a framework with which to describe interventions.
This framework is less commonly used to describe the control condition however, the instructions do
state that it should be used to describe each intervention not just the main intervention under
investigation. The checklist and guide were developed by an international panel of experts using an
extensive literature review and help to resolve the problem of insufficiently detailed reporting of trial
interventions (van Vliet et al., 2016). The TIDieR checklist contains twelve items and includes
general items related to the therapy such as task selection, therapy location and dosage as well as how
the intervention is tailored or personalised for the patient (Hoffmann et al., 2014). The use of a
checklist such as TIDieR has been emphasised in complex therapy interventions such as those for
people after stroke and it has been used in stroke rehabilitation studies as a systematic way to describe
the interventions (van Vliet et al., 2016). Both the CONSORT and TIDieR documents emphasise the
need to provide clear descriptions of the content of all interventions administered in a clinical trial
including the control group. The recent Cochrane Systematic Review for aphasia following stroke
(Brady et al., 2016) strongly recommends clinical trials adhere to and report the CONSORT and
TIDieR statements. Despite this emphasis, many published articles lack clear and consistent
descriptions of the content of the interventions administered (Roulstone, 2015) and in particular the
control group. Intervention detail is essential for replication, application and transparency.
7.1.5 Aims
While there is no consensus on the best treatment for aphasia (Brady et al., 2016) there is
evidence for the effectiveness of usual care therapy in the early aphasia recovery stage (Godecke et
al., 2018). This necessitates the investigation of usual care to explore the nature of therapy provided
including and examination of therapeutic inputs. Survey data alone is insufficient to do this and
intervention arms within RCTs afford a unique opportunity to look behind the therapy door. The
VERSE RCT was a three armed RCT which aimed to address gaps in the aphasia literature by
investigating whether intensive aphasia therapy was more effective and cost saving than usual care in
very early aphasia recovery after stroke (Godecke et al., 2016). The secondary hypothesis of the trial
addressed whether a prescribed therapy type (VERSE arm) was more efficacious than usual care
therapy (Usual Care-Plus arm) when provided at the same intensity and equal overall treatment
amount.
The aim of this study is to describe, in detail, the intervention given in the Usual Care-Plus
arm of the VERSE RCT. A sub aim of the research was to describe the dosage (number of client acts
and therapeutic inputs) delivered within the session in Usual Care-Plus. The TIDieR checklist has
been used as a conceptual framework for this study (Hoffmann et al., 2014).
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7.2 Method
7.2.1 Very Early Rehabilitation in SpEech (VERSE) Trial
The VERSE RCT provides the context for this study with the interventions provided in the
trial as follows (Godecke et al., 2016):
i)

Usual Care: Participants randomised to this group received care that is typical for aphasia
management and at the discretion of the treating SP. It also included management
(assessment, therapy and case management) of other speech pathology impairments such as
dysphagia, dysarthria and/or apraxia of speech.

ii) Usual Care-Plus: Participants received treatments typical of direct aphasia therapy, at the
discretion of the treating SP, but with a regimen of daily sessions for 45-60 minutes duration
over 20 sessions. Aphasia therapy included 1:1 impairment based therapy, impairment based
computer training, social training, group impairment based therapy, group social training or
Augmentative and Alternative Communication (AAC) training.
iii) VERSE RCT intervention: The intensity of this arm of therapy matched that of the Usual
Care-Plus arm but the intervention was prescribed and standardised according to the specific
VERSE RCT intervention protocol. This intervention was founded on principles of promoting
neuroplasticity through targeted early intensive language therapy. The main principles that
guided the VERSE RCT prescribed intervention were: i) massed practice; ii) error-free
learning; iii) increasing task complexity; iv) salience and v) maximising communicative
success.
This study is not concerned with the intensity of usual care therapy provision and so the Usual
Care-Plus arm represents the control arm. It is noted that for the primary hypothesis of an
investigation of intervention intensity, the Usual Care arm was the overall trial control arm.
Participants were recruited to VERSE RCT if they had aphasia secondary to an acute
intracerebral haemorrhage or ischaemic stroke, were 18 years of age or over, had corrected hearing
and vision, were medically stable at or before 14 days post stroke and could participate in aphasia
therapy in English without the need for an interpreter. Exclusion criteria included pre-existing aphasia
prior to admission into hospital, a history of progressive neurological disease, neurosurgery or major
depression, subdural or subarachnoid haemorrhage, and an inability to maintain alertness for 30
consecutive minutes at 14 days post stroke. VERSE RCT recruited and randomised 246 participants,
81 in Usual Care, 82 in Usual Care-Plus and 83 in VERSE or 82 participants per arm from sites across
Australia and New Zealand. Participants were assessed at baseline, 12 and 26 weeks post stroke on a
range of impairment, psychosocial and economic measures. The primary outcome measure and
dependent variable was the Western Aphasia Battery Revised – Aphasia Quotient (WABR-AQ)
(Kertesz, 2006) at 12 weeks.
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All therapists within the trial completed standardised therapist training, including the
provision of a manual. They were also required to log all session data. Therapists from the two
intensive therapy arms, VERSE and Usual Care-Plus, were also required to record four therapy
sessions over the 20 sessions completed. Therapists were encouraged to record one session a week. Of
the 246 participants included in the VERSE trial (81 in Usual Care, 82 in Usual Care-Plus and 83 in
the VERSE condition), 434 therapy videos (247 VERSE, 187 Usual Care-Plus) were recorded
between June 2014 and March 2018. For usual care therapists in the non-intensive arm video
recording sessions was optional. These video recordings were stored in a secure cloud based service
and were examined using broad treatment fidelity and differentiation analyses (Godecke et al., 2016).
7.2.2 VERSE RCT usual care investigation

7.2.2.1 Participants
One element of data for the current study involved the analysis of a subset of the treatment
fidelity therapy videos from the Usual Care-Plus arm of the VERSE RCT. To be included in this
study, participants were required to have a VERSE- RCT primary outcome score at 12 weeks and
twenty-six weeks on the Western Aphasia Battery Revised – Aphasia Quotient (WABR-AQ)
(Kertesz, 2006) and have completed the full treatment protocol. Additionally their treatment fidelity
videos needed to be at least forty minutes in length, not contain the present author as the therapist and
be playable on Windows Media Player. A research assistant not involved with the current project used
a computer generated block randomisation sample of videos stratified for aphasia severity to select a
sample of twenty-five Usual Care-Plus therapy videos to examine usual care activities in aphasia
therapy. Nineteen different participants received therapy across the 25 analysed videos. The computer
generated randomisation identified two different therapy sessions for four participants and three
different therapy sessions were selected for one participant. Table 45 displays demographic and stroke
characteristics for the nineteen participants.

Table 45. Participant demographic and stroke characteristics
Demographic

n = 19

Age, Mean (SD)

68.0 (14.7)

Female (%)

7 (37)

Oxford Stroke Classification
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Hemorrhagic (%)

1 (5)

PACs (%)

16 (84)

PoCs (%)

1 (5)

TACs (%)

1 (5)

Baseline WABR-AQ, Mean (SD)

43.1 (24.3)

Baseline WABR-AQ Severity Classification (%)

Mild

7 (37)

Moderate

6 (32)

Severe

6 (32)

Modified Rankin Scale Score

2 – Slight

1 (5)

3 - Moderate

10 (53)

4 – Moderate Severe

4 (21)

5 - Severe

4 (21)

National Institutes of Health Scale Score, Mean (SD)

8.7 (6.5)

Note. PACs= Partial Anterior Circulation syndrome; PoCs= Posterior Circulation syndrome; TACs=
Total Anterior Circulation syndrome.
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7.2.2.2 Template for Intervention Description and Replication (TIDieR)
Statement
The TIDieR checklist (Hoffmann et al., 2014) format was used as a framework to describe the
therapy provided to participants within this study as it contains a number of categories related to the
aims of this study. While the treatment fidelity videos were the primary source of data for examining
the therapy sessions, further information was gathered from a diverse range of sources to provide a
complete intervention description. See Table 46 for the detail of each TIDieR item and how it was
addressed within this study. Please note that items 10-12 are not reported within this study as they
were not applicable to the Usual Care-Plus arm of the VERSE RCT.

Table 46. TIDieR checklist as applied in this study (Hoffmann et al., 2014)
Item Number

Item

Detail

1

Brief Name

Provide the name or a phrase that describes the
intervention.

2

Why

Description of any rationale, theory, or goal of the
elements essential to the intervention.

3

What - Materials

Description of any materials used in the
intervention and where they can be accessed.

4

What - Procedures

Description of each of the procedures, activities,
and/or processes used in the intervention. This
includes a focus on the tasks that therapists
selected.

5

Who Provided

Description of the expertise of the interventionists.

6

How

Description of the modes of delivery of the
intervention.

7

Where

Description of the types of locations where the
intervention occurred.

8

When and How much

Description of the number of times the intervention
was delivered and over what period of time. Within
this study this also includes the dosage
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conceptualised as the number of therapeutic inputs
provided in the session.
9

Tailoring

Description of how the intervention was
personalised or adapted. This was conceptualised as
clinical decision making by the therapist that would
personalise the treatment given. Included in this
section is task explanations and therapy rationales.
Key therapeutic inputs were also cueing and
feedback and are reported in this section.

10

Modifications

Description of the modification of the intervention
during the course of the study.

11

How Well – Planned

Description of planned intervention adherence or
fidelity and how.

12

How Well - Actual

Description of the extent to which the intervention
was delivered as planned.

7.2.2.3 Data collection
Data for Item 5 (Who provided) and 7 (Where) were sourced from the VERSE RCT main
trial database. For the remaining items, each transcription was coded according to a set of measures,
reflecting therapeutic inputs, in order to complete an analysis of usual care aphasia therapy as per
TIDieR. Each therapy video was transcribed verbatim using Systematic Analysis of Language
Transcripts (SALT) (Miller, 2008) software and as per SALT guidelines (available at
http://saltsoftware.com/resources/tranaids).

7.2.2.3.1 Tasks and materials
The therapy tasks and materials were noted as they appeared on screen. A description of the
treatment task / activity (e.g. picture naming) along with the desired output level (i.e. single word,
sentence or conversation level) was generated.

7.2.2.3.2 Measures of therapeutic inputs
The measures chosen for therapeutic inputs are displayed in Table 45 and Table 46 along with
their corresponding TIDieR item. In SLP interventions tailoring is necessary by the therapist to
deliver a personalised intervention according to the participant’s preference, skills or situation
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(Hoffmann et al., 2014). Therapists in Usual Care-Plus tailored their inputs at their discretion based
on clinical judgement for how the therapy should be provided. Table 47 contains measures that were
coded by the primary researcher and counted by the SALT software. Table 48 contains measures that
SALT calculated based on the software formulas.

Table 47. Measures of therapeutic inputs
TIDieR Item

Measure

Definition

Item 4

Task

Description of the task used to deliver the
therapy.

Item 9

Task explanation

Presence of an introduction and/or explanation
of task from the therapist.

Item 9

Rationale Discussion

Presence of discussion from the therapist about
why the task was chosen.

Item 9

Total number of cues

Total number of cues used by the therapist.

used
Item 9

Cue Type

Where a cue was used it was coded according to
the type (phonological, semantic, orthographic,
visual, forced alternative, sentence completion,
articulatory placement, direct model).

Item 9

Item 9

Item 9

Cues used with

The number of times a cue was used by the

success

therapist and the participant responded correctly.

% cues that were

Percentage of the total number of cues used by

successful

the therapist that were successful.

Feedback

Type of feedback given. Two types were coded.
Supportive feedback aimed to facilitate word
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retrieval without providing specific word
information cues and included subtypes of
elaboration, clarification and requests for more
information. Problem solving feedback
represented a way of externalising the word
finding process and explaining the errors and
consisted of two sub-types, correct/incorrect and
an explanation of error (Byng, 1995).

Table 48. Measures of therapeutic inputs calculated by SALT software
TIDieR Item

Measure

Definition

Item 8

Total Utterances

Total number of utterances produced by the
therapist calculated by SALT software.

Item 8

MLU (words)

Mean Length of Utterance (MLU) in words
calculated by SALT software.

Item 8

MLU (morphemes)

Mean Length of Utterance (MLU) in morphemes
calculated by SALT software.

Item 8

Total words

Total number of words said by the therapist
calculated by SALT software.

Item 8

Item 8

Utterances Per Minute

Utterances per minute calculated by SALT

(UPM)

software.

Words Per Minute

Words per minute calculated by SALT software.

(WPM)
Item 8

Mean turn length

Mean turn length calculated by SALT software.

(words)
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Although not the main focus of this study, two measures related to client acts were collected
and are reported in the results to provide contrast and context to the therapeutic inputs. These
measures were the total words and the total utterances produced by the participant in the session.

7.2.2.4 Analysis
The language samples were analysed using the SALT software and the counts of the codes,
demographic data and SALT calculated measures were entered into the statistical software program
SPSS (IBM Corp, 2015). Measures of central tendency are presented for the counts of therapeutic
inputs. Descriptions of the categorical data are provided.

7.2.2.5 Reliability
Therapist inputs as per Table 48. were calculated by the automated SALT software and
considered consistent and reliable. Three videos (one from each severity in Usual Care-Plus) were recoded for inter and intra-rater reliability, comprising 12% of the total Usual Care-Plus sample. The
second rater was a fourth year Speech pathology student trained in the transcription and coding
procedure. Reliability is presented in Table 49 and was established using the intra-class correlation
coefficient (ICC) in SPSS (IBM Corp, 2015) with a consistency 2-way mixed effects model. The ICC
was established on the coding of cues used with success, as this measure was more subjective to code.
Koo and Li’s (2016) guidelines for reporting the ICC have been adhered to in the tables below. As the
ICC is in excess of 0.90, intra-reliability and inter-rater reliability can be rated as excellent for this
measure.

Table 49. Reliability for cues used with success
95% Confidence Interval

F Test With True Value 0

Intraclass
Correlation

Lower
Upper Bound

Value

df1

df2

Sig

Bound
Inter-rater

.927

-.195

.998

26.254

2

2

.037

Intra-rater

.993

.755

1.000

279.769

2

2

.004
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7.3 Results
Results are presented as per the corresponding item in TIDieR (Hoffmann et al., 2014).
7.3.1 Item 1 Brief name
The intervention was called the Usual Care-Plus intervention of the VERSE RCT trial.
7.3.2 Item 2 Why
Participants received treatments typical of usual care aphasia therapy, at the discretion of the
treating therapist at the prescribed intensity of: 20 sessions completed daily, 45-60 minutes duration
over 20 working days. As observed in the videos aphasia therapy included 1:1 impairment based
therapy. Therapy type was not prescribed and so the Usual Care-Plus arm of the trial represents a
control group for intervention type.
7.3.3 Item 3 Materials
As shown in Figure 11. visual materials were used most frequently within the sessions.
Sixteen sessions used visual materials (for example picture cards), six used electronic materials (for
example an iPad) and three used no materials. It should be noted that more than one type of material
was used in seven sessions (28%).

Electronic
24%

No materials
12%

Visual
64%

Figure 11. Materials used by therapists within treatment sessions.
7.3.4 Item 4 Procedures
The procedures in the therapy session are highly dependent on the type of therapy task and
the number of tasks used in the session. Table 50 summarises the number of therapy tasks completed
within the 25 analysed sessions. Twenty-three sessions (92%) contained multiple tasks.
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Table 50. Summary of the number of tasks completed across the therapy sessions
Task

n = 25

Total number

96

Total number of different tasks

51

Average no. per session

3.8

Output level (excludes iPad tasks)

Single word level

53/96 (55%)

Sentence level

27/96 (28%)

Conversation/paragraph level

10/96 (10%)

Modality

Verbal output

65/96 (68%)

Written output

11/96 (11%)

Receptive output

14/96 (15%)

iPad tasks

6/96 (6%)

A detailed list of the type of tasks performed in Usual Care-Plus is presented in Table 51
below. The type of task column lists the name of the task performed such as picture naming. On many
occasions multiple videos included the same type of task and therefore, the quantity is included in a
separate column. As shown in Table 50 single word tasks were dominant.
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Table 51. Tasks completed in treatment sessions
Type of Task, in order of most to least frequent (n = 51)

Quantity (n= 96)

Expressive Language - Verbal

Single Word Level

Picture Naming

12

Semantic association naming

5

Automatic Speech

4

Odd one out (semantic)

3

Naming minimal Pairs

2

Object naming

2

Question and Answer task

2

Selecting prepositions

2

Generating synonyms

2

Generating antonyms

1

Convergent naming

1

Repetition of non-words

1

Phonemic Generative Naming

1

Semantic Category identification

1
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Single word repetition

1

Sentence Level

Picture description (not personal photo)

5

Constraint Induced Aphasia Therapy (CIAT) style barrier game

3

Reading aloud

3

Verbal reasoning (idioms and problem solving)

2

Articulate game (verbal explanation)

1

Personal photo description

1

Procedural discourse (e.g. making a cup of tea)

1

Reading semantic feature analysis prompts for to generate words

1

Script training

1

Solitaire card game (verbal requests)

1

Taboo (verbal explanation)

1

Conversation Level

Conversation

4

Situational Language (e.g. ordering a coffee)

1

Expressive Language - Written

149

Single Word Level

List writing (self-generated words)

2

Single word writing (from dictation)

2

Crosswords

1

Functional writing (name, address etc.)

1

Hangman game (letter and word generation)

1

Sentence Level

Written work sheet for sentence composition

2

Writing answers to reading comprehension

1

Written picture description

1

Receptive- Reading Comprehension

Paragraph Comprehension (answering questions)

2

Receptive – Auditory Comprehension

Single Word Level

Object to picture matching

2

Picture matching (same picture to same picture)

1

Semantic association receptive task (match associated pictures)

1
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Semantic association (which one can you eat?)

1

Single word auditory comprehension

1

Sentence Level

Semantic description comprehension task

2

Following a receptive command to place a picture in a grid

1

Paragraph level

Newspaper article with multiple choice questions

1

Paragraph comprehension (listening for the main idea)

1

Yes/No Questions after listening to a paragraph

1

Other- iPad Tasks

iPad written single word to picture matching

2

iPad articulation app

1

iPad choosing the missing letter

1

iPad sorting jumbled letters

1

iPad verbal single word to picture matching

1
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7.3.5 Item 5 Who provided therapy
Sixteen different therapists provided the therapy over the 25 sessions in this sample. The
therapists were employed at 11 different Australian hospitals. The average years clinical experience
working with people with aphasia for the therapists (n = 14) was 5.5 years (median 3.5 years, range 116 years).
7.3.6 Item 6 How therapy was provided
All sessions included in the 25 videos were individual 1:1 therapy sessions conducted in
person.
7.3.7 Item 7 Where
Therapy took place predominately within the inpatient setting as per Figure 12. The majority
of sessions were conducted in Australian clinics (88%) with the remaining in New Zealand (12%).
Other
12%

Personal Home
36%
Inpatient
52%

Figure 12. Location of therapy in recorded sessions
7.3.8 Item 8 When and how much
Within the VERSE RCT participants received 20 sessions over five weeks in the intensive
arms of the trial (Usual Care-Plus and VERSE). Within this study, the focus of Item 8 of TIDieR was
on dosage which was defined as the number of key therapy inputs included in the session (Baker,
2012). The number of times a therapist input would occur was a function of the therapy session
duration as measured in minutes. This was controlled within the VERSE RCT as the sessions had to
be greater than 45 minutes in length and the selected participants completed 20 sessions of Usual
Care-Plus therapy. The average session time across the 25 Usual Care-Plus videos was 50.9 minutes
(SD 7.8). Figure 13. displays the most frequently analysed session numbers within this sample.
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Session number fourteen, nine and twenty within the intensive block of twenty sessions were the most
frequently viewed.

Figure 13. Most frequently analysed session number
A summary of the verbal output from the therapists in the sessions is presented in Table 52.
Therapists did most of the talking during the sessions which was reflected in the number of words and
utterances compared to the participant presented in figures 14 and 15. For further values related to
participant output please see Chapter Six.
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Table 52. Summary of verbal output from therapists per session
Measure

Mean (SD)

Total Therapist utterances

679.6 (226.0)

Therapist MLU (words)

4.4 (0.9)

Therapist MLU (morphemes)

4.9 (0.9)

Therapist Total words

2848.6 (857.9)

Therapist UPM

14.5 (7.6)

Therapist WMP

55.8 (14.0)

Mean turn length (therapist)

9.7 (2.8)

Note. MLU refers to Mean Length of Utterance, UPM refers to Utterances Per Minute, WMP refers to
Words Per Minute

1512 (35%)

2849 (65%)

Therapist

Participant

Figure 14. Total words produced by the therapist versus participant
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483 (42%)
680 (58%)

Therapist

Participant

Figure 15. Total utterances produced by the therapist versus participant
7.3.9 Item 9 Tailoring
When introducing a task, the majority of therapists gave a task explanation however, a
rationale for why the therapy or task was chosen was provided infrequently as per Table 53.

Table 53. Frequency of therapy rationale and task explanations
Measure

n =25

Therapy rationale discussion present in session

7 (28%)

Task explanation present in therapy session

22 (88%)

Average quantity of task explanations per session (SD)

2.3 (1.7)

Table 54 summarises the therapeutic inputs (cueing) for tailoring the sessions. Across the 25
sessions, 2165 cues were used by therapists with 962 being used successfully. The average number of
cues used each session was 86.6 (SD 74.7). These are displayed by category in Figure 16. The average
number of times these cues were successful is also displayed by category in Figure 17.
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Table 54. Summary of cues used by therapists per session across all task modalities
Measure

Mean (SD)

Number of cues provided

86.6 (74.7)

Cues used with success

38.5 (48.5)

% total cues used that were successful

38.2 (26.9)

35

32.6

30
25

23.4

20
15
10
5

12.9
8.2
4.1

2.3

2

1.3

0

Figure 16. Average number of cues used by cue category per session
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60.00%
54.6%
51.2%
50.00%
43.9%
40.00%

43.5%

42.7%
38.5%
35.0%

30.00%

20.00%
13.2%
10.00%

0.00%

Figure 17. Percentage of times a cue was used with success in a session by cue category
Table 55. Displays therapeutic inputs related to the feedback provided. Across the 25 therapy
sessions there were 1501 instances of problem solving feedback and 1193 instances of supportive
feedback. Problem solving accuracy feedback was most frequently provided. Feedback was provided
throughout tasks as well as at the end of a task.

Table 55. Summary of types of feedback used by therapists per session
Measure

Mean (SD)

Problem solving accuracy feedback

51.8 (34.7)

Supportive clarification feedback

10.9 (11.3)

Supportive elaboration feedback

8.9 (11.7)

Problem solving explains error feedback

8.3 (8.8)

Supportive requests feedback

7.5 (17.9)
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7.4 Discussion
This study has provided a comprehensive description from the Usual Care-Plus data of the
VERSE RCT trial. It offers a useful insight into the way in which aphasia therapy is provided in usual
care sessions within Australia and New Zealand and establishes a baseline for future research. With
the intensity regimen kept constant, therapy ingredients and therapist behaviours varied and these
behaviours are reflected upon here.
7.4.1 Description of therapy
We provided a description of usual care practices in aphasia therapy and decisions made by
the therapists regarding the content of their sessions. Across the 25 sessions analysed within this study
there was significant variety in the nature of the tasks and the modalities used within these tasks. Most
frequently, therapists used visual materials that were not electronic within therapy sessions. If
electronic materials were used, an iPad was favoured. The majority of tasks targeted the single word
level despite the sample being balanced for aphasia severity. This demonstrates a preference for
therapists to choose single word tasks even if a patient may be speaking at phrase or sentence level.
This finding is in line with previous research showing treatment for aphasia is typically concerned
with single word level treatments (Boyle, 2011). Additionally, 93% of Australian clinicians reported
the Western Aphasia Battery (WAB), Boston Naming Test (BNT) and Psycholinguistic Assessment
of Language Processing Activities (PALPA), predominantly single word level assessments, as the
main assessment tools used in practice (Verna et al., 2009). Clinicians may therefore believe word
finding difficulties are repaired through tasks focused at the single word level or may find the
transferability of evidence into practice easier at that level when using tasks involving single words.
The predominance of single word focused tasks in this study is noteworthy given that therapists
previously reported using a functional approach (Verna et al., 2009). This may mean that the
definition of functional therapy requires further clarification. Additionally, barriers to therapists
implementing conversation based therapies have been documented and this may influence the
selection of primarily single word tasks. These include a perceived lack of evidence for the active
ingredients of conversation based therapy and concerns about other professionals perceiving SLPs as
“just having a chat” (Sirman, Beeke, & Cruice, 2017).
On average therapists completed four tasks in a 51 minute therapy session and there were 51
different tasks observed across the 25 videos analysed. This is similar to investigations into dysphagia
by Carnaby (2013) who found over 90 therapy combinations were used to treat one case and
concluded that there was no ‘standard’ usual care in dysphagia management. It is likely that tasks may
have been targeting the same verbal output goal in a session or similar underlying language recovery
mechanisms. For example, a therapist might use three different tasks in a session targeted at
generating verbs. Regardless, for research, this level of variability within a usual care control group is
problematic for examining components of treatment fidelity and comparing control and intervention
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arms. Treatments are therefore being implemented in practices that combine several different forms of
intervention, typically the combination of therapies is untested and the implementation may be in
direct contrast to how they were evaluated (O'Hare & Doell, 2015; Waller, 2009). These have been
labelled as ‘third wave therapies’ (Waller, 2009) or ‘therapy cocktails’ which may include limited
outcome measurement and so have a reduced capacity to move the evidence base forward. The use of
therapy cocktails may be because clinicians often feel overwhelmed by conflicting evidence within
the intervention literature and are not confident in applying the evidence to their caseload (Douglas et
al., 2014; Foster, Worrall, Rose, & O'Halloran, 2015). Additionally, therapists may struggle to see
their patients in the homogenous groups of participants included in RCTs (Pring, 2004) or be
concerned about repeating tasks in sessions. However, clinical decision making is complex and the
management of people with aphasia is multi-faceted (Ciccone, Hersh, Armstrong, & Godecke, 2013).
Therapists make real world treatment decisions based on a variety of factors including client
motivation, family influences, setting constraints (Hersh & Ciccone, 2016) and their own therapy
ideologies (Hinckley, 2005). Therefore, they are likely to modify their interpretation and
implementation of research evidence based on their own therapy beliefs, individual needs of the
person with aphasia and the context they are working within. This is in line with the concept of
evidence based practice that is understanding the evidence base and then applying and adapting it to
the care of individual patients (Sackett et al., 1996).
7.4.2 The naturalness of therapy
To our knowledge this is the first study to provide data from across an entire aphasia therapy
session on the verbal outputs produced by therapists and PWA. In analysing the number of utterances
and words produced, it was clear therapists did the majority of the talking during sessions. The
dominance of the therapist in the therapy session with PWA has been previously documented (Silvast,
1990) with the therapist being perceived to have a greater share of the load compared to what is
expected of a ‘typical’ speaker in day to day conversation (Ferguson, 1996). This greater share of
talking is relevant when considering a possible dosage threshold for the number of client acts, or
amount of talking that may be required in a session to induce neuronal change. This paper was not
designed to provide an analysis of the conversational moves by the therapist however, the observed
ratio of therapist to participant talking could reflect the nature of the therapeutic relationship and the
control that the therapist takes over the session (Horton, 2006). This ratio may be expected as the
therapist was providing support for frequent communication breakdowns related to the reduced
communicative capacity of the PWA (Horton, 2006) which may contribute to a less natural
communicative interaction.
Pragmatic treatments for aphasia aim to improve the use of language in natural situations
(Basso, 2010). This approach is due to the fact that PWA frequently have intact pragmatic abilities
and the idea that returning communication to pre-morbid naturalness is the goal of therapy (Basso,
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2010). Additionally, increased saliency of therapy relates to neuroplasticity principles and increased
client motivation, both of which are thought to beneficial for recovery (Bryan, Kreuter, & Brownson,
2009; Pulvermuller & Berthier, 2008). Much of the above evidence such as the amount of therapist
talking, type of cueing used and the predominance of single word task selections, contributes to the
notion that the therapeutic environment is not a natural one. A “helper-helpee” type relationship may
be established that contains rehearsed conversation and is less representative of natural discourse
(Horton, 2006). Real-life discourse is complex and can be a difficult context to reproduce in therapy
(Boyle, 2011). The freedom in a conversation to change topics and vary the syntax and word selection
is challenging when treatment is focused at a specific linguistic level such as the single word level
(Boyle, 2011). The dynamic between a therapist and PWA is unique, it is not a ‘normal’ conversation
as would be observed in other settings. However, it is hoped that if the therapist can replicate
situations that are as close to possible as natural the PWA will gradually be able to produce more
information and be able to sustain it in daily living (Basso, 2010).
7.4.3 Therapist inputs
Therapy involves a complex sessional structure with layers of inputs, reactions and
interactions. Therapist inputs including task explanations, cueing and feedback are believed to
facilitate aphasia recovery. Therapists may aim to tailor sessions with their inputs adhering to adult
learning and neuroplasticity principles.

7.4.3.1 Task explanations
The “business” part of a therapy session involves doing the technical work of therapy tasks
(Horton, 2006) involving the delivering of therapeutic ingredients. Therapists may introduce this work
with an explanation of how to perform the task and why the task is being used within the session.
Task explanations were frequently surface level and the majority of the time there was no mention of
rationale behind the chosen tasks or a discussion of possible mechanisms of action in the brain. This is
not in line with adult learning principles that suggest tasks should be relevancy orientated and adults
need to be sufficiently informed to see the reason for learning to increase their motivation and
learning capacity (Bryan et al., 2009).

7.4.3.2 Cueing
Whilst the tasks were varied, the therapeutic inputs in the sessions appeared to be consistent
in relation to cueing and feedback. Cueing was the main therapeutic technique observed in this study
with an average of 87 cues used by therapists per session. Cueing is a facilitation technique used to
promote word retrieval in PWA and reflects the generally accepted concept that the essence of aphasia
rehabilitation is the elicitation of a response (Linebaugh, Shisler, & Lehner, 2005). A cueing hierarchy
is an established therapeutic technique for treating naming difficulties in aphasia (Abel et al., 2005)
and is reflective of a remedy for anomia, the most predominant symptom in PWA. Irrespective of the
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task, therapists consistently used cueing to support the participant in completing the task. While cues
were consistently used across tasks the use of a cue resulted in a successful response in 38% of
occurrences. This result suggests that either, other mechanisms of action are behind verbal
improvement or this level of cueing success is sufficient to induce change, as shown in the findings of
the VERSE RCT trial. However, it’s not known if this is the optimal level of success to produce the
maximal possible improvement for each person with aphasia and if the required level of successful
cueing is the same for all individuals. Treatments that aim for error minimisation intend the
participant to produce or comprehend the target word with the least amount of error practice, possible.
The rationale behind error minimisation treatments are that correct production of the target as quickly
as possible will strengthen neural networks and lay foundations for improved verbal production in
early stroke recovery (Varley, 2011). In this way, cueing is thought to be a potential active therapeutic
input.
Cueing may be restorative (i.e. word retrieval in therapy will facilitate future productions of
that word) or compensatory (i.e. cueing will facilitate word retrieval for functional language
production). Studies have investigated cueing in a research context particularly when contrasting
increasing and decreasing levels of cueing with corresponding errorful and error reducing therapy
techniques (Conroy, Sage, & Lambon Ralph, 2009a; Conroy et al., 2009b). Most studies have focused
on the investigation of semantic and phonological cueing (Cameron, Wambaugh, Wright, & Nessler,
2006; Wambaugh, 2003; Wambaugh, Cameron, Kalinyak-Fliszar, Nessler, & Wright, 2004). To our
knowledge, this is the first study to investigate cueing in a real world clinical context within a usual
care therapy arm. In our study, direct modelling was the most frequently used cue and unsurprisingly
most successful. This is because the target word is modelled to the patient, which in turn requires
word repetition, a simpler form of word production with less cognitive load and risk of error (J.K.
Fillingham, Sage, & Ralph, 2006) Phonological cueing followed by semantic cueing were the next
most frequently used. However, semantic cueing ranked last in effectiveness in contrast to other
evidence about the importance of semantic information for word retrieval (Abel et al., 2005).
Phonological cues were as effective as orthographic, visual and gestural cues. Given how frequently
semantic cues were used but how infrequently they were effective, clinicians may like to re-consider
the value of semantic cueing, especially if aiming for an error minimization approach. There is a
growing body of evidence for phonological cueing being effective in reducing error rates (Best,
Herbert, Hickin, Osborne, & Howard, 2002; Cheneval, Glize, & Laganaro, 2018) perhaps due to the
recruitment of many brain regions (Nardo, Holland, Leff, Price, & Crinion, 2017). However, further
research is needed regarding the mechanisms behind the different types of cueing and the longer term
effects of cueing on generalisation to other communication contexts outside the clinic room.
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7.4.3.3 Feedback
Investigating the therapists use of feedback and how the PWA responds to the feedback
provided, increases the understanding of the efficiency and effectiveness of aphasia treatment
(Simmons-Mackie, Damico, & Damico, 1999). Increasing the evidence base on the type and schedule
of feedback, and how that influences accuracy within the session and then more broadly across
aphasia recovery, will assist in deepening the understanding of the impact of therapy. However, it
remains under researched with a few studies addressing the area (J. K. Fillingham, Sage, & Ralph,
2005; McKissock & Ward, 2007; Simmons-Mackie et al., 1999). On average feedback was provided
at a similar frequency to cueing during a session and mostly related to a specific item rather than the
task as a whole. The majority of feedback was problem solving which informed the participant of
whether their answer was correct or incorrect and was often followed by a cue if an incorrect response
was given. This is consistent with previous research that showed feedback is usually limited to
providing information about whether a response is correct or incorrect but is rarely qualitative or
explanatory (Byng, 1995). It is understandable that a statement of whether the response was
correct/incorrect feedback was provided frequently given that the majority of tasks were single word
level and an utterance could be judged straightforwardly as correct or incorrect. However, this style
may contribute to the perception of therapy as ‘training’ involving a more passive recipient (Byng,
1995). Supportive feedback is frequently given in the form of praise or positivity as seen in this study.
As documented previously this was not necessarily related to the accuracy of the response (Byng &
Black, 1995) and may be related to the therapist’s perception that their role is to encourage the PWA
and reward functional attempts even if inaccurate. Further research is needed in relation to the impact
of feedback on the individual’s performance within a task in order to develop a greater understanding
of the impact of feedback on learning and maximising success within the session and generalisation of
skills into communicative contexts outside a clinical context. Additionally more research is needed
into the effect of different types of feedback and the timing with which the feedback is provided
within a session as has been investigated within the motor speech literature (Maas et al., 2008).
7.4.4 Clinical significance
There is much written about the evidence practice gap in acute stroke management, usually in
the context of practice not giving the recommended intensity (Foster et al., 2013). However, recent
evidence suggests that this gap has lessened as usual aphasia care of a few sessions per week is
sufficient and intensive rehabilitation schedules are not more efficacious in acute aphasia management
(Godecke et al., 2018). Therefore, it is important to develop a greater understanding of the content of
usual care aphasia therapy. This paper has provided an in depth examination of what happens behind
the therapy door in usual care and may serve as a baseline for future intervention research.
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7.4.5 Limitations
This study analysed 25 videos of Usual Care Plus speech pathology intervention. This
represents a small sample and so there is a limit to the extrapolation of results to represent usual care
and in the management of aphasia as a whole. Additionally, this study used videos from Usual Care
Plus, the usual care intensive arm of the VERSE- RCT, not usual care provision that was provided on
a non-intensive schedule. It is possible that when required to administer therapy on an intensive
schedule, usual care therapists changed their practice and therefore, results may not be generalizable.
7.4.6 Future directions
This study provides a snapshot of therapy provided within usual care, provided intensively, in
Australia and New Zealand. The study was possible due to the systematic collection of therapy data as
part of the VERSE RCT and so the collection of therapy type data in the control arm of a RCT should
be prioritised within the design of future studies. Growing the evidence in this way provides a
baseline for documenting change in usual care practices over time which provide an insight into the
way in which research findings are being translated into clinical care. However, further research is
needed to determine how to most effectively measure change in patient outcome in a clinical context.
Through establishing what usual care is there can be greater focus on establishing outcome measures.
There is research underway for establishing a consensus outcome set to enable accurate measuring of
the effect of therapy within a real-world clinical context (Wallace et al., 2019). Examining the
contents of the real-world clinical context that is usual care can heighten the sensitivity of outcome
measures to ensure that they accurately reflect recovery. Outcome measures are important for
comparing research results as well as in clinical contexts (Armstrong, 2018). Future studies can build
on the normative data gathered and research consumers can have greater confidence that the
researchers were able to make informed statements about treatments knowing what they were
sufficiently differentiated. Further aphasia studies addressing task explanations, cueing and feedback
as used in the clinical context and their effect on target attainment would benefit our understanding of
therapy mechanisms.

7.5 Conclusion
Therapists mix a therapy cocktail that is served in many types of glasses. Therapists rarely get
the opportunity to observe their peers or seniors after graduation from university. This study found
that therapists utilise a wide range of tasks, produce most of the verbal output in the session and
consistently use feedback, cueing and task explanations to tailor therapy sessions. We have
highlighted the therapist and the unique scenario that is therapy with people with aphasia. We have
reflected the importance of describing an intervention in the control arm of a trial. It is only through
documenting this aspect of treatment fidelity that a greater understanding can be gained of everyday
practices and how they differ from our proposed interventions.
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Chapter 8: Additional Results
This section provides results that were not included in the thesis publications but are
additional data of interest.

8.1 Location of therapy for the whole group
Chapter 7 included results related to the location of therapy for the Usual Care-Plus
condition. Considering the whole group the majority of sessions (60%) were conducted in an inpatient
setting as per Figure 18.
Other
8%

Personal Home
32%
Inpatient
60%

Figure 18. The location of therapy for the whole group

8.2 Therapy tasks completed in VERSE condition
The Chapter 7 publication detailed the therapy tasks completed within the Usual Care-Plus
condition. Table 56 details the tasks completed in the VERSE arm. Overall there were 18 different
tasks completed for a total of 56 tasks. As with Usual Care-Plus, picture naming was the most
commonly administered task within VERSE, however it was used less frequently than in Usual CarePlus. Additionally more tasks were completed at the sentence and conversation level and all
expressive tasks involved verbal, rather than written, language due to the nature of the VERSE RCT
treatment protocol.
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Table 56. Tasks completed in VERSE arm
Type of Task (n = 18)

Quantity (n = 56)

Expressive Language - Verbal

Single Word Level

Picture Naming

10

Memory Game with naming

1

Snap Game with naming

1

Automatic Speech

1

Sentence Level

Picture description

8

Opinion giving

1

Verbal reasoning

1

Procedural discourse

2

Sequence picture cards and asked to tell the story

4

Question and Answer

2

Spot the difference

1

Verb generation sentence level

1

Using three words to make a sentence

1
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Reading aloud

2

Conversation Level

Conversation

12

Receptive- Reading Comprehension

Paragraph Comprehension

3

Receptive – Auditory Comprehension

Single Word Level

Point to the picture multiple choice

4

Above Single Word Level

Sentence Comprehension

1
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8.3 Dosage Measures by Aphasia Classification
8.3.1 Error types by aphasia classification
Error patterns by baseline aphasia classification as per the WABR-AQ (Kertesz, 2006) are presented in Table 57.

Table 57. Error types by aphasia classification at baseline on the WABR-AQ
Error Type

Brocas

Global

Anomic

Wernickes

Conduction

(n = 19)

(n = 10)

(n = 7)

(n = 6)

(n = 3)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Filled pause

50.5 (58.7)

17.6 (13.1)

27.0 (33.0)

42.5 (39.9)

68.0 (25.1)

Unfilled pause

39.1 (36.3)

24.9 (17.1)

27.9 (24.7)

22.2 (19.7)

23.7 (9.7)

Phonemic errors

58.7 (59.7)

14.6 (25.2)

13.3 (17.1)

101.3 (53.4)

98.0 (120.0)

Perseverations

13.3 (18.6)

13.8 (18.5)

5.4 (7.7)

9.2 (9.0)

4.0 (6.9)

Circumlocutions

20.8 (29.0)

11.0 (20.1)

21.9 (16.5)

23.8 (26.2)

72.3 (75.8)

Semantic Errors

32.4 (31.5)

25.1 (31.2)

14.6 (10.0)

49.8 (34.8)

42.6 (47.7)
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Pronoun error

0.4 (1.0)

0.1 (0.3)

0.3 (0.5)

0.8 (1.3)

0.0 (0.0)

Grammatical Error

7.4 (14.5)

3.1 (5.2)

3.9 (4.5)

4.8 (4.3)

2.7 (0.6)

Repetition fluency error

35.4 (41.4)

5.0 (6.8)

26.6 (19.3)

36.8 (49.6)

101.3 (108.1)

Receptive error

1.8 (6.6)

14.3 (20.8)

0.9 (1.9)

1.8 (3.1)

2.3 (2.1)

Unintelligible error

8.7 (13.3)

18.9 (28.2)

1.9 (2.0)

1.0 (1.3)

4.0 (5.3)
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8.3.2 Dosage (number of client acts) measures by aphasia classification
Client acts as a measure of within session dosage are included in Table 58 for the different aphasia classifications at baseline.

Table 58. Dosage (number of client acts) by aphasia classification
Client Act

Brocas

Global

Anomic

Wernickes

Conduction

(n = 19)

(n = 10)

(n = 7)

(n = 6)

(n = 3)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Mean (SD)

Error free utterances

342.7 (129.3)

195.1 (109.6)

350.6 (86.7)

271.5 (122.5)

377.7 (191.9)

Total errors made

268.8 (141.6)

145.3 (81.2)

143.7 (60.7)

294.5 (83.0)

425 (181.6)

Self-Corrections

42.3 (41.7)

4.8 (7.1)

38.0 (27.2)

47.7 (64.7)

128.3 (129.6)

% Errors self-corrected

14.4 (10.9)

3.3 (4.2)

29.6 (20.5)

13.1 (16.0)

34.3 (35.9)

Utterance level errors

22.1 (30.3)

16.2 (21.2)

22.3 (16.6)

24.7 (25.8)

73.0 (76.3)

292.1 (175.7)

111.2 (97.5)

130.6 (59.2)

337.7 (108.9)

409.3 (166.5)

Quantity

Word level errors
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Mean length of

3.0 (1.5)

1.9 (1.6)

4.8 (1.5)

3.3 (1.5)

6.0 (1.7)

3.3 (1.7)

2.2 (1.9)

5.3 (1.6)

3.6 (1.6)

6.7 (1.9)

531.9 (215.5)

292.1 (210.1)

478.6 (104.4)

505.2 (134.5)

694.0 (249.1)

1757.7 (1328.0)

578.8 (602.0)

2293.1 (1003.0)

1659.8 (957.4)

4048.7 (602.1)

25.2 (22.3)

69.1 (80.1)

7.1 (3.1)

20.1 (6.3)

10.3 (3.1)

Utterances per minute

10.4 (2.8)

7.1 (3.4)

9.5 (2.1)

10.1 (2.2)

13.4 (4.9)

Words per minute

33.1 (24.8)

12.2 (13.3)

45.0 (18.0)

33.3 (17.5)

77.7 (9.4)

utterance (words)

Mean length of
utterance (morphemes)

Total utterances

Total words

Percentage of words
with errors
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8.4 Tailoring
8.4.1 Cueing
The publications above provided detail about cueing in general. Additional detail is provided
in Table 59 according to the types of cues used by therapists. This includes data across the 53 videos
analysed.

Table 59. Cue type, corresponding usage and usage with success
Cue Type

Usage

Used with Success

Mean (SD)

Mean (SD)

Phonological

21.0 (25.0)

8.5 (14.2)

40.5%

Semantic

11.4 (17.5)

1.7 (2.6)

14.9%

Orthographic

4.8 (10.4)

2.3 (7.3)

47.9%

Visual gestural

2.3 (4.1)

0.6 (1.4)

26.1%

Forced alternative

0.9 (1.8)

0.3 (0.7)

33.3%

Sentence completion

6.3 (12.9)

3.0 (8.4)

47.6%

Articulatory placement

1.2 (3.2)

0.4 (1.1)

33.33%

33.9 (45.4)

16.5 (26.4)

48.7%

Direct model

% successful

8.4.2 All tailoring measures
Additional therapeutic inputs for tailoring are separated by therapy group and presented in
Table 60.

171

Table 60. Tailoring measures by therapy group
Measure

Whole Group

Usual Care-Plus

VERSE

(n = 53)

(n = 25)

(n = 28)

Mean (SD)

Mean (SD)

Mean (SD)

33.8 (38.6)

38.5 (48.5)

29.6 (27.4)

Phonological

21.0 (25.0)

23.4 (25.6)

18.8 (24.6)

Semantic

11.4 (17.5)

12.9 (18.1)

10.1 (17.1)

Orthographic

4.8 (10.4)

4.1 (6.6)

5.4 (13.0)

Visual gestural

2.3 (4.1)

2.3 (4.7)

2.3 (3.6)

Forced alternative

0.9 (1.8)

1.3 (2.4)

0.4 (0.9)

Sentence completion

6.3 (12.9)

8.2 (17.4)

4.7 (6.5)

Articulatory placement cue

1.2 (3.2)

2.0 (4.1)

0.5 (2.0)

33.9 (45.4)

32.6 (47.7)

35.0 (44.0)

Supportive Positive

30.6 (29.7)

47.7 (28.0)

33.0 (34.0)

Supportive Elaboration

11.6 (13.3)

8.9 (11.7)

14.0 (14.3)

Supportive clarification

14.6 (18.5)

10.9 (11.3)

18.2 (22.8)

Supportive requests

9.1 (15.6)

7.5 (17.9)

10.5 (13.5)

Problem solving yes/no

45.7 (38.6)

51.8 (34.7)

40.3 (41.7)

5.7 (7.4)

8.3 (8.8)

3.4 (5.0)

Cues used with success

Direct model
Feedback

Problem solving explains error
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Therapist mean length of utterance

4.8 (0.9)

4.4 (0.9)

4.2 (0.9)

4.8 (1.0)

4.9 (0.9)

4.7 (0.9)

Therapist words per minute

52.5 (15.3)

55.8 (14.0)

49.6 (16.1)

Mean turn length (therapist)

9.1 (2.8)

9.7 (2.8)

8.6 (2.8)

(words)
Therapist mean length of utterance
(morphemes)
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Chapter 9: Final Discussion
9.1 Summary of Aims
This research completed a thorough analysis of treatment fidelity of an aphasia clinical trial. As
part of this process an update on current treatment fidelity practices and reporting was completed and
treatment integrity and differentiation of the intensive arms of the VERSE- RCT was investigated. By
closely examining the therapy provided within the VERSE RCT elements of therapy including dosage
and the behaviour of therapists and participants within therapy sessions was investigated. Finally the
study explored usual care aphasia therapy, which, when provided intensively, provided an insight into
therapeutic practices and a baseline for future studies that may include a usual care therapy aim within
their trial.
A summary of the key findings according to the main aims of this thesis are addressed below.
1. To provide an update on current treatment fidelity practices and reporting within aphasia
RCTs: The publication in Chapter 3 reported that 21% of articles explicitly mentioned
therapy fidelity in their reporting of RCTs. The planned aspects of therapy fidelity were more
frequently addressed than were the elements associated with the implementation of the study.
The reporting of active ingredients and theoretical underpinnings behind interventions was
poor.
2. To report and interpret the treatment integrity from a subset of the treatment delivered in the
VERSE RCT: As per Chapter 5, 97% of therapeutic inputs were adherent to the VERSE
protocol. The dose form (task) target goal level (e.g. target MLU) was achieved in 67% of
utterances. This is the first time an utterance level dosage analysis for treatment integrity has
been completed in an aphasia RCT.
3. To investigate the utterance level treatment differentiation from a subset of the high intensity
treatment delivered in the VERSE RCT: As per Chapter 5, treatment differentiation was not
established within the VERSE high intensity groups, on the sample and measures included in
the analysis. The frequency with which the measured key elements (therapeutic inputs and
client acts) occurred, at the utterance level of the Usual Care-Plus and VERSE intensive
intervention groups, were not statistically different.
4. To provide a thorough dosage analysis (number of therapeutic inputs and client acts) of
sessions from a subset of the treatment delivered in the VERSE RCT: As shown in Chapter 6,
the analyses indicated that an error minimization but verbal maximisation strategy using a
targeted cueing program is beneficial for people with aphasia. The active ingredients were
received on average 500 times a session for a total of over 10,000 active ingredients during
the treatment period.
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5. To document and describe usual care practices for aphasia therapy through observational
data: Within Chapter 7, the TIDieR checklist (Hoffmann et al., 2014) was used to describe
the intervention in the Usual Care-Plus arm of the trial. Visual materials were most frequently
used across the 96 tasks (57% single word level) seen in the Usual Care-Plus sessions.
Therapists did the majority of the talking during sessions and most frequently provided
models as cues or problem solving accuracy feedback. Models, sentence completion and
orthographic cues were the most successful at eliciting the target response.

9.2 Conclusions
A broad discussion of the main themes from the findings of this thesis is presented below. For
detailed discussion of the specific results please refer to the individual chapters.
9.2.1 ‘Theory-research’ gap with therapy fidelity
As with the evidence based practice gap for therapists there is a ‘theory-research’ gap for
researchers. That is, some theoretical concepts in research such as those surrounding treatment
fidelity, are not routinely implemented in research trials. Within the VERSE- RCT the outcomes of
participants who received the prescribed VERSE therapy did not differ from those who received usual
care aphasia therapy provided intensively, although the nature of the therapy provided did differ,
when the type of therapy task used within sessions was examined within both groups. However, when
the therapist and participant utterance level behaviour was analysed and dosage of client acts and
therapeutic inputs examined, the nature of therapy between the two groups did not differ. This
highlights the importance of examining treatment fidelity in aphasia intervention studies so that an
understanding of what happened within the therapy sessions can provide a context for examining
research findings.
Future studies should increase the level of focused attention given to planning, implementing
and measuring therapy integrity and differentiation in order to facilitate the interpretation of research
findings and increasing the potency of aphasia therapy in the longer term. While 88% of studies
included in our review addressed the study design aspect of treatment fidelity only 21% of RCTs
published between 2012-2017 explicitly used the terminology ‘treatment fidelity’. For a concept that
has such important real world implications, such as rejecting an efficacious treatment or accepting an
ineffective programme, reporting the explicit elements of treatment fidelity must be improved within
aphasia research. However, it is acknowledged that explicitly embedding treatment fidelity processes
within research, and measuring whether the intervention was given as intended, may be challenging
within behavioural research and requires more attention. Having models, from within the aphasia field
of research, may help to further incorporate treatment fidelity in future research so that these
processes are considered and planned for as a separate component of the overall study design.
Assuming an intervention is delivered as planned and therapy delivered within the arms of a trial are
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sufficiently different is not sufficient. The extent to which the delivered treatment matched the
intervention protocol and the extent to which therapy in the arms of a trial differed, should be
measured and reported within publications using an a priori checklist of therapeutic elements
including therapeutic inputs and client acts.
9.2.2 Operationalising treatment fidelity in aphasia RCTs
Treatment fidelity, as a theoretical concept, has been well established. Together with the tools
used to guide the publication of RCTs (such as TIDieR and CONSORT) it is possible to
operationalise treatment fidelity. This includes incorporating treatment fidelity as integral to piloting
the intervention and all early phases of treatment development. Aphasia therapy involves complex
behavioural interactions that present a challenge for treatment fidelity monitoring. Additionally, RCTs
need large participant numbers to demonstrate effectiveness and monitoring all of these sessions is not
feasible. Therefore, trialling treatment fidelity procedures in a pilot of the proposed intervention will
assist to streamline the process and facilitate scaling up. Aphasia therapy sessions would likely need
to be video recorded, transcribed and coded for key behaviours at the utterance level. As demonstrated
in this study, this is feasible on approximately 10% of the sample within an aphasia RCT containing
246 participants. It is acknowledged that in order to complete this level of analysis, future studies will
require funding to support treatment fidelity planning, implementation and analysis. It may also be
that with piloting and streamlining of the procedure a greater portion of sessions could be analysed in
the future.
From the knowledge gained throughout this doctoral work, it is suggested that the following
process could be used to establish therapy fidelity in an aphasia RCT to:
i)

Conceptualise active ingredients (therapeutic inputs and client acts) to be measured in the
study design phase.

ii) Pilot measuring these ingredients in all arms of the trial. This will involve designing and
piloting a data collection tool. The measurement of dose, the number of times the active
ingredients occur within the session should also be trialled.
iii) Video record therapy sessions and review these sessions according to the established a priori
criteria to examine therapy as it is provided within the pilot trial.
iv) Establish treatment integrity and differentiation in a pilot trial in the early phases of treatment
development (Phase I and II studies).
v) Fine tune the data collection procedure (select active ingredients) according to the treatment
integrity and differentiation results.
vi) Scale up the treatment fidelity procedure to the larger, full scale study.
vii) Report treatment fidelity findings for the control and intervention groups of the trial.
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9.2.3 Therapy fidelity adds value to trial interpretations
Completing a therapy fidelity analysis of a trial adds value to the interpretation of the overall
trial results (Cordray & Pion, 2006). Research consumers may expect this type of analysis in the
future and grant reviewers may also look for these analyses to strengthen research interpretation and
overall impact. The main VERSE trial results found that intensive therapy groups performed
equivocally on language and communication testing outcome measures at 12 and 26 weeks post
stroke compared to participants receiving Usual Care (Godecke et al., 2018). VERSE established
clearly that the intensity (number of sessions per week) at which the therapies were given between
Usual Care and the two intensive arms was statistically different. This result addressed the VERSE
main hypothesis showing that early aphasia therapy is important to enhance recovery but therapy is
not required to be intensive (greater than 3 times per week). The secondary VERSE hypotheses were
concerned with whether a prescribed protocol would result in a better outcome, compared to usual
aphasia therapy, when given at the same high intensity level (five sessions per week up to twenty
sessions). As such, the analysis was undertaken to determine treatment fidelity, specifically to
examine the treatment integrity with which the VERSE therapy was provided and the level of
intervention differentiation between the two intensive arms of the VERSE trial. This analysis was
undertaken at the utterance level. This component of the study examined whether the therapy
delivered between Usual Care-Plus and VERSE was different on identified key elements, when
intensity was kept constant (five sessions per week up to twenty sessions). The analyses showed that
therapists were highly adherent to protocol but within this sample, using the pre-specified utterance
level measures, treatment differentiation could not be established. This may provide a reason for why
the VERSE- RCT treatment type secondary hypothesis was not supported. A potential explanation is
that the therapy provided to the two groups shared the same active ingredients.
9.2.4 People with Aphasia in therapy
Research into therapy fidelity and treatment effectiveness should have a direct benefit PWA
as the ultimate aim is for therapists to implement effective treatments that reduce the burden of
aphasia on stroke survivors, their families and the healthcare system. Increasing the rigour
surrounding therapy fidelity processes will improve the efficacy for intervention and prescription of
intervention components to therapists. This study analysed the behaviours of PWA during therapy to
heighten our understanding of the therapeutic process and inform elements that need to be considered
and potentially planned for and measured when developing research based interventions. Treatment
fidelity is concerned with the individuals’ ability to use the cognitive skills being trained (Bellg et al.,
2004). As failure and errors are an inevitable part of aphasia therapy, the type and frequency of these
were investigated. People with severe aphasia made errors on 50% of the words that they produced
and were rarely able to self-correct (4% of errors self-corrected). This has implications for how
therapists frame their practice and could facilitate an improved approach to aphasia intervention
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incorporating realistic expectations on error rates and increased specificity about individualised
cueing strategies to facilitate task completion. Therapists may also expect that people with severe
aphasia will rarely be able to self-correct errors and so could prioritise word retrieval facilitation
techniques in this population. Even when aiming for an errorless or error minimisation learning
approach with someone with severe aphasia, therapists may not be able to restrict errors to less than
50% of words produced. It is possible that regardless of the therapists’ attempts to limit errors, there is
a predictability and a homogeneity to the way PWA respond in a task.
People with moderate and mild aphasia made more errors during a session in total quantity in
comparison to people with severe aphasia, however made less errors as a proportion of the total
amount of language that they produced. People with moderate aphasia and mild aphasia produced
errors on 16% and 10% of the words they said respectively. As the severity of aphasia reduced, this
was naturally reflected in the error rates within the session. Error patterns in this sample were
consistent for what is expected of certain aphasia classifications (Chapey & Hallowell, 2001). For
example, a participant classified with Wernicke’s aphasia at baseline made more semantic errors
during the session than someone classified with Broca’s aphasia. Error patterns may reflect the
underlying nature of the language impairment and the consistency of error patterns seen in this thesis
support this hypothesis.
9.2.5 Measuring ‘usual’ therapy
This research provides a snapshot of the therapy provided by sixteen usual care therapists
offering an insight into standard care for aphasia therapy. Turning the lens onto therapists serves to
empower the clinician by facilitating the development of a greater understanding of the therapeutic
inputs that enhance recovery. The analyses completed showed therapists used many different tasks
and combinations of tasks to elicit target behaviours throughout treatment sessions. As the quantity of
therapeutic inputs and client acts were not statistically different between therapy groups even with this
large variety in tasks, the data presented in this thesis suggests the therapy task appears to be less
important than the dosage of key ingredients given/received. A strength of this study is that it
measured the dosage, in terms of the number of active ingredients, within the usual care therapy arm
not just the tasks implemented. There is a challenge in measuring standard care given the large variety
of tasks, if the task is considered to be an important medium in therapy. Therefore, this fine grained
therapy fidelity analysis aimed to assist in answering questions not just about what was done in
therapy, but how much of it was done and how the PWA responded.
There is a need for pragmatic trials that reflect real world clinical situations, however these
trials must also be rigorously designed, and incorporate therapy fidelity, to answer key questions
about interventions. Behavioural interventions present a challenge for researchers to address, that is,
how to collect appropriate data that will support treatment fidelity analyses. Therapy fidelity relies on
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‘pure’ data that is interpreted to make conclusions about therapy. Gathering ‘pure’ data is difficult
with behavioural interventions because the ‘behavioural treatment petri dish’ is likely to be
contaminated with many elements. Researchers may embrace this variability and conduct trials that
are more reflective of the real world clinical context, with a potential trade off to treatment fidelity.
This will be interesting for the field to navigate as two different research concepts, pragmatic trials
and therapy fidelity prioritised treatment, gain momentum. A possible remedy for this, in the future, is
for therapy fidelity trials to also have an implementation hybrid approach (Curran, Bauer, Mittman,
Pyne, & Stetler, 2012; Lynch, Chesworth, et al., 2018). Another research alternative to address this
issue is to complete a large observational cohort study to enable researchers to better understand the
contaminants in the aphasia therapy petri dish (Ali et al., 2019).
9.2.6 Dosage – the search for a ‘sweet spot’
Despite the existence of definitions for intensity and dosage (Baker, 2012; Warren et al.,
2007), operational definitions of treatment intensity and dosage have not been agreed upon and are
not applied consistently within aphasia research. Dosage is an important concept to address, when
considering the way in which therapy is developed, implemented and analysed, as the dosage of
therapy may impact treatment finding. The lack of clarity around terminology presented a challenge
when writing this thesis. Frequently the way that dosage was conceptualised within this research, that
is the number of active ingredients within a session, needed to be explicitly stated. Cherney (2012)
proposed that inconsistent use of dosage terminology in aphasia treatment studies may explain some
of the reported differences in treatment effects. It is insufficient to express dosage in terms of the
session length of time as not all therapy minutes are of equal value. The intensity of the rehabilitation
schedule, and the dosage of ingredients within the session, must be viewed as separate entities. This
definition is encouraged, or consensus on an alternative definition, for future aphasia research.
Additionally, further consideration is needed concerning the concepts of therapeutic inputs, client acts
and the interaction of these. The concept of activity challenge and the level of task difficulty is a
parameter in stroke rehabilitation that is receiving increasing attention and will influence the outcome
of future study designs (Akizuki & Ohashi, 2015; Woodbury et al., 2016). Therefore, not only should
the quantity of therapeutic inputs and client acts be addressed but also the quality of these, such as a
measure of task difficulty relative to the individual, with an optimal challenge point identified
(Guadagnoli & Lee, 2004).
The work presented here built on the substantial ground work by Warren et al. (2007) and Baker
(2012) to conceptualise and report dosage in terms of the number of therapeutic inputs and client acts
within a session. It also documents within a small sample, averages for hypothesised ingredients. If
extrapolated to the trial as a whole this would indicate that the level of therapeutic inputs and client acts
supplied in the sample was sufficient to induce clinically meaningful gains. However, it cannot be said
whether or not these behaviours were in the dosage ‘sweet spot’ - where not too many or too few were
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given. There appears to be a relationship between minimising errors and maximising verbalisation
resulting in better outcomes according to the predictors analysis presented in Chapter 6. Teasing apart
the nature of this relationship is important for therapists and PWA alike. PWA can be guided by
therapists about how to overcome word finding difficulties to encourage the best recovery possible.
Therapists can be guided by research for how to handle errors in therapy to promote greater recovery.

9.3 Limitations
The limitations of each study have been outlined in the publication chapters throughout. As
such this section will focus on the limitations of the broader body of research.
The results presented throughout are from 53 videos or 12% of the available videos within the
VERSE trial. Given that the nature of the analyses completed within this thesis, including
transcription and coding, was time consuming, it was not feasible to analyse a larger sample. The
videos were randomly selected and balanced for aphasia severity and so are hypothesised to be
representative of the trial as a whole. However, if a larger sample was analysed it is possible that the
findings, interpreted in conjunction with the main trial results, may have changed. Many of the
measures reported had large standard deviations reflecting considerable variation in the data, video to
video. This may be reflective of aphasia therapy itself with heterogeneity between PWA. It is
acknowledged that an in-depth analysis was not completed to explore the nature of interactions
between the therapists and people with aphasia. This was not the aim of the work, however such an
undertaking is likely to capture a richness of therapy not represented in the quantitative data set. The
nature of this work was pioneering for aphasia research and so assessing the reliability and validity of
the tools used in this thesis would be necessary for scaling up the research. Aphasia severities and
classifications were determined using baseline data. However, the therapy videos were recorded in the
subsequent month after baseline when some recovery was likely to have occurred. It is probable that
participants did not remain in the same category that they were assigned at baseline. This means that
the data presented may not be a true reflection of their severity level at the time of the video
recording.

9.4 Recommendations
Recommendations for future research and for therapists have been made throughout this
thesis and are summarised here.
9.4.1 Recommendations for future research
The examination of therapy fidelity, within behavioural research, is a multifaceted process
which should be incorporated throughout all phases of a study. These findings encourage researchers
to undertake fine-grained dosage (number of therapeutic inputs and client acts) analyses of their
research in both intervention and control groups. The analyses completed here demonstrate that this is

180

feasible within a portion of the RCT cohort. Therapy fidelity results should be reported in main trial
publications or standalone publications but never omitted. The terminology of ‘treatment or therapy
fidelity’ should be used explicitly and concepts such as Bellg’s (2004) treatment fidelity concepts
should be more widely endorsed. Reporting needs to be based on factual observation of the treatment,
not whether treatments were designed to be different. The reporting of a study itself should also
include an interpretation of the main results considering the treatment fidelity findings, regardless of
whether this supports the overall result. It is proposed that therapy fidelity could also be included in
effectiveness implementation hybrid trials as increased rigor in therapy fidelity procedures will
increase the likelihood of uptake of evidence (Lynch, Chesworth, et al., 2018)
There is a need to improve the methodology used for the measurement of therapeutic
elements provided within sessions in order to help determine cumulative intervention intensity. This
must account for minutes of therapy, type of intervention and determine the difference between these
in a scientifically robust way. Future research would benefit from focusing on conceptualising dosage
in terms of number of key ingredients (therapeutic inputs and client acts) to progress the evidence
base. Research needs to document dosage in this way for treatments given in trials, however specific
research in which dosage is varied within a treatment is also needed (Kramer, Kaffenberger,
Cumming, Bernhardt, & Johnson, 2018). The rationales for interventions and their dosage need to be
consistently given in stroke rehabilitation research to assist in the development of breakthrough
treatments (Borschmann et al., 2018). Greater guidance from research on the desired number of
therapeutic inputs and client acts in a session will assist therapists to implement evidence based
practice. In order to investigate dosage in a methodical way a consensus definition of the term needs
to be established. It has been suggested in this thesis, based on the groundwork of others, that
conceptualising dosage in terms of the number of active ingredients, both client acts and therapeutic
inputs, is the path forward.
This study randomised by video and not by participant. Therefore, only a snapshot of the
therapy received by a participant was analysed. An interesting investigation would involve analysing
a series of videos from the one participant and evaluating the evolution of therapy and participant
characteristics over time. The client act and therapist input values would likely change to reflect the
PWA rehabilitation journey in a similar manner to the trends shown with aphasia severities presented
in Chapter 6. An alternative but related view of therapy could be gained through qualitative analysis
and/or systemic function linguistic analysis (O'Halloran, 2004) of therapy videos. This could
investigate more thoroughly aspects of the therapeutic relationship such as rapport and patient comfort
levels.
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9.4.2 Recommendations for therapists
As therapists are time poor and the demands on the health care budget are ever expanding, it
is pivotal to investigate which parts of therapy are essential and most beneficial for people with
aphasia. Whilst there was considerable variability in task selection within the therapy videos, the key
principles of therapy appeared consistently across the sessions. The prescribed treatment provided in
the VERSE arm of the trial was based on principles of neuroplasticity. Interestingly, the elements of
this approach, which were investigated here, were also shared in the Usual Care-Plus arm of the trial.
This suggests that the clinicians, providing Usual Care- Plus therapy, applied similar evidence in
developing their approach to therapy. Additionally, across both arms of the trials, it seems that
therapy that incorporates a targeted cueing program that favours maximisation of verbal output and
limiting of errors was effective and should continue to be used within treatments for people with
aphasia.
The results from the VERSE trial suggest that usual care of a few sessions per week is
sufficient for meaningful aphasia improvement and intensive rehabilitation schedules are not
efficacious in acute aphasia management (Godecke et al., 2018). A distributed regimen of therapy (23 times a week for 35 minutes) using current practice resulted in clinically significant improvement
for the participants in the main VERSE trial. Therapists can move forward and be confident that they
have been facilitating recovery and that they do not need to significantly change their practice. The
content of usual care therapy included in this sample, if extrapolated to the whole, is therefore
effective. Overall trial results also suggest sessions of longer duration were associated with better
recovery than a larger number of short sessions (Rai et al., 2019). Increasing the session duration will
likely increase the number of active ingredients in a session.

9.5 Knowledge Translation
Knowledge translation in the healthcare setting is the process of disseminating knowledge to
professionals and health care receivers to provide more effective service and enhance recovery
(Candian Institutes Health Research, 2015; Straus, Tetroe, & Graham, 2009). This is closely linked
with implementation science and both of these concepts recognise that research evidence alone is not
sufficient to change practice (Lynch, Mudge, et al., 2018). The target audience of this doctoral
research is researchers and therapists. Efforts to assist the translation of this research to this audience
are explained below:
i)

Publications related to this research are listed at the beginning of this thesis. Additional
publications will occur during 2019 and 2020 as per the articles in Chapters 5, 6 and 7.

ii) Conference presentations of this work are listed at the beginning of this thesis. This represents
dissemination of the research over a two year period to speech pathologists, aphasiologists,
stroke rehabilitation clinicians and researchers. Conferences were chosen to target different
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audiences for a wider dissemination. Formats of presentations included posters, round table
discussions and oral presentations.
iii) To assist the translation of this work to upcoming therapists, presentations were given to
students at Edith Cowan University.
iv) A presentation related to this work can be viewed online to assist wider dissemination to
therapists who are unable to attend conferences
https://www.youtube.com/watch?v=2QaILUmuLq4.
v) As social media, and, in particular Twitter become increasingly used by researchers and
therapists, all of the above dissemination actions have been advertised on my Twitter handle
@embrogan89.
This research will continue to be disseminated throughout 2019 and 2020 at conferences and
in publications.

9.6 Final comments
This thesis presented a multifaceted therapy fidelity analysis of an aphasia RCT. All of the
chapters discussed interwoven concepts surrounding treatment fidelity. Conceptualising the
boundaries between these was a challenge necessitated by the search for treatment efficacy for people
with aphasia. Treatment fidelity may seem like a complex unwieldy theoretical concept. However,
when applied it has the potential to have a considerable impact on the therapy for people with aphasia.
Ultimately, this research has aimed to improve the theory-evidence gap for therapy fidelity by braving
detailed application in a clinical trial. In the laboratory of the spirit, treatment fidelity is at the heart of
evidence.

183

10. References
Abel, S., Schultz, A., Radermacher, I., Willmes, K., & Huber, W. (2005). Decreasing and increasing
cues in naming therapy for aphasia. Aphasiology, 19(9), 831-848.
doi:10.1080/02687030500268902
Akizuki, K., & Ohashi, Y. (2015). Measurement of functional task difficulty during motor learning:
What level of difficulty corresponds to the optimal challenge point? Human Movement
Science, 43, 107-117. doi:10.1016/j.humov.2015.07.007
Ali, M., Lifshitz-Ben-Basat, A., Berthier, M., Blom Johansson, M., Breitenstein, C., Cadilhan, D. A., .
. . Brady, M. (2019). International Population Registry for AphasIa after StrokE (I-PRAISE).
Manuscript submitted for publication.
Ali, M., Lyden, P., & Brady, M. (2015). Aphasia and dysarthria in acute stroke: Recovery and
functional outcome. International Journal of Stroke, 10(3), 400-406. doi:10.1111/ijs.12067
Armstrong, E. (2018). The challenges of consensus and validity in establishing core outcome sets
Aphasiology, 32(4), 465-468. Retrieved from
https://doi.org/10.1080/02687038.2017.1398804.
Bakas, T., Austin, J. K., Habermann, B., Jessup, N. M., McLennon, S. M., Mitchell, P. H., . . .
Weaver, M. T. (2015). Telephone assessment and skill-building kit for stroke caregivers: A
randomized controlled clinical trial. Stroke, 46(12), 3478-3487.
doi:10.1161/strokeaha.115.011099
Bakas, T., McCarthy, M., & Miller, E. T. (2017). Update on the state of the evidence from stroke
family caregiver and dyad interventions. Stroke, 48, 122-125.
doi:10.1161/strokeaha.117.016052
Baker, E. (2012). Optimal intervention intensity. International Journal of Speech-Language
Pathology, 14(5), 401-409. doi:10.3109/17549507.2012.700323
Bakheit, M., Shaw, S., Barrett, L., Wood, J., Carrington, S., Griffiths, S., . . . Koutsi, F. (2007). A
prospective, randomized, parallel group, controlled study of the effect of intensity of speech

184

and language therapy on early recovery from poststroke aphasia. Clinical Rehabilitation,
21(10), 885-894. doi:10.1177/0269215507078486
Ball, A. L., de Riesthal, M., & Steele, R. D. (2018). Exploring Treatment Fidelity in Persons With
Aphasia Autonomously Practicing With Computerized Therapy Materials. American Journal
of Speech-Language Pathology, 27, 454-463. doi:10.1044/2017_AJSLP-16-0204
Basso, A. (2010). “Natural” conversation: A treatment for severe aphasia. Aphasiology, 24(4), 466479. doi:10.1080/02687030802714165
Behn, N., Hilari, K., Marshall, J., Simpson, A., Northcott, S., Thomas, S., . . . McVicker, S. (2018).
SUpporting well-being through PEeR-Befriending (SUPERB) trial: an exploration of fidelity
in peer-befriending for people with aphasia. Aphasiology, 32(sup1), 21-23. Retrieved from
https://doi.org/10.1080/02687038.2018.1489120.
Behn, N., Marshall, J., Togher, L., & Cruice, M. (2019). Reporting on novel complex intervention
development for adults with social communication impairments after acquired brain injury.
Disability and Rehabilitation, 1-10. doi:10.1080/09638288.2019.1642964
Bejot, Y., Daubail, B., & Giroud, M. (2016). Epidemiology of stroke and transient ischemic attacks:
Current knowledge and perspectives. Revue Neurologique, 172(1), 59-68.
doi:10.1016/j.neurol.2015.07.013
Bellg, A. J., Borrelli, B., Resnick, B., Hecht, J., Minicucci, D. S., Ory, M., . . . Czajkowski, S. (2004).
Enhancing treatment fidelity in health behavior change studies: best practices and
recommendations from the NIH Behavior Change Consortium. Health Psychology, 23(5),
443-451. doi:10.1037/0278-6133.23.5.443
Benaim, C., Cailly, B., Pelissier, J., & Perennou, D. (2004). Validation of the aphasic depression
rating scale. Stroke, 35, 1692-1696. doi:10.1161/01.STR.0000130591.95710.20
Best, W., Herbert, R., Hickin, J., Osborne, F., & Howard, D. (2002). Phonological and orthographic
facilitation of word-retrieval in aphasia: Immediate and delayed effects. Aphasiology, 16(1-2),
151-168. Retrieved from https://doi.org/10.1080/02687040143000483.
Bhogal, S. K., Teasell, R., & Speechley, M. (2003). Intensity of aphasia therapy, impact on recovery.
Stroke, 34(4), 987-993. doi:10.1161/01.str.0000062343.64383.d0
185

Biernaskie, J., & Corbett, D. (2001). Enriched rehabilitative training promotes improved forelimb
motor function and enhanced dendritic growth after focal ischemic injury. Journal of
Neuroscience, 21(14), 5272-5280. doi:10.1523/JNEUROSCI.21-14-05272.2001
Borrelli, B., Sepinwall, D., Ernst, D., Bellg, A. J., Czajkowski, S., Breger, R., . . . Orwig, D. (2005). A
new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of
health behavior research. Journal of Consulting and Clinical Psychology, 73(5), 852-860.
doi:10.1037/0022-006X.73.5.852
Borschmann, K., Hayward, K. S., Raffelt, A., Churilov, L., Kramer, S., & Bernhardt, J. (2018).
Rationale for intervention and dose is lacking in stroke recovery trials: A systematic review.
Stroke Research and Treatment, 2018, 9. doi:10.1155/2018/8087372
Boyle, M. (2011). Discourse treatment for word retrieval impairment in aphasia: The story so far.
Aphasiology, 25(11), 1308-1326. Retrieved from
https://doi.org/10.1080/02687038.2011.596185.
Brady, M. C., Kelly, H., Godwin, J., Enderby, P., & Campbell, P. (2016). Speech and language
therapy for aphasia following stroke. Cochrane Database of Systematic Reviews(6). Retrieved
from http://dx.doi.org/10.1002/14651858.CD000425.pub4.
Brogan, E., Ciccone, N., & Godecke, E. (2019). Treatment fidelity in aphasia randomised controlled
trials. Aphasiology, 33(7), 759-779. doi:10.1080/02687038.2019.1576442
Bryan, R. L., Kreuter, M. W., & Brownson, R. C. (2009). Integrating adult learning principles into
training for public health practice. Health Promotion Practice, 10(4), 557-563.
doi:10.1177/1524839907308117
Byng, S. (1995). What is aphasia therapy? In C. Cole & D. Muller (Eds.), The treatment of aphasia:
from theory to practice. London: Whurr.
Byng, S., & Black, M. (1995). What makes a therapy? Some parameters of therapeutic intervention in
aphasia. European Journal of Disorders of Communication, 30(3), 303-316.
Cameron, R. M., Wambaugh, J. L., Wright, S. M., & Nessler, C. L. (2006). Effects of a combined
semantic/phonologic cueing treatment on word retrieval in discourse. Aphasiology, 20(2-4),
269-285. doi:10.1080/02687030500473387
186

Candian Institutes Health Research. (2015). Knowledge translation. Retrieved from www.cihrirsc.gc.ca/e/29418.html
Carnaby, G. D., & Harenberg, L. (2013). What is “usual care” in dysphagia rehabilitation: A survey of
USA dysphagia practice patterns. Dysphagia, 28(4), 567-574. Retrieved from
http://dx.doi.org/10.1007/s00455-013-9467-8.
Carragher, M., Ryan, B., Worrall, L., Thomas, S., Rose, M., Simmons-Mackie, N., . . . Kneebone, I.
(2019). Fidelity protocol for the Action Success Knowledge (ASK) trial: A psychosocial
intervention administered by speech and language therapists to prevent depression in people
with post-stroke aphasia. British Medical Journal Open, 9(5), e023560.
doi:10.1136/bmjopen-2018-023560
Chapey, R., & Hallowell, B. (2001). Introduction to language intervention stragtegies in adult aphasia.
In R. Chapey (Ed.), Language intervention strategies in aphasia and related neurogenic
communication disorders. New York: Lippincott Williams and Wilkins
Cheneval, P. P., Glize, B., & Laganaro, M. (2018). The lexical or sub-lexical locus of facilitation by
phonemic cueing in aphasic speakers: the effect of onset cohort size. Aphasiology, 32(12),
1468-1489. Retrieved from https://doi.org/10.1080/02687038.2017.1423273.
Cherney, L. (2012). Aphasia treatment: intensity, dose parameters, and script training. International
Journal of Speech-Language Pathology, 14(5), 424-431. doi:10.3109/17549507.2012.686629
Cherney, L., Patterson, J. P., Raymer, A., Frymark, T., & Schooling, T. (2008). Evidence-based
systematic review: effects of intensity of treatment and constraint-induced language therapy
for individuals with stroke-induced aphasia. Journal of Speech, Language & Hearing
Research, 51(5), 1282-1299 1218p. doi:10.1044/1092-4388(2008/07-0206
Ciccone, N., Hersh, D., Armstrong, E., & Godecke, E. (2013). Speech pathologists' clinical decision
making in the provision of services to people with aphasia. International Journal of Stroke, 8,
27-51. doi:10.1111/ijs.12143
Ciccone, N., West, D., Cream, A., Cartwright, J., Rai, T., Granger, A., . . . Godecke, E. (2016).
Constraint-induced aphasia therapy (CIAT): a randomised controlled trial in very early stroke
rehabilitation. Aphasiology, 30(5), 566-584. doi:10.1080/02687038.2015.1071480
187

Conroy, P., Sage, K., & Lambon Ralph, M. A. (2009a). The effects of decreasing and increasing cue
therapy on improving naming speed and accuracy for verbs and nouns in aphasia.
Aphasiology, 23(6), 707-730. doi:10.1080/02687030802165574
Conroy, P., Sage, K., & Lambon Ralph, M. A. (2009b). Errorless and errorful therapy for verb and
noun naming in aphasia. Aphasiology, 23(11), 1311-1337. doi:10.1080/02687030902756439
Copland, D. (2017). Do measures of brain activity predict recovery of the ability to communicate after
stroke and predict response to speech therapy? (PAPAR). Retrieved from
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372403
Cordray, D. S., & Pion, G. M. (2006). Treatment strength and integrity: Models and methods. In R. R.
Bootzin & P. E. McKnight (Eds.), Strengthening research methodology: Psychological
measurement and evaluation (pp. 103-124). Washington, DC: American Psychological
Association.
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008). Developing and
evaluating complex interventions: the new Medical Research Council guidance. British
Medical Journal, 337, a1655. doi:10.1136/bmj.a1655
Crosson, B., Rodriguez, A. D., Copland, D., Fridriksson, J., Krishnamurthy, L. C., Meinzer, M., . . .
Leff, A. P. (2019). Neuroplasticity and aphasia treatments: new approaches for an old
problem. Journal of Neurology, Neurosurgery and Psychiatry. doi:10.1136/jnnp-2018319649
Cruice, M., Blom Johansson, M., Isaksen, J., & Horton, S. (2018). Reporting interventions in
communication partner training: a critical review and narrative synthesis of the literature.
Aphasiology, 1-32. Retrieved from https://doi.org/10.1080/02687038.2018.1482406.
doi:10.1080/02687038.2018.1482406
Curran, G. M., Bauer, M., Mittman, B., Pyne, J. M., & Stetler, C. (2012). Effectivenessimplementation hybrid designs: combining elements of clinical effectiveness and
implementation research to enhance public health impact. Medical Care, 50(3), 217-226.
doi:10.1097/MLR.0b013e3182408812

188

Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009).
Fostering implementation of health services research findings into practice: A consolidated
framework for advancing implementation science. Implementation Science, 4(1), 50.
Retrieved from https://doi.org/10.1186/1748-5908-4-50.
Damschroder, L. J., Goodrich, D. E., Kim, H. M., Holleman, R., Gillon, L., Kirsh, S., . . . Lutes, L. D.
(2016). Development and validation of the ASPIRE-VA coaching fidelity checklist (ACFC):
A tool to help ensure delivery of high-quality weight management interventions.
Translational Behavioral Medicine, 6(3), 369-385. doi:10.1007/s13142-015-0336-x
De Jong-Hagelstein, M., van de Sandt-Koenderman, W. M. E., Prins, N. D., Dippel, D. W.,
Koudstaal, P. J., & Visch-Brink, E. G. (2011). Efficacy of early cognitive-linguistic treatment
and communicative treatment in aphasia after stroke: A randomised controlled trial (RATS2). Journal of Neurology, Neurosurgery and Psychiatry, 82(4), 399-404.
DeJong, G., Horn, S. D., Conroy, B., Nichols, D., & Healton, E. B. (2005). Opening the black box of
poststroke rehabilitation: Stroke rehabilitation patients, pocesses, and otcomes. Archives of
Physical Medicine and Rehabilitation, 86(12, Supplement), 1-7.
doi:10.1016/j.apmr.2005.09.003
Dignam, J., Copland, D., McKinnon, E., Burfein, P., O'Brien, K., Farrell, A., & Rodriguez, A. D.
(2015). Intensive versus distributed aphasia therapy: A nonrandomized, parallel-group,
dosage-controlled study. Stroke, 46(8), 2206-2211. doi:10.1161/strokeaha.115.009522
Dijkers, M. P., Hart, T., Tsaousides, T., Whyte, J., & Zanca, J. M. (2014). Treatment taxonomy for
rehabilitation: Past, present, and prospects. Archives of Physical Medicine and Rehabilitation,
95(1, Supplement), S6-S16. doi:10.1016/j.apmr.2013.03.032
Dodd, B. (2007). Evidence-based practice and speech language pathology: Strengths, weaknesses,
opportunities and threats. Folia Phoniatrica et Logopaedica, 59(3), 118-129.
doi:10.1159/000101770
Dollaghan, C. A. (2011). The handbook for evidence-based practice in communication disorders.
Baltimore, Maryland: Brookes Publishing.

189

Doogan, C., Dignam, J., Copland, D., & Leff, A. (2018). Aphasia recovery: When, how and who to
treat? Current Neurology and Neuroscience Reports, 18(12), 90-90. doi:10.1007/s11910-0180891-x
Douglas, N. F., Hinckley, J. J., Haley, W. E., Andel, R., Chisolm, T. H., & Eddins, A. C. (2014).
Perceptions of speech-language pathologists linked to evidence-based practice use in skilled
nursing facilities. American Journal of Speech-Language Pathology, 23(4), 612-624.
doi:10.1044/2014_AJSLP-13-0139
Ellis, C., Simpson, A. N., Bonilha, H., Mauldin, P. D., & Simpson, K. N. (2012). The one-year
attributable cost of poststroke aphasia. Stroke, 43(5), 1429-1431.
doi:10.1161/strokeaha.111.647339
Embry, D. D., & Biglan, A. (2008). Evidence-based kernels: Fundamental units of behavioral
influence. Clinical Child and Family Psychology Review, 11(3), 75-113. Retrieved from
https://doi.org/10.1007/s10567-008-0036-x.
Enderby, P. (2012). How much therapy is enough? The impossible question! International Journal of
Speech-Language Pathology, 14(5), 432-437. doi:10.3109/17549507.2012.686118
Engelter, S. T., Gostynski, M., Papa, S., Frei, M., Born, C., Ajdacic-Gross, V., . . . Lyrer, P. A.
(2006). Epidemiology of aphasia attributable to first ischemic stroke: incidence, severity,
fluency, etiology, and thrombolysis. Stroke, 37(6), 1379-1384.
doi:10.1161/01.STR.0000221815.64093.8c
Ferguson, A. (1996). Describing competence in aphasic/normal conversation Clinical Linguistics &
Phonetics, 10(1), 55-63. Retrieved from https://doi.org/10.3109/02699209608985161.
Fillingham, J. K., Sage, K., & Ralph, M. A. (2005). Treatment of anomia using errorless versus
errorful learning: Are frontal executive skills and feedback important? International Journal
of Language and Communication Disorders, 40(4), 505-523.
doi:10.1080/13682820500138572
Fillingham, J. K., Sage, K., & Ralph, M. A. (2006). The treatment of anomia using errorless learning.
Neuropsychological Rehabilitation, 16(2), 129-154. doi:10.1080/09602010443000254

190

Foster, A., O’Halloran, R., Rose, M., & Worrall, L. (2016). “Communication is taking a back seat”:
Speech pathologists’ perceptions of aphasia management in acute hospital settings.
Aphasiology, 30(5), 585-608. Retrieved from https://doi.org/10.1080/02687038.2014.985185.
Foster, A., Worrall, L., Rose, M., & O'Halloran, R. (2013). Turning the tide: Putting acute aphasia
management back on the agenda through evidence-based practice. Aphasiology, 27(4), 420443 424p. doi:10.1080/02687038.2013.770818
Foster, A., Worrall, L., Rose, M., & O'Halloran, R. (2015). ‘That doesn't translate’: The role of
evidence-based practice in disempowering speech pathologists in acute aphasia management.
International Journal of Language and Communication Disorders, 50(4), 547-563. Retrieved
from http://dx.doi.org/10.1111/1460-6984.12155.
Foster, A., Worrall, L. E., Rose, M. L., & O’Halloran, R. (2016). ‘I do the best I can’: An in-depth
exploration of the aphasia management pathway in the acute hospital setting. Disability and
Rehabilitation, 38(18), 1765-1779 1715p. doi:10.3109/09638288.2015.1107766
Gearing, R. E., El-Bassel, N., Ghesquiere, A., Baldwin, S., Gillies, J., & Ngeow, E. (2011). Major
ingredients of fidelity: A review and scientific guide to improving quality of intervention
research implementation. Clinical Psychology Review, 31(1), 79-88.
doi:10.1016/j.cpr.2010.09.007
Godecke, E., Armstrong, E., Bernhardt, J., Middleton, S., Rai, T., Holland, A., . . . Hankey, G. J.
(2013). Very Early Rehabilitation in SpEech (VERSE): The development of an Australian
randomised controlled trial of aphasia therapy after stroke. International Journal of Stroke,
8(Suppl 1), 44-45.
Godecke, E., Armstrong, E., Middleton, S., Rai, T., Holland, A., Cadilhac, D. A., . . . Bernhardt, J.
(2015). Assessment of therapy fidelity processes in the Very Early Rehabilitatoin in SpEech
(VERSE) clinical trial. International Journal of Stroke. Issue Supplement, 10(Suppl 2), 424.
Godecke, E., Armstrong, E., Rai, T., Middleton, S., Ciccone, N., Rose, M., . . . Bernhardt, J. (2018).
World Stroke Congress Abstracts, 2018. International Journal of Stroke, 13(2_suppl), 3-217.
Retrieved from http://journals.sagepub.com/doi/abs/10.1177/1747493018789543.

191

Godecke, E., Armstrong, E. A., Rai, T., Middleton, S., Ciccone, N., Whitworth, A., . . . Bernhardt, J.
(2016). A randomized controlled trial of very early rehabilitation in speech after stroke.
International Journal of Stroke, 11(5), 586-592. doi:10.1177/1747493016641116
Godecke, E., Ciccone, N., Granger, A., Rai, T., West, D., Cream, A., . . . Hankey, G. J. (2014). A
comparison of aphasia therapy outcomes before and after a Very Early Rehabilitation
programme following stroke. International Journal of Language and Communication
Disorders, 49(2), 149-161. doi:10.1111/1460-6984.12074
Godecke, E., Hird, K., Lalor, E. E., Rai, T., & Phillips, M. R. (2012). Very early poststroke aphasia
therapy: a pilot randomized controlled efficacy trial. International Journal of Stroke, 7(8),
635-644. Retrieved from http://dx.doi.org/10.1111/j.1747-4949.2011.00631.x.
Gottesman, I. (1963). Genetic aspects of intelligent behavior. In N. R. Ellis (Ed.), Handbook of mental
deficiency (pp. 253-296). New York: McGraw-Hill.
Guadagnoli, M. A., & Lee, T. D. (2004). Challenge point: A framework for conceptualizing the
effects of various practice conditions in motor learning. Journal of Motor Behaviour, 36(2),
212-224. doi:10.3200/jmbr.36.2.212-224
Guo, Y. E., Togher, L., & Power, E. (2014). Speech pathology services for people with aphasia: What
is the current practice in Singapore? Disability and Rehabilitation, 36(8), 691-704. Retrieved
from https://doi.org/10.3109/09638288.2013.804597.
Hand, B. N., Darragh, A. R., & Persch, A. C. (2018). Thoroughness and psychometrics of fidelity
measures in occupational and physical therapy: A systematic review. American Journal of
Occupational Therapy, 72(5), 1-10. doi:10.5014/ajot.2018.025510
Harnish, S. M., Morgan, J., Lundine, J. P., Bauer, A., Singletary, F., Benjamin, M. L., . . . Crosson, B.
(2014). Dosing of a cued picture-naming treatment for anomia. American Journal of SpeechLanguage Pathology, 23(2), S285-299. doi:10.1044/2014_ajslp-13-0081
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research
electronic data capture (REDCap)—A metadata-driven methodology and workflow process
for providing translational research informatics support. Journal of Biomedical Informatics,
42(2), 377-381. doi:10.1016/j.jbi.2008.08.010
192

Hebb, D. O. (1949). The organisation of behaviour. A neuropsychological theory. New York: John
Wiley.
Hersh, D., & Ciccone, N. (2016). Predicting potential for aphasia rehabilitation: The role of
judgements of motivation. Journal of Clinical Practice in Speech-Language Pathology, 18(1),
3-7.
Hilari, K., Behn, N., Marshall, J., Simpson, A., Thomas, S., Northcott, S., . . . Goldsmith, K. (2019).
Adjustment with aphasia after stroke: Study protocol for a pilot feasibility randomised
controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB). Pilot and
Feasibility Studies, 5(1), 14. Retrieved from https://doi.org/10.1186/s40814-019-0397-6.
Hilari, K., Byng, S., D.L, L., & Smith, S. C. (2003). Stroke and Aphasia Quality Of Life scale-39
(SAQOL-39) evaluation of acceptability, reliability, and validity. Stroke, 34(8), 1944-1950.
Hildebrand, M. W. (2018). Treatment fidelity. British Journal of Occupational Therapy, 82(5), 261262. Retrieved from https://doi.org/10.1177/0308022618816602.
Hildebrand, M. W., Host, H. H., Binder, E. F., Carpenter, B., Freedland, K. E., Morrow-Howell, N., . .
. Lenze, E. J. (2012). Measuring treatment fidelity in a rehabilitation intervention study.
American Journal of Physical Medicine and Rehabilitation, 91(8), 715-724.
doi:10.1097/PHM.0b013e31824ad462
Hinckley, J. (2005). The piano lesson: An autoethnography about changing clinical paradigms in
aphasia practice. Aphasiology, 19(8), 765-779. doi:10.1080/02687030544000092
Hinckley, J., & Douglas, N. F. (2013). Treatment fidelity: its importance and reported frequency in
aphasia treatment studies. American Journal of Speech-Language Pathology, 22(2), S279S284. doi:10.1044/1058-0360(2012/12-0092)
Hoffman, L. (2009). Narrative language intervention intensity and dosage: Telling the whole story.
Topics in Language Disorders, 29(4), 329-343.
Hoffmann, T. C., Erueti, C., & Glasziou, P. P. (2013). Poor description of non-pharmacological
interventions: analysis of consecutive sample of randomised trials. British Medical Journal
(Clinical Research Ed.), 347, f3755. doi:10.1136/bmj.f3755

193

Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., . . . Michie, S. (2014).
Better reporting of interventions: Template for intervention description and replication
(TIDieR) checklist and guide. British Medical Journal, 348, g1687. doi:10.1136/bmj.g1687
Hoffmann, T. C., & Walker, M. F. (2015). 'TIDieR-ing up' the reporting of interventions in stroke
research: the importance of knowing what is in the 'black box'. International Journal of
Stroke, 10(5), 657-658. doi:10.1111/ijs.12524
Horton, S. (2006). A framework for description and analysis of therapy for language impairment in
aphasia. Aphasiology, 20(6), 528-564. Retrieved from
http://dx.doi.org/10.1080/02687030600590130. doi:10.1080/02687030600590130
IBM Corp. (2015). IBM SPSS Statistics for Windows (Version 23.0). Armonk, NY: IBM Corp.
Kaderavek, J. N., & Justice, L. M. (2010). Fidelity: An essential component of evidence-based
practice in speech-language pathology. American Journal of Speech-Langauge Pathology,
19(4), 369-379. doi:10.1044/1058-0360(2010/09-0097)
Kamhi, A. G. (2012). Pharmacological dosage concepts: How useful are they for educators and
speech-language pathologists? International Journal of Speech-Language Pathology, 14(5),
414-418. doi:10.3109/17549507.2012.685889
Kaplan, E., Goodglass, H., & Weintraub, S. (2000). Boston Naming Test. In (2nd ed.). New York:
NCS Pearson.
Karas, S., & Plankis, L. (2016). Consideration of treatment fidelity to improve manual therapy
research. Journal of Manual & Manipulative Therapy, 24(4), 233-237.
doi:10.1080/10669817.2015.1135555
Katz, R. C., Hallowell, B., Code, C., Armstrong, E., Roberts, P., Pound, C., & Katz, L. (2000). A
multinational comparison of aphasia management practices. International Journal of
Language and Communication Disorders, 35(2), 303-314. Retrieved from
http://dx.doi.org/10.1080/136828200247205.
Keith, R. A., & Lipsey, M. (1993). The role of theory in rehabilitation assessment, treatment, and
outcomes. In R. Glueckauf, L. Sechrest, G. Bond, & E. McDonel (Eds.), Improving
Assessment in Rehabilitation and Health (pp. 33-58). Newbury Park, CA: Sage.
194

Kertesz, A. (2006). Western Aphasia Battery - Revised. San Antonio, TX: Pro-Ed.
Kladouchou, V., Papathanasiou, I., Efstratiadou, E. A., Christaki, V., & Hilari, K. (2017). Treatment
integrity of elaborated semantic feature analysis aphasia therapy delivered in individual and
group settings. International Journal of Language and Communication Disorders, 52(6), 733749. doi:10.1111/1460-6984.12311
Kleim, J. A., & Jones, T. A. (2008). Principles of experience-dependent neural plasticity: implications
for rehabilitation after brain damage. Journal of Speech, Language & Hearing Research,
51(1), S225-239 221p. doi:10.1044/1092-4388(2008/018).
Kong, A. P.-H., & Tse, C. W.-K. (2018). Clinician survey on speech pathology services for people
with aphasia in Hong Kong. Clinical Archives of Communication Disorders, 3(3), 201-212.
doi:10.21849/cacd.2018.00409
Koo, T. K., & Li, M. Y. (2016). A Guideline of selecting and reporting intraclass correlation
coefficients for reliability research. Journal of Chiropractic Medicine, 15(2), 155-163.
doi:10.1016/j.jcm.2016.02.012
Kramer, S., Kaffenberger, T., Cumming, T., Bernhardt, J., & Johnson, L. (2018). Development and
dose parameters of exercise intervention in early stroke: A systematic review. Paper presented
at the The combined Stroke Society of Australiasia (SSA) 28th Annual Scientific Meeting and
the 14th Smart Strokes Australasian Nursing and Allied Health Stroke Conference, Sydney,
Australia.
Lalor, E. E., & Cranfield, E. (2004). Aphasia: A description of the incidence and management in the
acute hospital setting. Asia Pacific Journal of Speech, Language and Hearing, 9(2), 129-136.
Retrieved from https://doi.org/10.1179/136132804805575949.
Lang, C. E., Lohse, K. R., & Birkenmeier, R. L. (2015). Dose and timing in neurorehabilitation:
prescribing motor therapy after stroke. Current Opinion in Neurology, 28(6), 549-555.
doi:10.1097/WCO.0000000000000256
Linebaugh, C. W., Shisler, R. J., & Lehner, L. (2005). CAC classics. Aphasiology, 19(1), 77-92.
doi:10.1080/02687030444000363

195

Loban, W. (1963). The language of elementary school children. Urbana IL: National Council of
Teachers of English.
Lohse, K. R., Lang, C. E., & Boyd, L. A. (2014). Is more better? Using metadata to explore doseresponse relationships in stroke rehabilitation. Stroke, 45(7), 2053-2058.
doi:10.1161/STROKEAHA.114.004695
Ludemann, A., Power, E., & Hoffmann, T. C. (2017). Investigating the adequacy of intervention
descriptions in recent speech-language pathology literature: Is evidence from randomized
trials useable? American Journal of Speech-Language Pathology, 26(2), 443-455.
doi:10.1044/2016_AJSLP-16-0035
Lynch, E. A., Chesworth, B. M., & Connell, L. A. (2018). Implementation—The missing link in the
research translation pipeline: Is it any wonder no one ever implements evidence-based
practice? Neurorehabilitation and Neural Repair, 32(9), 751-761. Retrieved from
https://journals.sagepub.com/doi/abs/10.1177/1545968318777844.
Lynch, E. A., Mudge, A., Knowles, S., Kitson, A. L., Hunter, S. C., & Harvey, G. (2018). “There is
nothing so practical as a good theory”: A pragmatic guide for selecting theoretical approaches
for implementation projects. BMC Health Services Research, 18(1), 857. Retrieved from
https://doi.org/10.1186/s12913-018-3671-z.
Maas, E., Robin, D. A., Hula, S. N. A., Freedman, S. E., Wulf, G., & Ballard, K. J. (2008). Principles
of motor learning in treatment of motor speech disorders. American Journal of SpeechLanguage Pathology, 17(3), 277-298.
McKissock, S., & Ward, J. (2007). Do errors matter? Errorless and errorful learning in anomic picture
naming. Neuropsychological Rehabilitation, 17(3), 355-373.
doi:10.1080/09602010600892113
McLennon, S. M., Hancock, R. D., Redelman, K., Scarton, L. J., Riley, E., Sweeney, B., . . . Bakas, T.
(2016). Comparing treatment fidelity between study arms of a randomized controlled clinical
trial for stroke family caregivers. Clinical Rehabilitation, 30(5), 495-507.
doi:10.1177/0269215515585134

196

Miller, J. (2008). Systematic Analysis of Language Transcripts (SALT), English Demo Version 2008
[Computer Software]. In. Wisconsin: SALT Software LLC.
Moher, D. (2018). Reporting guidelines: doing better for readers. BMC Medicine, 16(1), 233.
Retrieved from https://doi.org/10.1186/s12916-018-1226-0.
Moncher, F. J., & Prinz, R. J. (1991). Treatment fidelity in outcome studies. Clinical Psychology
Review, 11(3), 247-266. doi:10.1016/0272-7358(91)90103-2
Murphy, T. H., & Corbett, D. (2009). Plasticity during stroke recovery: from synapse to behavior.
Nature Reviews Neuroscience, 10, 861-872.
Nardo, D., Holland, R., Leff, A. P., Price, C. J., & Crinion, J. T. (2017). Less is more: Neural
mechanisms underlying anomia treatment in chronic aphasic patients. Brain, 140(11), 30393054. doi:10.1093/brain/awx234
National Stroke Foundation. (2016). National stroke audit- Rehabilitation services report. Retrieved
from InformMe Melbourne, Australia: www.informme.org.au/stroke-data
Nelson, N., & Butler, K. (2009). From the Editor. Topics in Language Disorders, 29(3), 201-203.
Nicholas, L., & Brookshire, R. H. (1995). Presence completeness and accuracy of main concepts in
the connected speech of non-brain injured adults. Journal of Speech and Hearing Research,
38, 145-156.
NIH Rockville. (2002). Treatment as usual: Measurement, design and ethics. Paper presented at the
NIH Meeting summary, Rockville, MD.
Nudo, R. J. (2013). Recovery after brain injury: Mechanisms and principles. Frontiers in Human
Neuroscience, 7, 887-887. doi:10.3389/fnhum.2013.00887
O'Donell, C. (2008). Defining, conceptualizing, and measuring fidelity of implementation and its
relationship to outcomes in K-12 curriculum intervention research. Review of Educational
Research, 78(1), 33-84.
O'Halloran, K. (2004). Multimodal discourse analysis: Systemic functional perspectives: A&C Black.
O'Hare, M., & Doell, E. (2015). What supports speech-language pathologists to implement treatments
with fidelity? Journal of Clinical Practice in Speech-Language Pathology, 17(3), 140-143.

197

O’Shea, O., McCormack, R., Bradley, J., & O’Neill, B. (2016). Fidelity review: A scoping review of
the methods used to evaluate treatment fidelity in behavioural change interventions. Physical
Therapy Reviews, 21(3-6), 207-214. doi:10.1080/10833196.2016.1261237
Oakley, A., Strange, V., Bonell, C., Allen, E., & Stephenson, J. (2006). Process evaluation in
randomised controlled trials of complex interventions. British Medical Journal, 332(7538),
413-416. doi:10.1136/bmj.332.7538.413
Off, C. A., Griffin, J. R., Spencer, K. A., & Rogers, M. (2016). The impact of dose on naming
accuracy with persons with aphasia. Aphasiology, 30(9), 983-1011.
doi:10.1080/02687038.2015.1100705
Öst, L.-G. (2008). Efficacy of the third wave of behavioral therapies: A systematic review and metaanalysis. Behaviour Research and Therapy, 46(3), 296-321. doi:10.1016/j.brat.2007.12.005
Palmer, R., Cooper, C., Enderby, P., Brady, M., Julious, S., Bowen, A., & Latimer, N. (2015).
Clinical and cost effectiveness of computer treatment for aphasia post stroke (Big CACTUS):
Study protocol for a randomised controlled trial. Trials, 16(1), 18-18. doi:10.1186/s13063014-0527-7
Palmer, R., Witts, H., & Chater, T. (2018). What speech and language therapy do community
dwelling stroke survivors with aphasia receive in the UK? PloS One, 13(7).
doi:10.1371/journal.pone.0200096
Patterson, J. P., & Chapey, R. (2008). Assessment of language disorders in adults. In R. Chapey (Ed.),
Language intervention strategies in aphasia and related neurogenic communication disorders
(5th ed., pp. 64-152). Philadelphia, PA: Lippincott Williams and Wilkins.
Pedersen, P. M., Jorgensen, H. S., Nakayama, H., Raaschou, H. O., & Olsen, T. S. (1995). Aphasia in
acute stroke: incidence, determinants, and recovery. Annals of Neurology, 38(4), 659-666.
doi:10.1002/ana.410380416
Perepletchikova, F., & Kazdin, A. E. (2005). Treatment integrity and therapeutic change: Issues and
research recommendations. Clinical Psychology: Science and Practice, 12(4), 365-383.
doi:10.1093/clipsy.bpi045

198

Persch, A. C., & Page, S. J. (2013). Protocol development, treatment fidelity, adherence to treatment,
and quality control. The American Journal of Occupational Therapy, 67(2), 146-153.
doi:10.5014/ajot.2013.006213
Petticrew, M. (2011). When are complex interventions ‘complex’? When are simple interventions
‘simple’? The European Journal of Public Health, 21(4), 397-398.
doi:10.1093/eurpub/ckr084
Pollock, A., St George, B., Fenton, M., & Firkins, L. (2012). Top ten research priorities relating to life
after stroke. Lancet Neurology, 11, 209.
Pring, T. (2004). Ask a silly question: Two decades of troublesome trials. International Journal of
Language and Communication Disorders, 39(3), 285-302 218p.
Pulvermuller, F., & Berthier, M. L. (2008). Aphasia therapy on a neuroscience basis. Aphasiology, 22,
563-599.
Pulvermuller, F., Neininger, B., Elbert, T., Mohr, B., Rockstroh, B., Koebbel, P., & Taub, E. (2001).
Constraint-induced therapy of chronic aphasia after stroke. Stroke, 32(7), 1621-1626.
doi:10.1161/01.str.32.7.1621
Rai, T., Godecke, E., Armstrong, E., Cadilhac, D. A., Ciccone, N., Rose, M., . . . VERSE
Collaborators. (2019). Fewer but longer treatment sessions for aphasia are associated with
better recovery in the Very Early Rehabilitation in Speech (VERSE) clinical trial cohortGeneral Interest Sessions. European Stroke Journal, 4(1_suppl), 3-95.
doi:10.1177/2396987319845560
Ratner, N. B. (2006). Evidence-based practice: an examination of its ramifications for the practice of
speech-language pathology. Language, Speech and Hearing Services in Schools, 37(4), 257267. doi:10.1044/0161-1461(2006/029)
Raymer, A. M., Beeson, P., Holland, A., Kendall, D., Maher, L. M., Martin, N., . . . Gonzalez Rothi,
L. J. (2008). Translational research in aphasia: From neuroscience to neurorehabilitation.
Journal of Speech, Language, and Hearing Research, 51(1), S259-275. doi:10.1044/10924388(2008/020)

199

RELEASE Collaborators. (2019). Predictors of language recovery following stroke: Results from a
systematic review informed individual participant data (IPD) meta-analyses of the
REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE).
Lancet(submitted for review).
Resnick, B., Bellg, A. J., Borrelli, B., De Francesco, C., Breger, R., Hecht, J., . . . Czajkowski, S.
(2005). Examples of implementation and evaluation of treatment fidelity in the BCC studies:
Where we are and where we need to go. Annals of Behavioral Medicine, 29(2), 46.
doi:10.1207/s15324796abm2902s_8
Resnick, B., Michael, K., Shaughnessy, M., Nahm, E. S., Sorkin, J. D., & Macko, R. (2011). Exercise
intervention research in stroke: Optimizing outcomes through treatment fidelity. Topics in
Stroke Rehabilitation, 18(1), 611-619. doi:10.1310/tsr18s01-611
Richardson, J. D., Dalton, S. G. H., Shafer, J., & Patterson, J. (2016). Assessment Fidelity in Aphasia
Research. American Journal of Speech-Language Pathology, 25, S788-S797.
doi:10.1044/2016_AJSLP-15-0146
Rixon, L., Baron, J., McGale, N., Lorencatto, F., Francis, J., & Davies, A. (2016). Methods used to
address fidelity of receipt in health intervention research: A citation analysis and systematic
review. BMC Health Services Research, 16, 663. doi:10.1186/s12913-016-1904-6
Robbins, J., Butler, S. G., Daniels, S. K., Gross, R. D., Langmore, S., Lazarus, C. L., . . . Rosenbeck,
J. (2008). Swallowing and dysphagia rehabilitation: translating principles of neural plasticity
into clinically orientated evidence. Journal of Speech Language Hearing Research, 51(1),
S276-300.
Robey, R. (1998). A meta-analysis of clinical outcomes in the treatment of aphasia. Journal of
Speech, Language & Hearing Research, 41(1), 172.
Rodriguez, A. D., Worrall, L., Brown, K., Grohn, B., McKinnon, E., Pearson, C., . . . Copland, D. A.
(2013). Aphasia LIFT: Exploratory investigation of an intensive comprehensive aphasia
programme. Aphasiology, 27(11), 1339-1361. doi:10.1080/02687038.2013.825759

200

Rose, M., Cherney, L. R., & Worrall, L. E. (2013). Intensive comprehensive aphasia programs: An
international survey of practice. Topics in Stroke Rehabilitation, 20(5), 379-387.
doi:10.1310/tsr2005-379
Rose, M., Ferguson, A., Power, E., Togher, L., & Worrall, L. (2014). Aphasia rehabilitation in
Australia: Current practices, challenges and future directions. International Journal of
Speech-Language Pathology, 16(2), 169-180. doi:10.3109/17549507.2013.794474
Rose, M., Foster, A., Copland D, Nickels, L., Togher, L., Meinzer, M., . . . Godecke, E. (2017).
Embedding measures of therapy fidelity in "COMPARE": A RCT of complex behavioural
interventions for post-stroke aphasia. 3rd European Stroke Organisation Conference, 16th18th May 2017, Prague, Czech Republic. European Journal of Stroke, 2(1), 362.
Rose, T., Balse, A., Osmond, S., Poon, A., Simons, N., & Wallace, S. J. (2018). Aphasia education:
Speech-language pathologists’ perspectives regarding current and optimal practice
Aphasiology, 32(8), 967-988. doi:10.1080/02687038.2018.1472366
Roulstone, S. (2015). Exploring the relationship between client perspectives, clinical expertise and
research evidence. International Journal of Speech-Language Pathology, 17(3), 211-221.
doi:10.3109/17549507.2015.1016112
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., & Hayens, R. B. (1996). Evidence based
medicine: What it is and what it isn't. British Medical Journal, 312, 71-72.
Sage, K., Snell, C., & Lambon Ralph, M. A. (2011). How intensive does anomia therapy for people
with aphasia need to be? Neuropsychological Rehabilitation, 21(1), 26-41.
doi:10.1080/09602011.2010.528966
Schlosser, R. (2002). On the importance of being earnest about treatment integrity. Augmentative and
Alternative Communication, 18(1), 36-44. doi:10.1080/aac.18.1.36.44
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 Statement: updated guidelines
for reporting parallel group randomised trials. British Medical Journal, 340(332).
doi:10.1136/bmj.c332
Seng, E. K., & Lovejoy, T. I. (2013). Reliability and validity of a treatment fidelity assessment for
motivational interviewing targeting sexual risk behaviors in people living with HIV/AIDS.
201

Journal of Clinical Psychology in Medical Settings, 20(4), 440-448. doi:10.1007/s10880-0129343-y
Shrubsole, K., Worrall, L., Power, E., & O'Connor, D. A. (2018). Priorities for closing the evidencepractice gaps in poststroke aphasia rehabilitation: A scoping review. Archives of Physical
Medicine and Rehabilitation, 99(7), 1413-1423.e1424. doi:10.1016/j.apmr.2017.08.474
Shrubsole, K., Worrall, L., Power, E., & O’Connor, D. A. (2018). Barriers and facilitators to meeting
aphasia guideline recommendations: what factors influence speech pathologists’ practice?
Disability and Rehabilitation, 1-12. doi:10.1080/09638288.2018.1432706
Silvast, M. (1990). Aphasia therapy dialogues. Paper presented at the International Aphasia
Rehabilitation Congress, Edinburgh.
Simmons-Mackie, N., Damico, J. S., & Damico, H. L. (1999). A qualitative study of feedback in
aphasia treatment. American Journal of Speech-Language Pathology, 8(3), 218-230.
doi:10.1044/1058-0360.0803.218
Sirman, N., Beeke, S., & Cruice, M. (2017). Professionals’ perspectives on delivering conversation
therapy in clinical practice. Aphasiology, 31(4), 465-494.
doi:10.1080/02687038.2017.1278739
Smelt, A. F., van der Weele, G. M., Blom, J. W., Gussekloo, J., & Assendelft, W. J. (2010). How
usual is usual care in pragmatic intervention studies in primary care? An overview of recent
trials. British Journal of General Practice, 60(576), 305-318. doi:10.3399/bjgp10X514819
Smith, K., McCabe, P., Togher, L., Power, E., Munro, N., Murray, E., & Lincoln, M. (2010). An
introduction to the speechBITE database: Speech pathology database for best interventions
and treatment efficacy. Evidence-Based Communication Assessment and Intervention, 4, 148159. Retrieved from http://doi.org/10.1080/17489539.2010.516089.
Straus, S. E., Tetroe, J., & Graham, I. D. (2009). Defining knowledge translation. Canadian Medical
Association Journal, 181(3-4), 165-168. doi:10.1503/cmaj.081229
Thomas, S. A., Coates, E., das Nair, R., Lincoln, N. B., Cooper, C., Palmer, R., . . . Drummond, A. E.
R. (2016). Behavioural Activation Therapy for Depression after Stroke (BEADS): A study
protocol for a feasibility randomised controlled pilot trial of a psychological intervention for
202

post-stroke depression. Pilot and Feasibility Studies, 2(1), 45. doi:10.1186/s40814-016-00720
Turkstra, L., Norman, R., Whyte, J., Dijkers, M. P., & Hart, T. (2016). Knowing what we're doing:
Why specification of treatment methods is critical for evidence-based practice in speechlanguage pathology. American Journal of Speech-Language Pathology, 25(2), 164-171.
doi:10.1044/2015_AJSLP-15-0060
van de Sandt-Koenderman, M. E., van der Meulen, I., & Ribbers, G. M. (2012). Aphasia
rehabilitation: More than treating the language disorder. Archives of Physical Medicine and
Rehabilitation, 93(1, Supplement), S1-S3. doi:10.1016/j.apmr.2011.08.037
van Vliet, P., Hunter, S. M., Donaldson, C., & Pomeroy, V. (2016). Using the TIDieR checklist to
standardize the description of a functional strength training intervention for the upper limb
after stroke. Journal of Neurologic Physical Therapy, 40(3), 203-208.
doi:10.1097/NPT.0000000000000133
Varley, R. (2011). Rethinking aphasia therapy: A neuroscience perspective. International Journal of
Speech-Language Pathology, 13(1), 11-20. doi:10.3109/17549507.2010.497561
Verna, A., Davidson, B., & Rose, T. (2009). Speech-language pathology services for people with
aphasia: A survey of current practice in Australia. International Journal of Speech-Language
Pathology, 11(3), 191-205. doi:10.1080/17549500902726059
Vratsistas-Curto, A., Sherrington, C., & McCluskey, A. (2019). Dosage and predictors of arm practice
during inpatient stroke rehabilitation: An inception cohort study. Disability and
Rehabilitation, 1-8. doi:10.1080/09638288.2019.1635215
Walker, M. F., Hoffmann, T. C., Brady, M. C., Dean, C. M., Eng, J. J., Farrin, A. J., . . . Watkins, C.
L. (2017). Improving the development, monitoring and reporting of stroke rehabilitation
research: Consensus-based core recommendations from the Stroke Recovery and
Rehabilitation Roundtable. International Journal of Stroke, 12(5), 472-479.
doi:10.1177/1747493017711815

203

Wallace, S. J., Worrall, L., Rose, T., Le Dorze, G., Breitenstein, C., Hilari, K., . . . Webster, J. (2019).
A core outcome set for aphasia treatment research: The ROMA consensus statement.
International Journal of Stroke, 14(2), 180-185. doi:10.1177/1747493018806200
Waller, G. (2009). Evidence-based treatment and therapist drift. Behaviour Research and Therapy,
47(2), 119-127. doi:10.1016/j.brat.2008.10.018
Walton, H., Spector, A., Tombor, I., & Michie, S. (2017). Measures of fidelity of delivery of, and
engagement with, complex, face-to-face health behaviour change interventions: A systematic
review of measure quality. British Journal of Health Psychology, 22(4), 872-903.
doi:10.1111/bjhp.12260
Wambaugh, J. (2003). A comparison of the relative effects of phonologic and semantic cueing
treatments. Aphasiology, 17(5), 433-441. doi:10.1080/02687030344000085
Wambaugh, J., Cameron, R., Kalinyak-Fliszar, M., Nessler, C., & Wright, S. (2004). Retrieval of
action names in aphasia: Effects of two cueing treatments. Aphasiology, 18(11), 979-1004.
doi:10.1080/02687030444000471
Warren, S., Fey, M., & Yoder, P. (2007). Differential treatment intensity research: A missing link to
creating optimally effective communication interventions. Mental Retardation and
Developmental Disabilities Research Reviews, 13(1), 70-77. doi:10.1002/mrdd.20139
Wenke, R., Cardell, E., Lawrie, M., & Gunning, D. (2018). Communication and well-being outcomes
of a hybrid service delivery model of intensive impairment-based treatment for aphasia in the
hospital setting: A pilot study. Disability and Rehabilitation, 40(13), 1532-1541.
doi:10.1080/09638288.2017.1300949
Wheeler, J. J., Baggett, B. A., Fox, J., & Blevins, L. (2006). Treatment integrity: A review of
intervention studies conducted with children with autism. Focus on Autism and Other
Developmental Disabilities, 21(1), 45-54. doi:10.1177/10883576060210010601
Whitworth, A., Webster, J., & Howard, D. (2014). A cognitive neuropsychological approach to
assessment and intervention in aphasia (2nd ed.). New York: Psychology Press.

204

Woldag, H., Voigt, N., Bley, M., & Hummelsheim, H. (2017). Constraint- induced aphasia therapy in
the acute stage: What is the key factor for efficacy? A randomized controlled study.
Neurorehabilitation and Neural Repair, 31(1), 72-80. doi:10.1177/1545968316662707
Woodbury, M. L., Anderson, K., Finetto, C., Fortune, A., Dellenbach, B., Grattan, E., & Hutchison, S.
(2016). Matching task difficulty to patient ability during task practice improves upper
extremity motor skill after stroke: A proof-of-concept study. Archives of Physical Medicine
and Rehabilitation, 97(11), 1863-1871. doi:10.1016/j.apmr.2016.03.022
World Health Organization. (2001). International classification of impairments, disabilities, and
handicaps: A manual of classification relating to the consequences of disease. In. Geneva:
World Health Organization.
Worrall, L., Ryan, B., Hudson, K., Kneebone, I., Simmons-Mackie, N., Khan, A., . . . Rose, M.
(2016). Reducing the psychosocial impact of aphasia on mood and quality of life in people
with aphasia and the impact of caregiving in family members through the Aphasia Action
Success Knowledge (Aphasia ASK) program: Study protocol for a randomized controlled
trial. Trials, 17, 153-153. doi:10.1186/s13063-016-1257-9
Yamato, T., Maher, C., Saragiotto, B., Moseley, A., Hoffmann, T., Elkins, M., & Camargo, P. R.
(2016). The TIDieR checklist will benefit the physical therapy profession. Brazilian Journal
of Physical Therapy, 20(3), 191-193. doi:10.1590/bjpt-rbf.2014.0182
Yoder, P., Fey, M., & Warren, S. (2012). Studying the impact of intensity is important but
complicated. International Journal of Speech-Language Pathology, 14(5), 410-413.
doi:10.3109/17549507.2012.685890

205

11. Appendices
Appendix A. Treatment fidelity area checklist ................................................................................... 207
Appendix B. Summary of studies reviewed........................................................................................ 208
Appendix C. Areas of treatment fidelity investigated by the VERSE RCT ...................................... 216
Appendix D. SALT code definitions .................................................................................................. 223
Appendix E. Example Adapted TIDieR Checklist for Describing Care (ACDC) .............................. 239
Appendix F. VERSE goal summaries ................................................................................................. 243
Appendix G. Continued from 6.3.6.2: statistical sentences from post hoc analyses .......................... 244

206

Appendix A. Treatment fidelity area checklist
TIDieR
Element

Area (Bellg et
al. 2004)

Goal

Location (article,
supplement, author)

Description

Y/N
11.
Planned

Study Design

11.1 Ensure same treatment
dose within conditions
11.2 Ensure equivalent dose
across conditions
11.3 Plan for implementation
setbacks

Training
providers

11.4 Standardise training
11.5 Ensure provider skill
acquisition
11.6 Minimise therapist drift
11.7 Accommodate provider
differences

Delivery of
treatment

11.8 Control for provider
differences
11.9 Reduce differences
within treatment
12.1 Ensure adherence to
protocol

12. Actual

12.2 Minimise contamination
between conditions
Receipt of
treatment

12.3 Ensure participant
comprehension
12.4 Ensure participant ability
to use cognitive skills
12.5 Ensure participants
ability to perform behavioural
skills

Enactment of
treatment skills

12.6 Ensure participant use of
cognitive skills
12.7 Ensure participant use of
behavioural skills
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Appendix B. Summary of studies reviewed
Summary of Studies Reviewed (organised by Year)
Full Reference List below
Article

TF Explicitly Reported

TF Goals addressed

2012
(Barwood et al., 2012)*

No

11.1,11.2

(Bowen, Hesketh, Patchick, Young, Davies, Vail, Long, Watkins, Wilkinson, Pearl,
Lambon Ralph, et al., 2012)

No

11.1,11.2,11.4,11.6,11.9,12.1,12.2

(Bowen, Hesketh, Patchick, Young, Davies, Vail, Long, Watkins, Wilkinson, Pearl,
Ralph, et al., 2012)

Yes

11.1,11.2,11.4,11.5,11.6,11.8,11.9,12.1,12.2,12.3

(Conklyn, Novak, Boissy, Bethoux, & Chemali, 2012)

No

12.2

(Godecke et al., 2012)

No

11.1,11.2,11.4,11.5,11.9,12.1

(Kindler et al., 2012; Medina et al., 2012)*

No

11.1,11.2

(Medina et al., 2012)*

No

11.1,11.2

(Palmer et al., 2012)

No

11.1,11.4,11.6,11.9,12.1

(Raymer et al., 2012)

Yes

11.1,11.2,12.1

(Waldowski, Seniow, Lesniak, Iwanski, & Czlonkowska, 2012)*

No

Nil

(Barwood et al., 2013)*

No

11.1,11.2

(Heiss et al., 2013)*

No

Nil

(Kendall, Hunting Pompon, Brookshire, Minkina, & Bislick, 2013)

No

11.1,11.2,11.4

2013
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(Martins et al., 2013)

No

11.2,.11.4,11.6

(Polanowska, Lesniak, & Seniow, 2013)*

Yes

11.1,11.2,11.8,12.2

(Seniów et al., 2013)*

No

11.1,11.2,12.2

(Thiel et al., 2013)*

No

11.1,11.2

(Altmann et al., 2014)

No

11.1,11.2,11.8,12.1

(Cherney, Kaye, & van Vuuren, 2014)

Yes

11.1,11.2,11.4,11.5,11.6,11.7,11.8,11.9,12.1,12.3,12.5

(Khedr et al., 2014)*

No

11.1,11.2,11.7,11.8

(Mattioli et al., 2014)*

No

11.1,11.2

(Nouwens et al., 2014)

No

11.6

(Sickert, Anders, Münte, & Sailer, 2014)

No

11.1,11.2

(Tsai et al., 2014)*

No

11.1,11.2

(van der Meulen, van de Sandt-Koenderman, Heijenbrok-Kal, Visch-Brink, &
Ribbers, 2014)

No

11.1,11.2,11.4,11.9

(Wang et al., 2014)*

No

Nil

(Cherney, Kaye, Lee, & van Vuuren, 2015)

Yes

11.1,11.2,11.4,11.5,11.6,11.7,11.8,11.9,12.1,12.4

(Kendall, Oelke, Brookshire, & Nadeau, 2015)

Yes

11.1,11.2,11.4,11.5,11.6,11.7,11.9,12.2

(Rubi-Fessen et al., 2015)*

Yes

11.1,11.2,11.4,11.3(a), 12.2

(Szaflarski et al., 2015)

Yes

11.1,11.2,11.4,11.5(a),11.6(a),11.7(a),11.9

(Wilssens, Vandenborre, Van Dun, Verhoeven, & Visch-Brink, 2015)

No

11.1,11.2,11.4,11.5,11.7,11.9,12.1,12.2

2014

2015

2016
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(Ciccone et al., 2016)

Yes

11.1,11.2,11.3,11.4,11.6,11.8(a),11.9,12.1(a),12.2(a)

(Kurland, Stanek Iii, Stokes, Minming, & Andrianopoulos, 2016)

No

11.1,11.2,12.2,12.3

(Marshall et al., 2016)

No

11.1(a),11.2(a),11.3(a),11.5(a),11.6(a),11.7,11.9(a),
12.4(a),12.5(a),12.6(a),12.7(a)

(Meinzer, Darkow, Lindenberg, & Flöel, 2016)*

No

11.1,11.2,11.4(a),11.8,11.9,12.1

(Raglio et al., 2016)

No

11.1,11.2

(Stahl, Mohr, Dreyer, Lucchese, & Pulvermüller, 2016)

No

11.1,11.2

(Breitenstein et al., 2017)

No

11.1,11.2,11.4,11.5,11.6,11.9,12.1,12.2

(Höeg Dembrower, von Heijne, Laska, & Laurencikas, 2017)

No

Nil

(Nouwens et al., 2017)

No

11.1,11.2,11.6,11.9(a),12.1

(Woldag et al., 2017)

No

11.1,11.2

(Zumbansen et al., 2017)

No

11.1,11.2

2017

Note. *denotes a Transcranial Magnetic Stimulation study. (a) = changed according to additional information provided by the author. Not reported in original
article or any available supplement.
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Appendix C. Areas of treatment fidelity investigated by the VERSE RCT

TIDieR

Area

Checklist

(Bellg,

Details

2004)
•

11. HOW

11a Study

11.1 Ensure same

WELL

Design

treatment dose within

was expected to have varying

conditions

doses within the condition. Two

Planned: If

Usual care or control condition

intervention

intensive arms designed to deliver

adherence

the same dose within each

or fidelity

condition. Each group was

was

monitored to ensure the amount of

assessed,

therapy within each group was

describe

within the expected range.
•

how and by

All recorded sessions were cross-

whom, and

checked with data entered into the

if any

REDCaPTM system to ensure

strategies

sessions were of the correct

were used

length, session type (direct

to maintain

aphasia therapy as compared to

or improve

assessment, counselling or

fidelity,

education) treatment type (e.g.

describe

VERSE treatment as compared to

them.

Usual Care therapy).
11.2 Ensure equivalent
dose across conditions

•

Usual care or control condition
was expected to have a different
therapy amount compared to the
intensive treatment arms. The two
intensive treatment arms, Usual
Care-Plus and VERSE received
equivalent dosage of 20 hours of
direct therapy. This was
monitored by the therapy fidelity
monitor.
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•

All recorded sessions were crosschecked with data entered into the
REDCaPTM system to ensure
sessions were of the correct
length, session type (direct
aphasia therapy as compared to
assessment, counselling or
education) treatment type (e.g.
VERSE treatment as compared to
Usual Care therapy).

11.3 Plan for

•

An additional five working days

implementation

was allowed for the intensive

setbacks

intervention to be completed due
to the vulnerable nature of some
participants.
•

A pool of potential therapists was
available at any given time so that
implementation did not rely on
one therapist.

•

Provider attrition was tracked
through a VERSE substudy.

11b

11.4 Standardise

Training

training

•

Therapists met a-priori criteria in
order to be recruited such as being

providers

qualified speech pathologist.
•

All treating therapists and
assessors received 1-2 hours of
either face-to-face or
teleconference (zoom, Scopia or
skype) training.

•

Usual care therapists and Main
investigators received:
o Written study protocol
o Training powerpoint slides
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o Written training manual
o Written data entry manual
o Access to the ‘training mode’
database
o Introduction to all trial
monitoring staff who could
support them throughout the
trial.
•

VERSE therapists received
o General trial training same as
usual care therapists
o Specific VERSE training for
one hour
o VERSE specific training
manual
o Examples of VERSE
treatment plans for each goal
of the treatment hierarchy
o Pre-reading material outline
the theory behind VERSE
o VERSE treatment task
hierarchy
o Therapy recording sheets
o Video recorded examples of
VERSE therapy
o Frequently asked questions
document
o VERSE training kit with
therapy materials

11.5 Ensure provider
skill acquisition

•

Usual Care-Plus and VERSE
sessions were required to video
record treatment sessions 5, 10, 15
and 20 and send these recordings
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to the trial treatment monitor. The
videos were examined as soon as
they were received and feedback
was provided to treating speech
pathologists if 10% of the targeted
behaviour was deemed to be nonadherent.
11.6 Minimise

•

therapist drift

Monitoring of therapy videos as
per 11.5

•

Ongoing updates and reminders
about the trial were included in a
monthly emailed VERSE
newsletter

11.7 Accommodate

•

provider differences

The VERSE Expert Advisory
Committee (EAC) determined that
80% of behaviours in a session
was a clinically acceptable level
of protocol adherence while also
accommodating for provider
differences within sessions. A
session was considered compliant
if 80% of the total activities
within the session were adherent.

11c

11.8 Control for

Delivery

provider differences

•

All video recorded sessions were
reviewed and rated against target

of

criteria. If sessions in the VERSE

treatment

group were deemed not compliant
or close to not compliant by the
Therapy Monitor (TM) these
sessions were reviewed by the
Therapy Integrity Co-Ordinator
(TIC) who contacted the therapist
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to offer strategies to address the
behaviour that was non-compliant.
•

Participant complaints were
monitored by the trial staff.

•

Qualitative interviews were
conducted at the end of the study
with participants.

11.9 Reduce

•

differences within
treatment

Therapy manual provided to
therapists

•

Feedback provided to therapists if
protocol adherence needed to be
increased.

12. Actual

12.1 Ensure adherence

If

to protocol

•

Videoed therapy sessions were
monitored for protocol adherence

intervention

as per 11.5
•

adherence
or fidelity

Example therapy plans with
scripted task explanations

•

was

Therapy deviations were reported

assessed,

to trial staff and recorded in

describe the

REDCapTM
•

extent to

12.2 Minimise

which the

contamination between

specific and only provided to

intervention

conditions

therapists within that role.

was

•

Treatment materials were role

VERSE therapists were trained

delivered as

specifically in relation to

planned.

minimising intervention
contamination and were instructed
not to talk about VERSE therapy
to other non-VERSE therapists.
•

Sessions were conducted where
possible in a quiet and private
place so as not be in ear-shot of
others.
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•

Videoed sessions from both
conditions were reviewed to
identify any contamination.

12a

12.3 Ensure participant

•

Informed consent was obtained.

Receipt of

comprehension

•

Participants with very low

treatment

comprehension were not recruited
for the trial.
•

Within the VERSE condition
participants were treated with an
intervention plan that stipulated a
demonstrated comprehension of at
least 50 single words (Goal 1 was
a comprehension only goal)
before progressing to Goal 2.

•

During this language based
intervention, the provision of
feedback from the therapist aided
the participant’s comprehension.

12.4 Ensure participant

•

The intervention was structured

ability to use cognitive

around achievement based

skills

objectives.
•

The VERSE therapy program
included the introduction of
incremental levels (Goals 2-8) of
communication complexity
involving comprehension and
verbal expression. If 80%
accuracy on the current goal was
achieved it was determined that
the participant had sufficient
comprehension and cognitive
skills to progress to the next goal
in therapy.
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12.5 Ensure

•

As per 12.4 above.

•

Within the prescribed VERSE

participants ability to
perform behavioural
skills
12b

12.6 Ensure participant

Enactment use of cognitive skills

condition therapy tasks were

of

designed to practice everyday

treatment

communication behaviours to

skills

encourage generalisation.
Enactment of these skills beyond
the therapy session was not
monitored.
12.7 Ensure participant

•

As per 12.6 above.

use of behavioural
skills
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Appendix D. SALT code definitions
Client Acts
Area

Meaning

Code

Group

Definition

Response

Error free

[ef]

Usual

Each utterance is marked as [ef] if:

Accuracy

Care-



Plus



Participant correctly identifies the stimulus at the word, short phrase or sentence
level
Participant responds appropriately in conversational context
Each utterance can only be marked once with this code.

Allowances:
-

Minor articulatory errors
Dysarthric speech

Caveats:
•

If the appropriate response was hard to determine i.e. the stimulus couldn’t be
seen in the video, the correctness was judged on the therapists response. I.e. It is
presumed incorrect and marked [e] if:
 The therapist provided a cue
 Therapist gave corrective feedback
 Therapists asked for repetition
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VERSE

Each utterance is marked as [ef] if:




Participant without an error at the appropriate goal level
Participant responds appropriately in conversational context
Each utterance can only be marked once with this code.

Allowances:
-

Minor articulatory errors
Dysarthric speech

Caveats:
•
•

[efd]

VERSE

Each utterance is marked as [efd] if:


Error

[e]

Usual
Care-

Response must be verbal if at Goal2 or greater otherwise marked with a
protocol deviation code.
If the appropriate response is hard to determine i.e. the stimulus can’t be seen in
the video, the correctness will be judged on the therapists response. I.e. It is
presumed incorrect and marked [e] if:
 The therapist provides a cue
 Therapist gives corrective feedback
 Therapists asks for repetition

Participant responds without an error but it is not at the appropriate goal level.
See VERSE goal summaries for details. Each utterance can only be marked
once with this code.

Each error is marked as [e] if:


Plus


Participant does not respond in a timely manner and a cue is offered from the
therapist
Participant makes an error as identified by the codes below.

Caveats:
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•

If the participant self corrects it is also marked [sc]

All [e] codes are accompanied by the appropriate error code as listed below.
VERSE

Each error is marked as [e] if:



Participant makes an error as identified by the codes below.
Goal level of utterance is appropriate for participant.

All [e] codes are accompanied by the appropriate error code as listed below.
[ed]

VERSE

Each utterance is marked as [ed] if:




Participant does not respond in a timely manner and a cue is offered from the
therapist
Participant makes an error as identified by the codes below.
Error is made within an utterance that is not at the appropriate goal level for the
participant. Each utterance can only be marked once with this code.

All [ed] codes are accompanied by the appropriate error code as listed below.
Non verbal

[ges]

Usual

Usual Care-Plus - Each expressive utterance is marked as [ges] followed by [ef] if the

Care-

participant responds with a non-verbal response/gesture that is appropriate. [ges] can

Plus /

accompany a [fp][e] code if the participant is using a gesture while having a word

VERSE

finding difficulty.

VERSE GOAL 1 – [ges] accompanies [ef] if the participant responds appropriately to
the receptive task with a gesture. Or if the gesture is appropriate in conversation. If the
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therapist requests a verbal response a gesture can be marked as an error but will be
accompanied by a [fp] code.

VERSE Goal 2 and above – [ges] accompanies [efd] as responses within therapy tasks
at goal 2 or above are only adherent to VERSE therapy if verbal. E.g. participant is
responding not at the correct goal level.
Reading

[read]

Usual

Utterances will be marked with this code when the participant is producing verbal

Care-

output that is from reading.

Plus /
VERSE
Above goal

[goal

level

up]

VERSE

Each utterance that is error free and above the goal level of the participants is marked
[goalup]. It will be accompanied by the code error free therapy adherent [ef]. If the
participant is below Goal 7 or 8 but is having a conversation, only the utterances above
their goal level within the conversation will be marked as [goalup]. It cannot be [goalup]
if it is an error or the person is repeating after the therapist or reading.

Self-Correction

[sc]

Usual

Each utterance is marked [sc] if the participant self corrects their response immediately

Care-

after the error with no assistance from the therapist. The participant cannot correct the

Plus

error with another error. E.g. if a filled pause is followed by a semantic error then there

/VERSE is no [sc] marked.
Repetition

[rep]

Usual

Accurate repetition from a model of the target. Marked at the utterance level.
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Plus
/VERSE
Metalinguistic

[met]

comment

Usual

A comment from the participant related to their communication difficulty. E.g. ‘I can’t

Care-

find the word’. In general these will be marked as error free and metalinguistic

Plus

comment. If there is an error within the metalinguistic comment then it may be marked

/VERSE as an error.
Humour

[hu]

Usual

Instances of humour. Judged by the transcriber.

CarePlus
/VERSE
Error

Filled pause

[fp]

Usual

Hesitancy and no word given. Filled with ums and ahs and/or automatic speech or

Care-

gesture if person is nonverbal. If a participant is non-verbal and they use an incorrect

Plus

gesture this is marked as a filled pause accompanied by [e]. Marked at the word level

/VERSE and accompanied by an [e] code.
Unfilled pause

[ufp]

Usual

This is marked by hesitancy and word searching. Example: Participant says ‘It feels

Care-

like...’ and pauses while generating the word. No word is generated. If a word is

Plus

verbalised then it can be marked using one of the other error codes. Marked at the word

/VERSE level and accompanied by an [e] code.
Close
Phonological
Error

[phec]

Usual

Phonemic error differing by one sound. If a participant begins to say the word and stops

Care-

because of self-monitoring it can be marked as a close phonological error if only
differing by one sound at the beginning. e.g. participant wants to say ‘sock’ but says
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Plus

‘sh’. Even though the target word and the actual production differ by more than one

/VERSE sound, the participant hasn’t completed the word due to self-monitoring and therefore it
can be marked as only one sound different e.g. [phec]. Marked at the word level and
accompanied by an [e] code.
Distant

[phed]

Usual

Phonemic error differing by more than one sound but obviously related to target word.

phonological

Care-

Marked at the word level and accompanied by an [e] code.

error

Plus
/VERSE

Neologism

[phen]

Usual

Jargon word. Marked at the word level and accompanied by an [e] code.

CarePlus
/VERSE
Stuck in set

[pers]

perseveration

Usual

Perseveration of immediate previous word. Marked at the word level and accompanied

Care-

by an [e] code.

Plus
/VERSE
Recurrent
perseveration

[per]

Usual

Perseveration of a word verbalised previously but not recently. Marked at the word

Care-

level and accompanied by an [e] code.

Plus
/VERSE
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Circumlocution [circ]

Usual

Talking around the word. Marked at the utterance level and accompanied by an [e]

Care-

code.

Plus
/VERSE
Related

[seer]

Usual

Semantic error. Target is obviously related. Marked at the word level and accompanied

Care-

by an [e] code.

Plus
/VERSE
Unrelated

[seeu]

Usual

Verbalisation of a real word that is unrelated to the target word. Marked at the word

Care-

level and accompanied by an [e] code.

Plus
/VERSE
Irrelevant

[irre]

Usual

Verbalisation of an off topic, unrelated phrase that cannot be attributed to another type

Care-

of error. Marked at the utterance level and accompanied by an [e] code.

Plus
/VERSE
Pronoun error

[pro]

Usual

An error in using pronouns. Marked at the word level and accompanied by an [e] code.

CarePlus
/VERSE
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Repetition

[repf]

fluency error

Usual

Mazes and repetitions creating errors in fluency. Marked at the word level and

Care-

accompanied by an [e] code.

Plus
/VERSE
Syntax

[gre]

Usual

Error in grammar in the utterance. Marked at the word level and accompanied by an [e]

Care-

code.

Plus
/VERSE
Receptive

[re]

Usual

Error in comprehension. Marked at the utterance level and accompanied by an [e] code.

CarePlus
/VERSE
Intelligibility

X

Usual

If the response is unable to be transcribed due to unintelligibility it is marked with an X

Care-

accompanied by an [e] at the word level.

Plus
/VERSE
Therapist
Inputs
Cues

Cue used with
Success

[cs]

Usual
Care-

Each utterance from is marked as [cs] if:



The therapist uses a cue such as those listed below AND
The participant responds to the cue with a correct response as per definitions
above
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Plus
/VERSE
Phonemic cue

[phc]

Usual



Must be a verbal response to the cue. e.g. [cs] not marked for receptive
activities.

Therapist gives the first sound or sounds of the stimulus e.g. /k/ for /cat/

CarePlus
/VERSE
Semantic Cue

[sec]

Usual

Therapist gives information about the word E.g. /It’s a pet/. One cue may go over

Care-

several utterances. If an utterance is providing new information thought it will be

Plus

marked as a separate semantic cue.

/VERSE
Orthographic

[orc]

Cue

Usual

Therapist writes the first letter or letters of the word.

CarePlus
/VERSE

Visual Cue

[vic]

Usual

Therapist uses a gesture, shows a picture etc.

CarePlus
/VERSE
Forced
alternative Cue

[fac]

Usual

Therapist offers two choices

Care-
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Plus
/VERSE
Sentence

[scc]

Usual

Completion

Care-

Cue

Plus

Therapists begins a sentence for the participant to finish

/VERSE
Articulatory

[arc]

placement

Usual

Therapist explains how to make the sound using articulatory placement cues e.g. the

Care-

sound is made at the back of your mouth.

Plus
/VERSE
Model

[mod]

Usual

Therapist models the answer

CarePlus
/VERSE
Feedback

Supportive
Feedback

[supf]

Usual
CarePlus

Positive feedback

[supf]

If multiple utterances in a row are positive feedback only the first
utterance is marked as it is one instance of positive feedback.

/VERSE
Example:
T Great [supf].
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T Excellent.
Elaboration of patients utterance

[supfb]

Example:
T And what do you need to put on the envelope?
P The name of the place it/’s go/ing to [e][circ].
T So you/’ve got your address written on the envelope [supfb].
Clarification of patients utterance

[supfc]

Example:
P I think i/’ve probab/ly had about three since I/’ve been here [ef].
T Three dinner/s out [supfc]?
P Three KFC [ef].
Requests for information

[supfd]

Example:
P I/’d love to add a little more [e][circ].
P Just to top it up a bit [ef].
T What might you add [supfd]?
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P Potash [e][seer].
Problem

[prof]

Usual

Says whether it is correct or incorrect. Not necessarily yes/no but

solving

Care-

confirms to participant that they have responded correctly.

Feedback

Plus

[prof]

Example:

/VERSE
T Drink from a c* [phc][cs][csphc]>
P Cup [ef].
T Good [prof].
Explains error to the participant.

[profb]

Example:
P Keychain [e][seer].
T (shakes head) [prof].
T You add/ed a little bit at the end [profb].
Treatment

Humour

Humour

[hu]

Usual

Instances of humour. Judged by the transcriber.

Care-

Integrity

Plus
/VERSE
Protocol
Adherence

[pdbs]

VERSE

The utterance will be marked as [pdbs] if it does not adhere to VERSE protocol because
the same cue is used twice for a stimulus.
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Protocol

[pdbe]

VERSE

The utterance will be marked as [pdbe] if it does not adhere to VERSE protocol. A cue

Deviant

must be given within three errors or after the third error. Should be a model after the

Behaviour

third error. If a fourth error is made by the participant regardless of whether a cue was
given the therapist’s utterance will be parked as deviant. Every subsequent cue (not
model) and utterance following the participant ’s errors will be marked as a deviation.
[pdbne] VERSE

The utterance will be marked as [pdbne] when the therapist does not prompt the
participant to expand to the appropriate goal level. The preceding participant utterance
would be marked as error or error free therapy deviant as it is not at the correct goal
level. Applies also when the participant uses a gesture and the therapist does not ask for
a verbal response.

Other

Task

[te]

Explanation

Usual

Each utterance is marked as [te] if the therapist gives an explanation of the task.

CarePlus
/VERSE

Rationale
Discussion

[rd]

Usual

Each utterance is marked as [rd] if the therapist gives some insight into why this tasks is

Care-

being done.

Plus
/VERSE
Session
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Intervention Materials

Visual stimuli

[vs]

Description

Usual

Utterance marked as [vs] after the presentation of the material. Visual Stimuli refers to

Care-

non-electronic stimuli such as picture cards that are being directly used in therapy. Only

Plus

the first presentation of the stimuli is marked.

/VERSE
Electronic

[es]

stimuli

Usual

Utterance marked as [es] after the presentation of the material. Electronic Stimuli refers

Care-

to items such as iPads or computers that are being directly used in therapy.

Plus
/VERSE
Functional

[fs]

item

Usual

Utterance marked as [fs] after the presentation of the material. Items such as objects.

CarePlus
/VERSE

Other

[om]

Usual

All other materials used not encapsulated within above categories marked as [om].

CarePlus
/VERSE
No materials

[ns]

Usual

Marked [ns] at the end of the utterance relating to the task introduction where no

Care-

materials are used.

Plus
/VERSE
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Type of

Impairment

Task

based

[ibt]

Usual

Utterance marked as [ibt] after the task introduction from the therapist. Impairment

Care-

based tasks focus on the level of breakdown in the participant’s aphasia.

Plus
/VERSE
Social Training

[stt]

Usual

Utterance marked as [stt] after the task introduction from the therapist. These tasks are

Care-

functional in nature.

Plus
/VERSE
Compensatory

[ct]

Usual

Utterance marked as [ct] after the task introduction from the therapist. Tasks are not

Care-

focusing on verbal production.

Plus
/VERSE
Social

[soc]

utterance

Usual

Utterance is social in nature.

CarePlus
/VERSE

Location

Inpatient

[is]

Usual

Marked at the beginning of the transcript. Marked as [is] if it is a hospital setting.

CarePlus
/VERSE
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Personal Home

[ph]

Usual

Marked at the beginning of the transcript. Marked as [ph] if it is a home.

CarePlus
/VERSE
Nursing Home

[nh]

Usual

Marked at the beginning of the transcript. Marked as [ns] if it is a residential facility

CarePlus
/VERSE
Other

[os]

Usual

Marked at the beginning of the transcript. Marked as [os] if it is not a setting listed

Care-

above.

Plus
/VERSE

238

Appendix E. Example Adapted TIDieR Checklist for Describing Care (ACDC)
Participant Number:

11504_CLE_1

Video:

1

Session:

14

SPSS Row Number:
Session Duration (min)
TIDieR Elements
1. Name of therapy

2. Rationale, theory or task
discussion

3. Materials Used

Quantity
☒1.0 Specific therapy regimen (VERSE)

N/A

☐Rationale discussion [rd] 0 No 1 Yes

0

☒Task explanation [te] 0 No 1 Yes

2

☐0 No materials [om]

N/A

☒1 Visual stimuli [vs]

☐2 Electronic stimuli [es]
☐3 Functional items [fs]
4. Type of task

☒Impairment based [ibt] 0 No 1 Yes
☐Social Training [stt] 0 No 1 Yes

2
0
0
4
0

☐Compensatory [ct] 0 No 1 Yes

0

5. Therapist

Therapist code:

N/A

7. Location

☒1 Inpatient in Hospital

N/A

☐2 Personal home
☐3 Nursing home
☐4 Other
8. When and How Much
(Dosage)

Error free therapy adherent [ef]

92

Total error free verbal ([ef]+[efd]-[ges])

93

Error free therapy deviant [efd]

178

Error free therapy deviant verbal ([efd][ges])

1

Total error free [ef]+[efd]

270

Errors therapy adherent [e]

176

Error therapy deviant [ed]

48
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Error total [e]+[ed]

224

Verbal errors (error total – [re])

195

Accurate repetitions [rep]

62

Spontaneous verbal (error free verbal –
[rep]-([ef][read])

31

Non-verbal responses [ges]

177

Reading [read]

0

Error free reading [ef][read]

0

Above goal level [goalup]

0

% utterances above goal level

0

Not at target goal level [efd]+[ed]
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% utterances at correct goal level

51.81%

Social utterances [soc]

/

Self-Corrections [sc]

2

% errors self-corrected

0.89%

Metalinguistic comments [met]

0

Humour [hu]

0

Error type
☒Filled pause [fp]

☒Unfilled pause [ufp]

☒Close phonological error [phec]

☒Distant phonological error [phed]
☒Neologism [phen]

☒Stuck in set perseveration [pers]
☒Recurrent perseveration [per]
☐Circumlocution [circ]
☒Related error [seer]

☒Unrelated error [seeu]
☐ Irrelevant error [irre]
☐ Pronoun error [pro]

☐ Repetition fluency error [repf]
☐Grammatical error [gre]

11
16
15
29
10
33
26
0
5
29
0
0
6
0
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☒Receptive error [re]

9. Tailoring

29

☒Unintelligible XX

17

MLU (words)

1.39

MLU (morphemes)

1.51

Total turns

469

Total verbal utterances

263

Average errors per utterance (errors/utt.)

0.74

Average utterances per error (utt/errors)

1.35

Total words

323

% total words with errors

69.35%

UPM

10.44

WPM

7.19

Mean turn length (words)

0.75

Cues used with success [cs]

65
Amount

With
Success

2

2

0

0

0

0

0

0

0

0

0

0

0

0

☒Direct model [mod]

201

63

Total number of cues used

203

% Cues used that are successful

32.02%

Cue Type
☒Phonological [phc]
☐Semantic [sec]

☐Orthographic [orc]

☐Visual gestural [vic]
☐F/A [fac]

☐Sentence completion [scc]

☐Articulatory placement cue [arc]

Feedback
☒Supportive Positive [supf]

☐Supportive Elaboration [supfb]

☐Supportive clarification [supfc]
☐Supportive requests [supfd]

28
0
0
0
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☐Problem solving yes/no [prof]

☐Problem solving explains error [profb]

12. Adherence to protocol

54
4

☐Conceptual focus [conf]

0

Humour [hu]

0

Total therapist utterances

662

Protocol deviant utterances (same cue)
[pdbs]

0

Protocol deviant utterances – x 3 errors
[pdbe]

17

Total deviant utterances
[pdbe]+[pdbs]+[pdne]

17

Protocol adherent behaviours

645

% Utterances that adhere to protocol

97.43%

Therapist social utterances [soc]

/

Therapist MLU (words)

2.21

Therapist MLU (morphemes)

2.53

Therapist Total words

1464

Therapist UPM

14.73

Therapist WMP

32.58

Mean turn length (therapist)

3.40
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Appendix F. VERSE goal summaries

Goal level

Definition

Coding

1a

Receptive: Identification of verb pictures

Any verbal output is

from spoken words

appropriate. Cannot mark

Receptive: Identification of noun pictures

[efd] or [ed] at this level.

from spoken words

[goalup] is marked for any

Receptive: Identification of adjectives

verbal output that is not an

pictures from spoken words

error.

Verbal production of single words

If not responding verbally

1b

1c

2

then mark as [efd] or [ed].

3

Verbal production of two element phrases

If responding at single word

SV, VO, VA, AdjN, DetN, NumN

level then mark as [efd] or
[ed].

4

Verbal production of three element clauses

If responding below three

SVO, SVA NumAdjN

element clause then mark as
[efd] or [ed].

5

Verbal production of complex clauses and

If responding with three

phrases SVOA, SVOO

element clauses or less then
mark with [efd] or [ed].

6

Verbal production of complex phrases (verb

If responding below a

and noun) clauses and sentence

complex phrase mark as
[efd] or [ed].

7

Verbal conversation about familiar topics

Cannot use [goalup]. At

8

Verbal conversation about unfamiliar topics

conversation level utterances
must be above a complex
phrase otherwise they will be
marked as [efd] or [ed].
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Appendix G. Continued from 6.3.6.2: statistical sentences from post hoc analyses
The effect of severity on spontaneous verbal utterances was significant F (2,50) = 13.87, p = 000. Post
hoc analyses indicated that the number of spontaneous verbal utterances was significantly higher in
the mild to severe (p =0.000) and moderate to severe (p = 0.000) groups. The effect of severity on
non-verbal utterances was significant F (2,50) = 11.541, p = 000 and significantly higher in the severe
compared to mild group (p =0.001) and the moderate to severe (p = 0.000) group. The number of selfcorrections was significantly affected by aphasia severity F (2,50) = 8.762, p = 001. Post hoc analysis
indicated that the number of self-corrections was significantly greater in the mild compared to severe
group (p = 0.000). Percent of errors self-corrected was significantly affected by aphasia severity F
(2,50) = 21.137, p = 000. Post hoc analyses indicated that the mild group had a significantly higher
percentage of self-corrections compared to the moderate (p = 0.001) and severe groups (p = 0.000)
and the moderate group had a significantly higher percentage of self-corrections compared to the
severe group (p = 0.050). The effect of aphasia severity on mean length of utterance (words) was
significant F (2,50) = 22.619, p = 000. Post hoc analyses indicated that the mild group had a
significantly higher mean length of utterance compared to the moderate (p = 0.034) and severe groups
(p = 0.000) and the moderate group had a significantly higher mean length of utterance compared to
the severe group (p = 0.001).The effect of aphasia severity on mean length of utterance (morphemes)
was significant F (2,50) = 21.649, p = 000. Post hoc analyses after Bonferroni correction indicated
that the mild group had a significantly higher mean length of utterances (morphemes) compared to the
moderate (p = 0.043) and severe groups (p = 0.000) and the moderate group had a significantly higher
mean length of utterance (morphemes) compared to the severe group (p = 0.001). Aphasia severity
significantly affected the number of total utterances in a session F (2,50) = 4.051, p = .023. In post
hoc analysis the severe group had significantly fewer total utterances than the moderate severity group
(p = 0.019). Aphasia severity significantly affected the number of total words in a session F (2,50) =
17.695, p = .000. Post hoc analyses demonstrated that the number of total words in a session was
significantly higher in the mild group compared to the severe group (p = 0.000). And the moderate
severity group said significantly more words than the severe group (p = 0.000). Aphasia severity
significantly affected the percent of total words that had errors F (2,50) = 7.689, p = .001. Post hoc
analyses indicated that the number of total words with errors was significantly lower in the mild group
compared to the severe group (p = 0.003). And the moderate severity group had significantly less
percentage of total words with errors compared to the severe group (p = 0.010). The effect of aphasia
severity on utterances per minute was significant F (2,50) = 4.053, p = 023 with the moderate severity
group having a significantly higher utterance per minute ratio than the severe group (p= 0.019). The
effect of aphasia severity on words per minute was significant F (2,50) = 16.825, p = 000. Post hoc
analyses revealed that the mild severity group and the moderate severity group had a significantly
higher words per minute ratio compared to the severe group, (p= 0.000) and (p=0.000) respectively.
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The effect of aphasia severity on mean turn length (words) was significant F (2,50) = 12.063, p = 000.
Post hoc analyses indicated that the mild severity group and the moderate severity group had a
significantly higher mean turn length compared to the severe group (p= 0.000) and (p=0.008)
respectively. Aphasia severity significantly affected the number of cues used successfully in a session
F (2,50) = 6.137, p = .004, as significantly less cues were used with success in the mild compared to
severe severity groups (p= 0.003). Aphasia severity significantly affected the number of total cues
used F (2,50) = 7.660, p = .001. Post hoc analyses indicated that significantly less cues were used in
total in the mild compared to severe severity groups (p= 0.001). The effect of aphasia severity on the
total utterances used by the therapist was significant F (2,50) = 11.086, p = 000. In a post hoc analysis
there were significantly less utterances by the therapist in the mild compared to severe group (p=
0.000).
All other variables (Table 41, 42 in Chapter 6) did not meet significance in post hoc testing p > 0.05.
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